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Foreword
« For more than 25 years I have looked at the little fruit fly Drosophila and 
each time I find fresh delight. 
When I see Drosophila under moderate magnification of a binocular 
microscope I marvel at the clear cut form of the head with giant red eyes, 
the antennae, and elaborate mouth parts; at the arch of the sturdy thorax 
bearing a pair of beautifully iridescent, transparent wings and three pairs of 
legs; at the design of the simple abdomen composed of a series of ringlike 
segments. A shining, waxed armor of chitin entirely covers the body of the 
insect. In some regions this armor is bare, but in other regions there arise 
short or long outgrowths, the bristles, strong and wide at the base and 
gently tapering off to a fine point. Narrow grooves, as in fluted columns with 
a slightly baroque twist, extend along their lengths. A short stalk fits each 
bristle into a round socket within the body armor so that the bristle can be 
moved within this articulation. »
Curt Stern
American Scientist, Vol. 42, No. 2 (APRIL 1954), pp. 212-247
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Preface
Two host defense strategies, called resistance and tolerance, have recently 
been conceptualized in the field of immunology. Resistance involves 
mechanisms that sense, signal, and eliminate microbial invaders. However, 
the host may also elevate its tolerance to infection as a defense strategy, 
by minimizing the damage caused by the infection. Our understanding of 
cellular and molecular mechanisms underlying resistance and tolerance 
remains limited, but recent advances shed light on the complexity of these 
processes. 
The following introductory chapter first discusses the importance of 
understanding insect immunity in the context of global epidemics caused 
by arthropod-borne viruses. The second part gives an overview of our 
current knowledge about immunity in Drosophila, mosquitoes, and its 
conservation with mammalian innate immune pathways. Going beyond the 
established role of RNA interference in antiviral defense, the contribution 
of three canonical immune pathways (Toll, Imd and Jak-Stat) and other 
cellular pathways, such as autophagy, is described. In recent years, external 
factors, such as the presence of endosymbionts or the composition of 
the microbiota, have been shown to strongly affect immune responses to 
pathogens; they are discussed in the third part. Finally, concepts of immune 
tolerance and resistance are defined in the context of antiviral defense in 
the last part. 
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Insects and transmission of arthropod-borne 
viruses
Insects are among the most diverse and numerous animals on earth 
and populate almost every habitat (1). As agricultural pests, they cause 
severe economic losses by damaging and killing crops, but insects also 
pose an important threat to human and animal health. Indeed, insects are 
vectors for numerous pathogens, including viruses, bacteria, protozoa and 
nematodes. Over 500 arthropod-borne viruses (arboviruses) have been 
identified, among which ~100 are harmful to humans (2). Most arboviruses 
are RNA viruses from the families of Bunyaviridae (e.g. Rift Valley fever 
virus, La Crosse virus), Togaviridae (e.g. Chikungunya virus) and Flaviviridae 
(e.g. West Nile virus, WNV; Dengue virus, DENV; Yellow fever virus) (3).
Due to increased global travel and urbanization, adaptation of insects to 
new habitats, and possibly climate change, arboviruses are spreading from 
tropical areas to new territories (4). For example, the incidence of DENV 
infection increased 30-fold over the last 50 years and the virus is estimated 
to infect 390 million people annually (5). Recently, DENV infections not 
associated with travel to endemic countries have been reported in Florida 
and France (6, 7). The rapid spread of WNV throughout Northern America 
(8) and the (re-)emergence of Chikungunya in Africa, Asia, South America, 
the Caribbean, and Southern Europe (9-13) exemplifies how introduction of 
arboviruses into new territories and adaptation of existing arboviruses to 
new vectors can cause epidemics. Insect vector control is instrumental to 
prevent the spread of arboviruses, but insecticide resistance is a threat to its 
effectiveness. Other vector control tools are therefore urgently needed (14).
Arbovirus infection of the vector is established upon blood-feeding of a 
susceptible female mosquito on a viremic vertebrate host. Within the insect 
vector, arboviruses have a complex life cycle that includes replication in 
the midgut, followed by systemic dissemination via the hemolymph and 
the salivary glands (15). Transmission of an arbovirus to a naive vertebrate 
host during blood-feeding requires high viral titers in the saliva. Anatomical 
and immunological barriers affect the ability of the virus to reach such titers 
and thus to accomplish successful transmission to a naive host. Despite 
efficient replication, arboviruses do not cause overt pathology and are only 
associated with minor fitness costs in the insect vector (16), suggesting 
that the insect immune system restricts virus infection to non-pathogenic 
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levels. Understanding the mechanisms of insect antiviral immunity may 
provide opportunities for restricting the spread of arboviruses.
Insect innate immunity
Innate immunity provides the first line of defense against microbial invaders 
and is defined by its rapid activation following pathogen recognition by 
germline-encoded receptors. These receptors recognize small molecular 
motifs that are conserved among classes of microbes, but are absent from 
the host, such as bacterial cell wall components and viral double-stranded 
(ds) RNA. Collectively, these motifs are called pathogen-associated 
molecular patterns (PAMP). Innate immunity is traditionally distinguished 
from adaptive immunity, which emerged ~500 million years ago in 
vertebrates (17). Adaptive immunity is based on pathogen recognition by a 
large repertoire of highly diverse antigen receptors generated by somatic 
gene rearrangements. In contrast to innate immunity, the adaptive immune 
system is endowed with long-term memory that allows a more rapid and 
robust response upon re-exposure to previously encountered pathogens. 
Whether invertebrates are also capable of generating immunological 
memory is a long-standing matter of debate. The extreme diverse repertoire 
of isoforms of the immunoglobulin domain containing receptor DSCAM 
(Down syndrome cell adhesion molecule) with a role in specific immunity 
in Drosophila and Anopheles gambiae (18, 19), as well as the existence of 
memory traits in the immune systems of several invertebrate species (20, 
21) challenged the paradigm that anticipatory immunity and memory were 
exclusive to the vertebrate immune system.
The fruit fly Drosophila melanogaster is a powerful model to study innate 
immunity. Over the years, detailed insights into antibacterial and antifungal 
immunity have been obtained, greatly facilitated by the extensive genetic 
toolkit for this model organism (22, 23). However, Drosophila is also a host 
to numerous viruses (24). Natural populations of Drosophila melanogaster 
can be infected with RNA viruses, such as Sigma virus, (DmelSV) (25, 
26), Drosophila C Virus (DCV) (27), and Nora virus (28). Several other RNA 
viruses efficiently replicate in Drosophila after experimental inoculation, 
including Cricket paralysis virus (CrPV) (29), Drosophila X virus (DXV) (30), 
Flock House virus (FHV) (31, 32), Sindbis virus (SINV) (33), and Vesicular 
stomatitis virus (VSV) (34). Recently, two DNA viruses from the Nudivirus 
15
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genus have been identified in wild populations of Drosophila innubila (35) 
and Drosophila melanogaster (36). Frequently used experimental infection 
models are presented in Table 1.
Antiviral defense mechanisms of insects remain poorly understood. Many 
studies on antiviral immunity have been performed in Drosophila, but 
the functional dissection of vector competence in mosquitoes is gaining 
momentum. The completion of the genome sequence of important vector 
species (Anopheles gambiae, Aedes aegypti and Culex quinquefasciatus) 
and the development of genome-wide transcriptomics and RNA interference 
(RNAi) technology has been instrumental in studies of mosquito immunity 
(37-39). Both in Drosophila and mosquitoes, RNAi plays a crucial role in the 
defense against RNA viruses (40-43). More recently, the piwi-interacting 
(pi) RNA pathway, a related but distinct small RNA silencing pathway, has 
also been implicated in antiviral defense in Aedes mosquitoes (44-48). 
Small RNA-based antiviral defense is not discussed in this chapter, but 
have been recently reviewed elsewhere (49-51).
Inducible immune pathways
The Toll and Imd (Immune deficiency) pathways mediate systemic immunity 
against bacteria and fungi in Drosophila (for detailed reviews, see refs (22, 
23)), and have more recently been implicated in antiviral defense responses 
(Fig. 1). 
The Toll pathway
Upon infection by Gram-positive bacteria or fungal pathogens, the Toll 
pathway is activated by two pathogen-sensing systems. First, the PAMPs of 
entomopathogenic fungi (beta-glucans) and Gram-positive bacteria (Lysine-
type peptidoglycan) are detected by the pattern-recognition receptors Gram-
negative binding protein (GNBP)-1 and -3, and peptidoglycan recognition 
proteins (PGRP)-SA and -SD, respectively. Second, the proteolytic 
activity that accompanies microbe invasion of the hemolymph and can be 
considered a danger signal, is sensed by the protease Persephone (52, 53). 
Both branches initiate an extracellular signaling cascade that leads to the 
cleavage of pro-Spätzle into the active cytokine Spätzle, which then binds 
the transmembrane receptor Toll. Subsequently, an intracellular signaling 
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pathway leads to the translocation of the NF-ĸB like transcription factors Dif 
(Dorsal-related immunity factor, inadults) and Dorsal (in larvae and adults) 
to the nucleus. Here, Dif and Dorsal bind to NF-ĸB responsive elements, 
thereby inducing the expression of many genes, including a specific set of 
antimicrobial peptides (AMPs), such as Drosomycin and Defensin.
The Imd pathway
Gram-negative bacteria activate the Imd pathway via the detection of 
monomeric or polymeric diaminopimelic (DAP)-type peptidoglycans by 
PGRP-LC and -LE. These receptors then recruit Imd and activate the 
intracellular signaling cascade that leads to the activation of a NF-ĸB like 
factor, Relish, after cleavage of its inhibitory IĸB domain. Upon activation, 
the Rel domain of Relish translocates to the nucleus and induces 
transcription of set of immune genes and AMPs that is distinct from those 
induced by Toll, such as Diptericin and Cecropin. Collectively, the Toll 
and Imd pathways induce factors that participate in killing of microbes, 
phagocytosis, production of reactive oxygen species, and the melanization 
cascades that are essential for wound healing and pathogen sequestration 
(23). Within minutes after pathogen sensing, a cocktail of AMPs is secreted 
by the fat body (54). As a consequence, the concentration of AMPs in the 
hemolymph rapidly increases over time, each AMP displaying a specific 
concentration range and dynamics (55). Although Toll and Imd activate 
many different genes, induction of AMP expression is traditionally used as 
a read-out for Toll and Imd activation (56-59).
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Figure 1 |  Inducible immune pathways in Drosophila.   
Toll pathway: Detection of pathogen-associated molecular patterns 
(PAMPs) of fungi (beta-glucans) and Gram-positive bacteria (Lys-type 
peptidoglycan) or danger signals (such as proteolytic activity in the 
hemolymph) triggers a proteolytic cascade, leading to cleavage of the 
precursor of the dimeric cytokine Spätzle. Mature Spätzle binds to the 
membrane-anchored Toll receptor, thereby inducing its dimerization. 
Three intracellular Death domain–containing proteins, MyD88, Tube, 
and Pelle are then recruited. The kinase Pelle is likely responsible for 
phosphorylation of Cactus, thereby directing its degradation by the 
proteasome. Dif (Dorsal-related immunity factor) is then able to translocate 
to the nucleus, where it induces transcription of immune genes, 
including the antimicrobial peptides (AMPs) Drosomycin and Defensin.  
Imd pathway: Binding of microbial diaminopimelic (DAP)-type peptidoglycan 
(PGN) from Gram-negative bacteria to peptidoglycan recognition proteins 
(PGRP-LC or PGRP-LE) induces the recruitment of the adaptor molecules 
Imd (Immune deficiency) and dFADD (Drosophila Fas-associated death 
domain). This leads to activation of the caspase DREDD (Death related 
ced-3/Nedd2-like protein) and of TAK1 (Transforming growth factor-β-
activated kinase 1). TAK1 and its adaptor TAB2 (TAK1-binding protein 2) 
activate a complex of IĸB Kinase (IKK)-β and IKK-ү (also known as ird-
5 and kenny, respectively), which then directs phosphorylation of Relish, 
followed by its proteolytic cleavage by DREDD. The inhibitory domain (IĸB) 
of Relish remains stable in the cytoplasm, whereas the REL domain of Relish 
translocates to the nucleus and induces transcription of immune genes, 
such as the AMPs Diptericin and Attacin. PGRP-LE can act as an intracellular 
receptor, and in a truncated form as an extra-cellular receptor.  
Jak-Stat pathway: Upon virus infection, the Janus kinase (Jak) - 
signal transducers and activators of transcription (Stat) pathway is 
activated, presumably by binding of an unpaired (Upd) cytokine to the 
dimeric Domeless receptor. The Jak tyrosine kinase Hopscotch (Hop), 
in association with Domeless, then phosphorylates both itself and the 
cytoplasmic tail of Domeless, creating binding sites for Stat92E. Upon 
binding, Stat92E is phosphorylated, dimerizes and translocates into the 
nucleus where it induces transcription of target genes that contain Stat 
binding sites in their promoters, such as virus induced RNA-1 (vir-1).  
RNAi: Viral double-stranded RNA (dsRNA) is recognized and processed 
by Dicer-2 into small interfering (si) RNAs, which are then incorporated 
in an Argonaute-2 (Ago-2) containing RNA-induced silencing complex 
20
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(RISC). Within RISC, these siRNAs guide the recognition and cleavage of 
complementary viral RNA sequences, thereby restricting virus replication. 
Autophagy: Vesicular stomatitis virus binds to the transmembrane 
receptor Toll-7 and induces autophagy. This is likely mediated through 
negative regulation of the phosphatidylinositol 3-kinase (PI3K)-Akt kinase 
pathway. It is likely that cell debris or damaged virus-infected cells release 
or act as immunostimulatory damage-associated molecular patterns that 
activate immune signaling pathways via undefined mechanisms. 
The Jak-Stat pathway
A third evolutionary conserved pathway, Jak-Stat (Janus kinase – signal 
transducers and activators of transcription), originally studied for its role 
in Drosophila development (60-62), was recently shown to participate 
in antibacterial and antiviral immunity (63-66). The pathway is activated 
by three ligands of the Unpaired (Upd) family. The founding member is 
Upd; two additional ligands, Upd2 and Upd3, have been identified by 
sequence homology (67). No obvious sequence homologies between Upd 
and vertebrate proteins exist, but predicted alpha-helical structures seem 
to be reminiscent of canonical mammalian cytokines (i.e Interleukin-6), 
characterized by four-helix bundles that bind to cytokine receptors (68). 
The stimuli and mechanisms that trigger Upd secretion remains thus far 
undefined. Binding of the Upd proteins to their receptor, domeless, triggers 
intracellular signaling by stimulating the receptor-associated Janus kinase 
(Jak), named hopscotch (hop). Once activated, hopscotch phosphorylates 
the receptor domeless, which becomes a docking site for the Drosophila 
Stat protein, Stat92E. After phosphorylation by hopscotch, Stat92E 
dimerizes and translocates to the nucleus to direct transcription of genes 
with Stat binding sites in their promoter (Fig. 1) (63).
Evolutionary conservation of innate pathways
The importance of Drosophila as a model for innate immunity relies on 
the evolutionary conservation of immune signaling pathways. Comparative 
genomics of Drosophila and the major vector mosquitoes Anopheles 
gambiae, Aedes aegypti and Culex quinquefasciatus suggest a conserved 
system of immune signaling pathways with the potential for evolutionary 
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plasticity to adapt to new pathogens (39, 69, 70). Whereas the core signaling 
pathways have remained highly conserved, the upstream receptors and 
downstream effectors have diverged quite significantly during evolution 
between vector mosquitoes and Drosophila melanogaster. Mosquitoes do 
not possess the Dif transcription factor of the Toll pathway, but rely on the 
Dorsal orthologs Rel1 (A. gambiae) or Rel1A and Rel1B (A. aegypti) and the 
Relish ortholog Rel2 (A. gambiae and A. aegypti) for expression of effector 
genes of the Toll and Imd pathways, respectively (69-71).
Evolutionary conservation of immune pathways even extends to the class 
of mammals. The Toll and Imd pathways of insects are strikingly similar to 
the mammalian Toll-like receptor (TLR) and Tumor Necrosis Factor (TNF) 
pathways, respectively. Mammalian TLRs contribute to innate antiviral 
immunity by sensing viral nucleic acids in endosomal compartments, 
leading to the activation of the NF-ĸB and IRF-3 transcription factors and 
production of cytokines, among which the potent antiviral type I interferons 
(72, 73). Also some AMPs seem to be conserved from plants to humans. For 
example, a Drosomycin-like Defensin in humans exerts antifungal activity in 
the skin (74). The TNF signaling pathway regulates basic cellular processes, 
such as inflammation and cell death, and is essential for innate and adaptive 
immune functions (75, 76). As a consequence, some mammalian viruses 
evolved strategies to counteract and manipulate TNF signaling (77). Jak-
Stat is a central signaling pathway that mediates the response to a wide 
range of growth factors and cytokines, including type I interferon (78). The 
mammalian pathway is comprised of four JAKs and seven STATs, whereas 
the invertebrate pathway has fewer family members for each component. 
However, the mechanisms for signal transduction remain identical (79). 
The role of Toll, Imd, and Jak-Stat pathways in 
antiviral defense
The central role of the Toll and Imd pathways in antimicrobial immunity of 
Drosophila and the importance of the TLR and Jak-Stat pathway in antiviral 
immunity in mammals (80, 81) are strong incentives to analyze the role 
of these pathways in antiviral immunity of insects. Expression of AMPs is 
often used as a proxy for Toll and Imd activation. Several studies failed to 
detect robust induction of AMP expression in virus infection (Table 2). For 
example, proteomic analyses of flies infected with the positive stranded 
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(+) RNA viruses DCV and FHV did not detect induction of AMP expression 
(82, 83). Microarray analyses and quantitative RT-PCR also failed to detect 
robust AMP induction in DCV and CrPV infection (84, 85). Furthermore, 
a microarray analysis of A. gambiae infected through a blood meal with 
O’nyong-nyong virus (ONNV) did not detect induction of components or 
downstream effectors of the Toll, Imd and Jak-Stat pathways at 14 days 
after infection (86). In the non-Dipteran insect, Apis mellifera (the honey 
bee) neither AMP secretion, nor a cellular melanization response was 
induced upon Acute bee paralysis virus infection (87). Together, these 
reports suggest that the Toll, Imd and Jak-Stat pathways do not play major 
roles in RNA virus infections in Drosophila and mosquitoes. Nevertheless, 
studies using other infection models suggest a more convoluted situation 
and are described below (Table 2).
Antiviral role of the Toll pathway
Drosophila infected with the dsRNA virus DXV produced robust levels of 
the AMPs Drosomycin and Metchnikowin at 24 h after inoculation (88). The 
level of induction was comparable to that triggered by systemic infection 
with the Gram-negative bacterium Escherichia coli. These AMPs are 
typically induced in a Toll (Drosomycin) or a Toll and Imd (Metchnikowin) 
dependent manner. Indeed, a role for the Toll pathway was suggested by 
a screen for DXV sensitivity among flies with defects in genes with known 
immune function. Among ~60 tested fly lines, a loss-of-function mutation 
in Dif, the Toll-activated NF-ĸB transcription factor, and a gain-of-function 
mutation in Toll increased the susceptibility to DXV infection. Both mutants 
succumbed faster to virus infection. Viral titers were higher in the Dif mutant, 
but remained close to control levels in the Toll mutant. A direct antiviral 
activity of the induced AMPs could not be established: over-expression of 
single AMPs in a Toll and Imd pathway double mutant did not affect viral 
load or overall survival. Hemocytes, the immune cells that circulate in the 
hemolymph, are more numerous in the Toll gain-of-function mutant (89). 
These results may thus suggest a role for phagocytosis or other hemocyte 
activities in control of virus infection.
Microarray-based transcriptional profiling of A. aegypti mosquitoes 
identified 240 genes that were upregulated after DENV infection via an 
infectious blood meal (90). Interestingly, among the induced genes were 
components of the Toll pathway, such as Toll, Spätzle, and Rel1A, as well 
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as Toll-dependent antimicrobial peptides such as Cecropin and Defensin. 
The importance of this pathway in DENV infection was supported by an 
increase in viral titers in the midgut after RNAi mediated knockdown of 
the Toll adaptor protein MyD88 (90). Other mosquito infection models 
also suggest a role for Toll in the response to virus infection. A differential 
display approach in midguts of Culex pipiens quinquefasciatus infected 
with WNV via a blood meal identified a transcript (CQ G12A2) that shares 
33% similarity with the A. aegypti Toll-like receptor (91). Furthermore, a 
microarray analysis of SINV infected A. aegypti detected a modest 1.8-
fold induction of the Toll dependent transcription factor Rel1 among the 
19 genes that were upregulated at one day after infection (92). However, 
neither Rel1, nor other canonical immune genes were induced at later time 
points (4 and 8 days after infection).
Antiviral role of the Imd pathway
Two studies suggested a role for the Imd pathway in the defense against 
RNA viruses in Drosophila. Several isogenic mutants of the Imd pathway 
displayed higher levels of viral RNA and increased mortality after CrPV 
infection (85). Mutants for the receptor PGRP-LC, as well as downstream 
signaling components Tak1, ird5, kenny, and Relish were more sensitive 
to infection. However, mutants of two other pathway components, Imd 
and dFADD did not show an increased CrPV susceptibility. This might 
originate from the position of Imd at a branch-point of the pathway, which 
transduces a signal into two distinct arms of the pathway downstream of 
that adaptor protein. The authors thus suggest that distinct branches of the 
Imd pathway contribute differently to antiviral immunity. Despite the genetic 
support for a role for the Imd pathway in control of CrPV infection, no AMP 
induction could be detected, suggesting that activation of the Imd pathway 
and AMP induction can be uncoupled in the response to virus infection.
In another study, a transgenic fly line expressing a SINV replicon was crossed 
to Toll, Imd and Jak-Stat mutants to screen for host factors modifying virus 
replication (93). Mutants for intracellular components of the Imd pathway, 
such as Relish, Imd, dFADD and Dredd, and the Jak-Stat mutant Stat92E 
showed higher viral RNA loads. No difference was observed in Toll pathway 
mutants. In accordance, the Imd-dependent AMP Diptericin and the partially 
Imd-dependent AMP Metchnikowin were induced by virus replication. Viral 
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RNA loads remained normal in mutants for PGRP-LC and PGRP-LE, the 
receptors that bind peptidoglycans to initiate the Imd pathway in a bacterial 
infection. Thus, it is likely that yet undefined receptors detect intracellular 
viral RNA and activate the Imd pathway.
Transcriptional profiling of the immune response of A. gambiae to another 
alphavirus, ONNV, revealed altered expression of Imd pathway genes early 
after systemic infection by injection. The IĸB Kinase IKK-1, a component 
of the Imd pathway, was downregulated at 4 days after inoculation. In 
contrast, the AMPs Diptericin and Cecropin were modestly upregulated 
(94). However, silencing of the Imd dependent transcription factor Rel2 
did not significantly affect virus titers, suggesting a limited contribution of 
this pathway to antiviral defense in Anopheles. This observation is also 
consistent with the lack of a significant induction of immune genes in 
ONNV-infected A. gambiae at 14 days after infection in another study (86). 
Analyses of the transcriptome of Drosophila infected with Sigma virus, a 
negative stranded (-) RNA virus, revealed that two PGRPs and four Imd 
dependent AMPs were potently induced (95). Nevertheless, another study 
found no activation of the Toll, Imd and Jak-Stat pathways in response to 
Sigma virus (96)0 . The discrepancies between these reports may be due 
to differences in experimental set-up, including the genetic background of 
the Drosophila strains analyzed.
Antiviral role of the Jak-Stat pathway
A microarray analysis on DCV-infected Drosophila identified 138 genes 
that were upregulated at 24 and 48 h after infection (84). Two thirds of 
these genes did not overlap with those induced upon bacterial or fungal 
infection. Several of the virus-induced genes contained Stat binding sites 
in their promoters, including virus induced RNA-1 (vir-1), the antimicrobial 
peptide Listericin/CG9080, and a putative GNBP-like receptor, CG12780 
(84). Different DCV strains could activate these genes, but UV-inactivated, 
non-infectious DCV particles or dsRNA did not (97), suggesting that 
active virus replication or virus-induced cellular damage and cell debris 
is required for activation of Jak-Stat signaling. Mutants for the Jak kinase 
hop expressed lower levels of vir-1, harbored higher viral loads, and 
succumbed faster to infection (84). Vir-1 null mutants, however, did not 
show an enhanced sensitivity to DCV infection, indicating that the Jak-
Stat pathway is important for antiviral defense, but that vir-1 is not a direct 
27
Introduction
1
antiviral effector. Interestingly, the tissues with the highest vir-1 expression 
were not the same as the ones with the highest virus levels, suggesting 
that a putative cytokine alerts non-infected cells to the presence of virus 
via Jak-Stat activation. 
Comparative genomic analyses of Drosophila, A. gambiae, and A. aegypti 
identified orthologs for core components of the Jak-Stat pathway (domeless, 
hop, Stat, PIAS, SOCS) in these insects (69, 98). The role of the Jak-Stat 
pathway in antiviral defense in A. aegypti was suggested by a transcriptome 
analysis that detected an upregulation of the receptor domeless and three 
other Jak-Stat genes at 10 days after DENV infection via an infectious blood 
meal (90, 98). In accordance, RNAi mediated knockdown of hop, a positive 
regulator of the Jak-Stat pathway, resulted in increased virus titers in the 
mosquito. Furthermore, knockdown of the Jak-Stat dependent, DENV-
induced genes Q1HR00/Dengue virus restriction factor 1 (DVRF1) and 
AAEL000896/DVRF2 resulted in higher DENV replication in the midgut. An 
additional observation hinting at a role for the Jak-Stat pathway in antiviral 
defense consists of the downregulation of expression of four Cecropin 
A-like AMPs and one defensin l-like AMPs (previously suggested to be Jak-
Stat dependent (98)), in DENV, WNV, and Yellow fever virus infection of A. 
aegypti (99).
Do Toll, Imd and Jak-Stat mediate antiviral defense 
in insects?
Together, above-mentioned studies imply that the Toll, Imd, and Jak-
Stat pathways, classically implicated in antimicrobial responses, can also 
contribute to antiviral defense in some virus infections in Drosophila and 
mosquitoes. Nevertheless, the literature remains fragmentary and in some 
cases even contradictory. For example, two studies obtained conflicting 
results regarding the induction of AMPs in Sigma virus infections of 
Drosophila (95, 96). Moreover, for viruses within the same family, different 
model systems yielded different conclusions. Within the alphavirus 
genus of the Togaviridae, a study that used transgenic flies expressing 
a SINV replicon implicated the Imd pathway in antiviral defense (93). In 
contrast, neither a transcriptome analysis of SINV in blood-fed A. aegypti 
nor a functional assay in systemic ONNV infected A. gambiae supported 
a major function for Imd in the defense against alphaviruses (92, 94). It 
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remains unclear whether the observed differences are due to the different 
experimental approaches, to the unique properties of these viruses, or to 
the different host species. More generally, the limited consistency between 
infection models, inoculation routes, and other experimental conditions 
makes it difficult to identify consistent patterns in the activation of specific 
immune pathways in response to virus infection.
Standardized, systematic approaches will be required before firm 
conclusions can be drawn about the antiviral activity of specific pathways, 
especially in relation to host species, routes of inoculation, virus family, and 
pathogenicity. One such study analyzed the transcriptional response of A. 
aegypti to infection with three flaviviruses, DENV, WNV, and Yellow fever 
virus, under the same experimental conditions (99). Thirty-five genes were 
differentially expressed at 1 day after infection by all three viruses. Overlap 
between these viruses was more limited or even absent at later stages, 
suggesting that the specific response of the host may be unique for each 
virus. Finally, we note that although transcriptomic approaches are essential 
to detect inducible responses, they should be extended with functional 
assays using genetic mutants or other gene inactivation methods before 
conclusions can be drawn about the importance of specific pathways in 
antiviral defense.
Additional antiviral responses
Vago
Vago is one of the genes with the highest induction upon DCV infection of 
Drosophila, but it does not contain a Stat-binding site in its promoter (84). 
This gene encodes a 160 amino acid peptide that is mainly expressed in the 
fat body, the main target organ for DCV (84). Viral replication is enhanced 
in the fat body of Vago null mutants, which suggests a direct role for Vago 
in restricting virus infection (100). Strikingly, Vago induction depends on the 
DExD/H-box helicase domain of Dicer-2, but not on the Toll, Imd and Jak-
Stat signaling pathways. Dicer-2 is the ribonuclease that processes viral 
dsRNA into small interfering (si) RNAs to initiate an antiviral RNAi pathway. 
Yet, Argonaute 2 and R2D2, other central actors of the RNAi pathway, are 
not involved in Vago induction. These results suggest that Dicer-2 is a 
sensor for viral dsRNA that not only initiates an antiviral RNAi response, but 
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also activates an inducible antiviral response. Strikingly, the DExD/H-box 
helicase domain of Dicer-2 is similar to the helicase domain of the RIG-I like 
helicases RIG-I and MDA-5 that sense viral RNA and initiate an interferon 
response in mammals. This is likely due to convergent evolution, as Vago 
does not seem to be evolutionary conserved in other insect species, such 
as Aedes, Anopheles, or Culex species.
Autophagy pathway
Autophagy is a mechanism for degradation of cell components by 
lysosomes that is essential for growth and homeostasis. The interaction 
between viruses and the autophagy pathway is complex. Some viruses 
exploit the pathway for production of membranous replication organelles 
or for non-lytic virus secretion (101). In plants, autophagy is a well-known 
defense mechanism (102), but its role in antiviral immunity in animals has 
only recently been demonstrated in Herpes simplex virus and SINV infection 
in mice, and in VSV infection in Drosophila (103, 104). VSV is a (-) sense 
RNA arbovirus from the Rhabdoviridae family that, under experimental 
conditions, also infects Drosophila (105). Adult flies deficient for components 
of the autophagy pathway support increased levels of VSV replication. As 
a consequence, mutant flies succumb to VSV infection, whereas wild-type 
control flies do not. The detection of the VSV-G glycoprotein by an unknown 
receptor results in downregulation of the phosphatidylinositol 3-kinase 
(PI3K)-Akt pathway that under normal nutritional conditions represses 
autophagy. Thereby, VSV mimics a starvation state that favors autophagy 
in virus-infected cells. More recently, it was demonstrated that VSV binds 
Toll-7, a member of the Drosophila Toll family, at the cell surface, thereby 
activating autophagy (106).
A role for autophagy is also suggested by the observation that a polymorphism 
in the Drosophila ref(2)p gene confers resistance against Sigma virus, another 
member of the Rhabdoviridae family (107, 108). Intriguingly, ref(2)p is involved in 
autophagy (109, 110) but also in Toll dependent signaling (111). Nevertheless, 
direct evidence that the antiviral effect of ref(2)p is mediated by its role in 
autophagy is thus far lacking. In contrast to the observations in VSV-infected 
flies, the PI3K-Akt-Tor pathway seems to be proviral in SINV infection of 
Drosophila and A. albopictus. Moreover, SINV infection activates this pathway, 
thereby increasing viral replication and promoting cell survival (112).
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Heat-shock response
The alphavirus O’nyong nyong virus (ONNV) is the only known arbovirus 
that is transmitted by A. gambiae. A microarray analysis of blood-fed 
ONNV infected A. gambiae did not detect induction of the Toll, Imd, and 
Jak-Stat pathways, but identified Hsc70B as the gene with the strongest 
induction at 14 days after infection (86). Hsc70B is a chaperone protein of 
the heat-shock protein family that can be induced by a variety of stresses. 
Knockdown of Hsc70B increased ONNV replication in head, thorax, and 
abdomen, suggesting an important role in control of virus infection (113). 
Interestingly, a proteomic analysis on FHV infected Drosophila S2 cells also 
revealed robust induction of the heat-shock proteins Hsp23 and Hsp27 (83). 
Heat-shock responses are known to play various roles in virus infections 
in mammals (reviewed by (114)). For example, heat-shock proteins may 
constitute a danger signal that initiates innate immune responses (115). 
The role of the heat-shock response in insect immunity awaits further 
characterization. Strikingly, the Hsp70/Hsp90 machinery is critical in loading 
of siRNAs into the RNAi effector complex RISC (RNA-induced silencing 
complex) in flies (116). An intriguing and testable hypothesis therefore is 
that the induction of heat shock proteins upon virus infection facilitates 
loading of RISC with viral siRNAs, thereby strengthening the antiviral RNAi 
response.
Contribution of symbionts to antiviral immune 
defenses
Wolbachia
Wolbachia is an obligate intracellular Gram-negative bacterium from the 
Rickettsiales order that infects ~65% of invertebrate species, including 
nematodes, crustaceans and insects (117). Its high prevalence is based 
on the remarkable ability to manipulate the reproductive system of the 
host via cytoplasmic incompatibility. This mechanism provides a selective 
reproductive advantage to infected females ensuring efficient spread 
of Wolbachia in the population (118). Many wild populations, as well as 
laboratory stocks of D. melanogaster carry Wolbachia (119). Strikingly, 
Wolbachia infected flies are less sensitive than Wolbachia-free flies to 
infection with the RNA virus DCV, which is associated with a reduction in 
viral titers (120, 121). Wolbachia also provides protection against FHV and 
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Nora virus-induced mortality, but this is not associated with a decrease in 
viral titers (121). Wolbachia does not increase resistance to experimental 
infection with the DNA virus Invertebrate iridescent virus 6 (121), but it 
remains to be established whether the same holds true for a natural DNA 
virus pathogen of Drosophila. Additionally, some, but not all Wolbachia 
strains protect Drosophila simulans against DCV and FHV infection, 
suggesting an evolutionary conserved, but strain specific mechanism for 
Wolbachia mediated antiviral protection (122).
Whereas Wolbachia-induced viral resistance may contribute to the 
evolutionary success of the symbiont, its mechanism remains unclear. 
An intriguing hypothesis is that Wolbachia instructs the immune system 
to respond faster and more potently to a microbial challenge (immune 
priming). However, the lack or low induction of AMP expression in 
D. melanogaster (123) or D. simulans (124) infected with Wolbachia argues 
against this hypothesis. In accordance, two different strains of Wolbachia 
(wMelPop or wMel) inhibited DENV replication in Drosophila, but did not 
induce consistent changes in expression of AMPs and other immune 
genes (125). Moreover, Wolbachia did not alter survival after challenge with 
several bacteria, including Pseudomonas aeruginosa, Serratia marcescens 
and Erwinia carotovora (123). These results suggest that the Toll and Imd 
pathways and downstream AMPs do not mediate Wolbachia induced viral 
resistance in Drosophila.
Surprisingly, Wolbachia does not naturally infect A. gambiae and A. aegypti, 
although it is found in other mosquito species. Nevertheless, Wolbachia 
inhibited DENV midgut replication and subsequent dissemination to thorax 
and head in A. aegypti (126). Infection of A. aegypti with the more virulent 
strain, wMelPop-CLA, reduced the lifespan of the mosquitoes by 50% (127) 
and limited the replication of DENV, Chikungunya virus, and Plasmodium 
gallinaceum (128). As the specific responses against pathogens as diverse 
as RNA viruses and eukaryotic parasites are likely to be very dissimilar, these 
results suggest that Wolbachia interferes with global immune responses. 
Indeed, transcriptome analyses showed that Wolbachia induces several 
immune genes in A. aegypti, including components of the Toll (PGRP-SA, 
GNBP, Rel1), Imd (Rel2), Jak-Stat (SOCS36E), and melanization pathways, 
as well as their downstream effectors, such as AMPs (Cecropin and 
Defensin) and thio-ester containing proteins (90, 125, 128, 129). Activation 
of these pathways by Wolbachia is not well understood. Toll activation 
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seems to be mediated through the production of reactive oxygen species 
(ROS) and activation of the NADPH oxidase upon infection by the bacterium 
(130). These results are in striking contrast to those obtained in Drosophila, 
in which these pathways were not activated (123, 124). The lack of co-
evolution with the symbiont may provide a partial explanation for activation 
of inducible immune pathways by Wolbachia in mosquitoes.
Competition between bacterium and virus for essential resources may 
provide an alternative explanation for the antiviral effect of Wolbachia. 
Indeed, Wolbachia invades several tissues in A. aegypti, including brain 
and fat body, which are also target organs for DENV. In Wolbachia-infected 
mosquitoes, DENV levels in these tissues were strongly reduced, which 
may suggest a cell-autonomous antiviral effect (128). Moreover, Wolbachia 
is unable to synthetize cholesterol and has to obtain it from host cells 
(131, 132). Since cholesterol is also required for flavivirus and alphavirus 
replication, the presence of Wolbachia could compete for cholesterol, 
thereby restricting DENV infection and pathogenesis (133, 134). Two lines 
of evidence exclude a role for the RNAi pathway in Wolbachia mediated 
protection. Wolbachia inhibits DENV replication in the A. albopictus derived 
C6/36 cell line that lacks functional Dicer-2 expression (135). Furthermore, 
Wolbachia infection renders Argonaute-2 mutant flies resistant to WNV 
infection (136).
Wolbachia mediated protection from arbovirus infection inspired the 
development of a new DENV control strategy that is based on a population 
replacement approach. In 2011, a groundbreaking field trial demonstrated 
the successful replacement of a wild A. aegypti population with Wolbachia 
infected mosquitoes with reduced susceptibility to DENV (137, 138). 
Follow-up studies revealed the successful establishment of Wolbachia in 
release areas, some persisting for three consecutive years (139). However, 
implementation of more virulent Wolbachia strains has been hindered by 
the high fitness costs for host mosquitoes. Ongoing studies in Dengue 
endemic countries such as Indonesia and Vietnam will hopefully give 
insights into the efficiency and feasibility of this intervention method (140). 
Other organisms that boost the mosquito’s immune response, such as 
the entomopathogenic fungus Beauveria bassiana, might be exploited in a 
similar fashion to limit transmission of arboviruses (141).
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Gut microbiome
The gut lumen of mammals and insects contains a dense population of 
mutualistic bacteria, referred to as the gut microbiome. This bacterial 
community plays crucial roles in host physiology, such as nutrition and 
digestion (142), immune system maturation (143, 144), insulin-signaling 
and metabolic homeostasis (145-147), and mating preference (148). In 
Drosophila, the resident gut bacteria activate Imd signaling in intestinal 
epithelial cells. As a consequence, the transcription factor Relish localizes 
to the nucleus; nevertheless, only very low levels of AMPs are produced. 
The homeobox gene Caudal represses NF-ĸB dependent AMP expression, 
preventing clearance of the microflora from the gut lumen (149). Knockdown 
of Caudal results in AMP upregulation, a modification of the resident 
bacterial population, and a predominance of a pathogenic bacterium, 
resulting in gut apoptosis and pathology. This and other studies imply that 
negative regulation of the Imd pathway is crucial for maintenance of the 
equilibrium of the gut microbiome (146, 147, 150-152).
Several studies suggest a role for the gut microbiome in arbovirus infection 
and transmission by mosquitoes. Elimination of gut bacteria by antibiotic 
treatment results in higher DENV loads in A. aegypti midguts (90). Several 
bacterial species of the microbiome contribute to virus control in the 
midgut, possibly through activation of immune pathways and induction of 
AMPs. In return, DENV indirectly diminishes the overall bacterial load, likely 
through upregulation of AMP expression, creating an intricate tripartite 
relationship between mosquito, virus, and gut bacteria (153). Two recent 
reports highlight the importance of the gut microbiome in virus infection in 
mice, although in these cases, the presence of gut bacteria enhanced virus 
transmission, replication and pathogenesis (154, 155).
Together, these studies imply that the gut microbiome is not merely a 
passive commensal population with limited functions in digestion, but that 
it also contributes to local and, perhaps, systemic immune responses. 
Gut bacteria influence local AMP production by epithelial cells, as well 
as systemic AMP secretion by the fat body (149, 156). This suggests the 
existence of cross-talk between these organs, possibly mediated by motile 
cells or secreted factors (156, 157). Understanding these interactions may 
provide opportunities to manipulate virus infection in insect vectors.
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Chapter 1
Immune resistance and tolerance 
The immune system is historically defined by its ability to detect, neutralize 
and eliminate pathogens, thereby protecting the host from excessive 
pathology. Many of those resistance mechanisms have been characterized. 
Resistance is essential to host protection, but often has a cost for host 
fitness. Not only is elimination of pathogen often accompanied by tissue 
damage, it also has an energetic cost that may become very high in the 
case of exuberant immune responses. The unavoidable consequence of 
immune defenses on host fitness is called immunopathology (158). For 
example, the reacting oxygen species (ROS) produced during infection to 
fight infection can also be toxic and cause severe damage, thereby reducing 
tolerance (159). Because mild immune responses are insufficient for 
pathogen neutralization and increase mortality, and overly strong immune 
responses are linked to high immunopathology, additional processes are 
needed to untangle those trade-offs. 
Medzhitov et al. (160) recently proposed that tolerance mechanisms, which 
limit tissue damage, and thus make strong immune responses sustainable 
for hosts, must exist along resistance mechanisms. Tolerance reduces the 
host susceptibility to tissue damage or other fitness costs, which may be 
inflicted by the pathogen itself or by the immune response. For example, 
the p38 MAP kinase (Dmp38b) has been implicated in regulating tolerance 
to Salmonella infection in Drosophila. Dmp38b-deficient flies exhibited 
lower survival rates than wild-type flies upon bacterial challenge, but did 
not harbor increased pathogen loads. The kinase was shown to regulate 
phagocytic encapsulation, thereby sequestering bacteria from extracellular 
areas and preventing damage to host tissues. This is a mechanism of 
tolerance, permitting the host to suppress infection-induced damage 
(161). Currently, the mechanisms of tolerance remain mostly undefined; the 
few studies available suggest that there is a wide diversity in tolerance 
mechanisms (162). Because multiple aspects of host physiology can be 
affected by pathogens and immunopathology, many tolerance pathways 
might collaborate to minimize the host’s vulnerability to infection. 
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Outline of this thesis
Research on insect immunity not only brings fundamental insights into 
highly conserved immune processes, but it may also contribute to the 
fight against insect-borne diseases. The aim of this thesis is to improve 
our understanding of antiviral defense mechanisms in Drosophila. We 
describe in chapter 2 a set of principles and methods that can be used 
for the analysis of tolerance and resistance against viruses in Drosophila. 
This includes all procedures necessary for fly stock preparation, virus 
preparation, and experimental infections. In chapter 3, we describe a novel 
mechanism for immune tolerance, consisting of the immunoregulatory 
function of the histone-modifying enzyme G9a during viral infection in 
Drosophila. We demonstrate that G9a epigenetically dampens the Jak-Stat 
pathway to prevent immune hyperactivation and immunopathology upon 
RNA virus infection. In chapter 4, we provide evidence that the heat shock 
response is involved in resistance to virus infection. We found that heat 
shock-deficient flies are more sensitive to viral infections, whereas flies with 
a constitutive activated heat shock response are protected from infection. 
Next, we describe in chapter 5 the identification of a novel antiviral factor 
called Sgroppino, which resides in peroxisomes and is likely involved in lipid 
metabolism. Loss of Sgroppino function in adult flies triggers an increase in 
body weight, altered fat metabolism, and hypersensitivity to virus infection. 
Finally, chapter 6 provides a general discussion on the results of this thesis, 
and an outlook on future research in the field of resistance and tolerance to 
virus infection in Drosophila. 
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Abstract 
Host defense to virus infection involves both resistance mechanisms that 
reduce viral burden and tolerance mechanisms that limit detrimental effects 
of infection. The fruit fly, Drosophila melanogaster, has emerged as a model 
to identify and characterize the genetic basis of resistance and tolerance. 
This protocol describes how to analyze host responses to virus infection in 
Drosophila and covers preparation of virus stocks, experimental inoculation 
of flies, and assessment of host survival and virus production, which are 
indicative of resistance or tolerance. It also provides guidance on how to 
account for recently identified confounding factors, including natural genetic 
variation in the pastrel locus and contamination of fly stocks with persistent 
viruses and the symbiotic bacterium Wolbachia. Our protocol aims to be 
accessible to newcomers to the field and, although optimized to carry out 
virus research using Drosophila, some of the techniques could be adapted 
to other host organisms and/or other microbial pathogens. Preparation of 
fly stocks requires about a month, virus stock preparation 17-20 days, virus 
injection and survival assays 10-15 days, and virus titration 14 days.
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Introduction 
When facing infection, host organisms use at least two combined strategies 
to fight off microbial invaders and return to a healthy state. The first 
strategy, called resistance, involves the activation of immune pathways that 
target pathogens to control their replication. The second strategy, termed 
tolerance, reduces the impact of infection on host fitness by dampening 
excessive immune responses or minimizing tissue damage (1, 2). 
Here, we describe the use of the fruit fly, Drosophila melanogaster, to 
uncover mechanisms of antiviral resistance and tolerance. Drosophila is 
a well-established genetic model organism that is widely used to study 
fundamental aspects of host defense, by virtue of easy stock maintenance, 
genetic tractability, and high degree of evolutionary conservation with other 
metazoans (3, 4). Studies in Drosophila uncovered an important role of the 
RNA interference pathway in resistance to major classes of viruses (5-9). In 
addition, several evolutionarily conserved inducible immune pathways, such 
as Toll, Imd, and Jak-Stat, have been shown to contribute in a virus- and 
tissue-specific manner to antiviral defense (10-14). Genetic defects affecting 
resistance cause high morbidity and mortality due to incomplete control 
of virus replication. Conversely, mutants with reduced tolerance present 
higher level of pathogenesis, without an increase in viral burden. Resistance 
and tolerance in Drosophila are typically assessed by comparing survival 
between mutant flies and their wild-type controls upon viral challenge 
and by analyzing virus loads, for example, by end-point dilution assays or 
quantitative reverse transcription-PCR (qRT-PCR). In addition, transcriptional 
induction of immune genes, such as those encoding antimicrobial peptides 
or stress-induced proteins, may be assessed by qRT-PCR or genome-wide 
approaches (10-12, 15-17). 
Several viruses have been used to study antiviral immunity in Drosophila (18) 
(Table 1). Amongst them are natural pathogens that infect wild Drosophila 
populations (e.g. Drosophila C virus, Nora virus, and Sigma virus), viruses 
that were originally identified in other insects, such as crickets (Cricket 
paralysis virus), beetles (Flock House virus), or moths (Invertebrate iridescent 
virus-6; (18)), as well as arthropod-borne viruses that shuttle between 
blood-feeding insects and vertebrate hosts during their natural transmission 
cycle (Vesicular stomatitis virus, Sindbis virus). Viral tropism remains mostly 
uncharacterized, but has been reported for some viruses:  
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Table 1 | Viruses used in Drosophila melanogaster.
Virus name (abbreviation) Family Genome Replication in 
S2 cells
Cricket paralysis virus (CrPV)a Dicistroviridae (+) ssRNA 
Drosophila A virus (DAV) Unassigned (+) ssRNA  b
Drosophila C virus (DCV)a Dicistroviridae (+) ssRNA 
Drosophila X virus (DXV)a Birnaviridae dsRNA, bipartite 
Flock House virus (FHV) a Nodaviridae  (+) ssRNA, bipartite 
Invertertebrate iridescent virus 6 (IIV-6) Iridoviridae dsDNA  c
Nora virus Unassigned (+) ssRNA - d
Sigma virus (DmelSV) Rhabdoviridae (-) ssRNA  e
Sindbis virus (SINV) Togaviridae (+) ssRNA  f
Vesicular stomatitis virus (VSV) Rhabdoviridae (-) ssRNA  f
aAvailable upon request from our laboratory. bDAV is able to replicate in DL2 cells, but 
may not reach high titers. Virus stocks may be prepared from infected flies (42). cIIV-6 
replicates in S2 and in DL2 cells (5,16), which can be used to prepare virus stocks. 
Alternatively, virus stocks may be prepared on Galleria mellonella, as described pre-
viously (5). dThus far, no cell line has been identified that supports high level of Nora 
virus replication. Virus stocks may be prepared from infected flies. eSigma virus esta-
blishes persistent infections in S2 cell cultures, but it is not cytopathic (58). fAlthough 
SINV and VSV replicate in S2 cells, virus stocks are usually prepared on permissive 
mammalian cell lines, such as BHK-21 and Vero cells (8,30), on which these viruses 
reach much higher titers. 
DCV replicates in diverse tissues, including the fat body, the periovarian 
sheath, and the digestive tract (15, 17, 19), Flock house virus has been 
characterized as cardiotropic (20), and Nora virus is an enteric virus that 
is transmitted through feces (21). Pathological symptoms, possibly linked 
with tissue and cell tropism, have been described for some viral infections, 
and these physiological changes may be used as additional read-outs for 
infection. For instance, DCV infection of the crop, a nutrient storage organ 
located at the proximal region of the digestive track of Drosophila, leads 
to severe intestinal obstruction (19). FHV induces morphological changes 
in mitochondria of cardiomyocytes and longitudinal fibers of the cardiac 
muscle. Finally, it has been suggested that Sigma virus infects the thoracic 
ganglion, which might explain the CO2 sensitivity of infected fly stocks (22). 
When selecting a virus for study, it is important to consider the genetic make-
up and replication strategy, natural host, tropism, and systemic effects, as 
these parameters may affect the defense response that is induced.
Recent studies have uncovered several confounding factors that have 
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the potential to dramatically affect the outcome of experimental infections 
and skew their interpretation. First, Drosophila laboratory strains are often 
persistently infected with RNA viruses, such as DCV, Drosophila A virus 
(DAV), and Nora virus (23-25). These viruses are inducers and suppressors 
of host RNAi pathways, and activate a number of other cellular pathways 
involved in host physiology and metabolism (14, 19, 20). These persistent 
infections are likely to affect the response to experimental inoculation with 
a particular virus, and it is therefore recommended to clear fly stocks of 
persistent infections by treating eggs with household bleach. Second, 
it was demonstrated that infection with the endosymbiotic bacterium 
Wolbachia strongly affects resistance to RNA viruses (DCV, FHV, and Nora 
Virus), as Wolbachia-infected flies show lower mortality rates and, in the 
case of DCV, harbor significantly lower levels of virus. Of note, fly stocks 
may be infected with different Wolbachia variants that provide differential 
protection to virus infection (16, 26). The presence and levels of endogenous 
viruses and Wolbachia differ between Drosophila stocks, which makes it 
difficult to interpret survival assays obtained from fly lines that differ in their 
infection status. Therefore, it is essential to rid fly stocks of viruses and 
symbionts, prior to experiments investigating resistance and tolerance (26). 
Third, susceptibility of flies to infection can also originate from unaccounted 
genetic variability between Drosophila stocks. For example, it has been 
reported that single nucleotide polymorphisms (SNPs) in the pastrel locus 
modulate the susceptibility of flies to DCV infection, but not to Flock House 
virus (FHV) or Sigma virus (27). Another polymorphism, located in the Ref(2)
p locus, confers resistance to Sigma virus (28, 29). Taken together, it is 
critical for the correct interpretation of experimental infections that these 
confounders are accounted for.
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Overview of the procedure
This protocol describes a series of methods routinely used in our laboratory 
to study the genetic and functional basis of tolerance and resistance in the 
fly (5, 12, 30). The workflow is depicted in Figure 1. The key stages are as 
follows:
1.  Preparation of fly stocks (Steps 1-23). This stage is the most time-
consuming of the entire workflow (Fig. 1) and it is recommended to 
start this procedure as soon as the laboratory receives a new fly strain. 
Because of possible infestation of fly stocks with mites, the incoming 
stocks should be kept in quarantine (31). As soon as a critical number 
of flies has emerged (≈ 30-50 flies), eggs can be subjected to treatment 
with bleach. This procedure will eliminate extracellular parasites, as 
well as horizontally transmitted viruses or bacteria that are present on 
the outer shell of the egg (chorion), which itself will be dissolved by the 
treatment. Dechorionated eggs are then collected and transferred to a vial 
containing standard fly food. After 10 days, offspring flies will emerge and 
successful decontamination is confirmed by PCR-based assays, using 
primers for a panel of viruses commonly found in fly stocks (Table 2). 
To clear fly stocks of the endosymbiont Wolbachia, flies are treated for 
2 generations with the antibiotic tetracycline, as previously described 
(16). Flies are confirmed to be Wolbachia-free using standard PCR 
assays on fly DNA extracts, using Wolbachia-specific primers (Table 2). 
The final stage in fly stock preparation consists of PCR amplification 
and sequencing of the genomic pastrel locus. Six SNPs in pastrel are 
associated with natural resistance to DCV and CrPV infection, with a SNP 
located in the last exon having the strongest effect on DCV infection (27, 32) 
(Figure 3). If discordance in the SNP profile is detected between fly 
lines to be analyzed, it will be difficult to determine whether phenotypic 
differences are due to the allele of interest, or to variation in the pastrel 
locus. 
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Figure 1 |  Overview of the experimental workflow.  
Analysis of tolerance and resistance to virus infection in Drosophila requires 
multiple steps. Preparation of fly stocks (left side) involves successive steps 
of treatment against infections with persistent viruses (egg bleaching, 
1 day) and the endosymbiont Wolbachia (tetracycline treatment, 20-25 
days), and sequencing of the pastrel locus to evaluate if it contains SNPs 
that are associated with resistance to virus infection (1 day). Preparation 
of viral stocks (right side) requires virus stock amplification (2-5 days), 
titration (14 days), and preparation of the virus inoculum (15 min). Once 
these steps are completed, replicate pools of the flies of interest and all 
relevant controls are inoculated with virus (1-4 hours, depending on the 
size of the experiment). Flies can be injected intra-thoracically or intra-
abdominally. Survival rates and viral loads are assessed over time (2-3 
weeks) to characterize tolerance or resistance mechanisms. 
2.  Preparation and titration of virus stocks (Steps 24-31). The viral isolate 
is first amplified by propagation on Drosophila S2 cells or other cell lines 
that support replication. Our protocol has been optimized for DCV, but 
it can be adapted to other viruses (5-12, 33) (Table 1 and Experimental 
Design). After inoculation, cells should be carefully monitored for cell 
death (also called cytopathic effect, CPE) and the culture supernatant 
is harvested when the viral titers are as high as possible, but before 
excessive cell debris appears in the supernatant. The virus stock is 
titered using a classic end-point dilution assay, and a 50% Tissue Culture 
Infectious Dose (TCID50) is established. S2 cells do not strongly adhere 
to the culture plate and exhibit poor viability under agar overlay, which 
precludes the use of plaque assays for virus titration. 
3.  Inoculation of flies (Steps 32-35). We describe inoculation of flies by 
capillary-mediated injection. Injection ensures precise control of the 
viral inoculum and triggers an immediate systemic infection. Alternative 
methods, which are described in detail elsewhere (13, 26, 34-37), are 
discussed in Experimental Design.
4.  Assessment of survival and viral load (Steps 36-42). Survival of infected 
flies is measured daily by scoring the number of dead flies in each test 
tube. Survival data can be evaluated using Kaplan-Meier and Cox 
proportional hazard analyses, which allow inclusion of censored 
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Table 2 | Oligonucleotide sequences and description.
Target Purpose Primer sequence (5’-3’) Expected 
product size
DCV DCV detection AAAATTTCGTTTTAGCCCAGAA 250 bp
TTGGTTGTACGTCAAAATCTGAG
DAV DAV detection AGGAGTTGGTGAGGACAGCCCA 146 bp
AGACCTCAGTTGGCAGTTCGCC
Nora virus Nora virus detection ATGGCGCCAGTTAGTGCAGACCT 410bp 
CCTGTTGTTCCAGTTGGGTTCGA
Actin 42A Housekeeping gene GCGTCGGTCAATTCAATCTT 522bp
CTTCTCCATGTCGTCCCAGT
Wolbachia Wolbachia  
detection (16) 
TGGTCCAATAAGTGATGAAGAAAC 610 bp
AAAAATTAAACGCTACTCCA
Pastrel Pastrel 
locus amplification 
CCATTCCGGTTCAAAATTCTCC 2629 bp
CTGGGATCTGTAAGTACTGC
Pastrel sequencing  CCATTCCGGTTCAAAATTCTCC n.a. 
ACATGAAGTACACCCTTACG
TTCTGGTCGCCTTCAACTGG
CTGGGATCTGTAAGTACTGC
n.a., not applicable.
cases, such as flies that are lost to follow-up and flies that have not died 
at the end of follow-up (38). Viral loads may be assessed by end-point 
dilution assays using the Reed and Muench method. Time courses 
may be needed, as differences in viral titers might be detectable only at 
some stages of the infection. In end-point dilution assays, cell death is 
monitored visually over time and scored after 14 days. Note that DCV only 
induces mild CPE, which necessitates this long follow-up during titration. 
Viruses that induce stronger CPE, such as Cricket paralysis virus (CrPV), 
can be scored at an earlier time-point.
Advantages and limitations of the protocol
Our protocol describes virus inoculation by injection, rather than more 
natural routes, such as feeding. Injection warrants high experimental 
reproducibility and systemic infection of all flies within an experiment. 
However, reliable protocols for natural infections have been developed 
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recently, and are discussed below (Experimental design, virus inoculation). 
One putative limitation of our protocol for fly stock preparation is that it is 
impossible to eliminate viruses that infect germline cells, such as Sigma 
virus, by bleaching. It had been suggested that transmission of Sigma virus 
was strongly reduced, or even absent, in aged flies (22, 39). However, Sigma 
virus only infects about 4% of Drosophila in the wild (40), and does not seem 
to be present in laboratory stocks, therefore vertically transmitted viruses do 
not represent a major concern when using standard fly stocks. 
a b
nylon mesh
water
50% bleach
cap
tube
Figure 2 |  Practical set-up for bleaching of embryos.   
(a) Filters for embryo collection are built using a sectioned 50mL tube, 
and a nylon mesh. The center of the cap is cut out, leaving the screw 
thread and a small rim intact. The mesh is then immobilized between the 
tube and the cap. (b) After collection, embryos are incubated in 50% (v/v) 
household bleach for 10 min, and rinsed 3 times for 5 min in demineralized 
water.
Pastrel
5’UTR
7,350,452 T/G
7,350,453 A/G
7,350,895
(C/T) Ala/Thr*
7,351,494
C/T
7,352,880
T/C (Glu/Gly)
7,352,966
T/G
3’UTR
Figure 3 |  Structure of the pastrel locus and location of SNPs.   
Boxes represent exons (5’ and 3’-untranslated regions in gray, and coding 
sequence in white), horizontal lines represent introns. Chromosomal 
position and sequence variation are shown for each SNP. The asterisk (*) 
indicates the SNP with the strongest effect on viral resistance. The extent 
to which the other SNPs contribute to resistance could not be defined due 
to strong linkage disequilibrium between the SNPs (27). 
b
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Experimental design
Genetic background. If flies are discordant in the pastrel locus, it is 
recommended to isogenize the genetic background of the fly line of interest 
by genetic crosses or by sequential back-crosses to the control strain, 
using methods previously described (13, 33). It has recently been reported 
that natural genetic variation in other loci (Ubc-E2H and CG8492) is also 
associated with DCV sensitivity, and with susceptibility to other viruses 
(Ubc-E2H, CrPV; CG8492, FHV), even though the presence of such genetic 
variation in laboratory stocks remains to be formally demonstrated (32). It 
is possible that additional as-yet-unknown polymorphic loci may affect the 
sensitivity to DCV and other viruses. Although labor-intensive, isogenizing the 
strain of interest to the control strain will effectively eliminate the contribution 
of unknown polymorphic sites to the observed resistance and tolerance 
phenotypes. Alternatively, a direct link between a gene and a resistance 
phenotype can be confirmed using additional alleles of the gene of interest, 
which could include RNAi-knockdown lines, by analyzing a deficiency line 
that uncovers the locus of the gene of interest, or by performing genetic 
rescue experiments. 
Preparation of virus stock. Several viruses are currently used in Drosophila 
laboratories to analyze resistance and tolerance to infection. A list of the 
most commonly used viruses is provided in Table 1. If no susceptible 
cell line is available for virus amplification, or when cell culture does not 
support a high level of replication (for example Nora virus and Drosophila 
A virus), a virus stock may be amplified in infected adult flies and purified 
on a sucrose density gradient (16, 41, 42). It is important to be aware that 
some Drosophila S2 cell lines, such as S2R+, may be chronically infected 
with multiple viruses, including the Flock house virus (FHV) variant American 
nodavirus (ANV) (43, 44). Virus stocks should therefore be prepared on cell 
lines that are not persistently virus infected, which can be assessed by RT-
PCR, as described previously (43-45). After inoculation, the optimal time of 
harvesting may depend on the virus used, its CPE-inducing effects, and on 
the titer of the inoculum, and should therefore be experimentally established. 
In the Procedure, we describe preparation of viral stocks by centrifugation, 
but they can also be purified and concentrated using sucrose-gradient 
centrifugation, as previously described (46). 
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Figure 4 |  Parameters that affect mortality in survival assays.   
(a) Sensitivity to DCV infection does not depend on the injection site 
(thoracic or abdominal). (b) Male flies are slightly more sensitive to DCV 
infection than female flies. (c) Sensitivity to DCV infection varies between 
different genetic backgrounds (w1118, CnBw, Oregon-R). (d) The dynamic 
range of survival assays is modulated by the titer of the virus inoculum. 
(e) Incubation temperature strongly affects survival rates after DCV 
infection. Data represent means and s.d. of three biological replicates 
of at least 15 female flies (a-e), or 15 male flies (b) per replicate for each 
condition. In all experiments, w1118flies were inoculated by intra-thoracic 
injection of 1,000 TCID50 units of DCV and incubated at 25°C, unless 
stated otherwise (a, c, d, e). All experiments of this figure were run in 
parallel, the reference infection (w1118 female flies inoculated with 1,000 
TCID50 in the thorax, and incubated at 25°C) is the same for all panels. 
Kaplan-Meier analyses and Cox proportional hazard analyses were used 
to analyze the data (Supplementary table 1).
ba
c
59
Analysis of antiviral resistance and tolerance
2
Virus inoculation. We describe methods for systemic infection of flies by 
capillary-mediated injection. However, flies can also be infected by pricking 
with tungsten needles or with 0.15 mm diameter insect pins (26, 37), by 
feeding on experimentally contaminated fly food, or by exposure to virus-
containing sucrose solution (35, 36). We use injection because it allows 
precise control of inoculation and triggers an immediate systemic infection. 
Also, injection is often better for delivery of a lethal dose, whereas infection 
by feeding generally triggers a slower, milder, and sometimes local infection, 
as illustrated by low mortality rates in orally infected fly stocks (13, 34, 35). 
Moreover, the route of inoculation may influence the sequence in which target 
tissues are infected, and thereby, the nature and magnitude of the immune 
response. With this in mind, the site of injection should be consistent, as 
it may define the initial site of replication and could theoretically influence 
the experimental outcome. Limited experimental data are available on this 
issue for virus infections, but the injury site has been shown to influence 
the outcome of bacterial infection in Drosophila (47, 48). We tested whether 
the injection site changed the outcome of systemic DCV infection, but no 
difference in survival rates was noted between intra-thoracic and intra-
abdominal injections (Fig. 4a, P = 0.104, log-rank test, see supplementary 
data 1 for further statistics). However, we cannot exclude that the injection 
site could affect the course of other virus infections.
Intra-abdominal
Intra-thoracica
Mesopleura
Pteropleura
b
Ventral abdomen
Dorsal abdomen
Figure 5 |  Intra-thoracic and intra-abdominal injection sites.   
Flies can be injected (a) intra-thoracically, between the pteropleura and 
mesopleura, or (b) intra-abdominally, at the junction of the dorsal and 
ventral abdomen. 
b
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Gender and age of flies. Either male or female flies can be used for survival 
experiments, but female flies may be easier to inject due to their larger size. 
Moreover, as males do not deposit eggs and no larvae grow in the medium, 
it easily dries out and requires more frequent passages to fresh vials. A 
small difference in survival can occur between genders (Fig. 4b, P < 0.001, 
supplementary data 1) and this must be taken into account by analyzing 
one sex only within a single experiment. Flies should be staged, e.g. at 
three-to-five days old, as aging influences survival rates (33). This can be 
further optimized and standardized for a given virus or study. 
Controls. It is critical to include all necessary controls in survival assays. The 
genetic background may affect the experimental outcome, as illustrated here 
by comparing survival of 3 different control strains (w1118, Cinnabar Brown, 
Oregon-R) upon DCV infection (Fig. 4c, P < 0.001 for OreR, and P = 0.085 
for CnBw, compared to w1118, supplementary data 1). For genetic mutants, a 
strain with the best-matched genetic background should therefore be used 
as a control. When analyzing the offspring of genetic crosses, for example 
between a Gal4-driver line with a UAS-responder line, it is recommended to 
include the offspring of control crosses of the driver line and the responder 
line to the corresponding wild-type strain. In addition, mock infections 
must be performed alongside the experimental infections. Mutant lines 
might be sensitive to the stress caused by the needle injury, the incubation 
temperature, or natural aging, and putative differences in survival between 
fly lines might not be fully attributed to the viral infection. Additionally, when 
investigating the activation of immune pathways, normalization to a mock 
control is essential, as the injury itself induces a small, but non-negligible 
immune response (49). 
Determining the optimal inoculum. Pilot studies should be performed to 
monitor survival upon inoculation of 10-fold serial dilutions of viral stocks, 
as shown for different DCV doses in wild-type flies (Fig. 4d, supplementary 
data 1). The virus dose should not be too high to mask possible differences 
between genotypes, but high enough to ensure that all flies are consistently 
infected. We typically use 1,000 TCID50 units, but depending on the aim of 
the experiment a range of doses from 100 to 10,000 TCID50 units may be 
used. 
Growth conditions. After virus inoculation, flies are kept in an incubator with 
controlled 12h-light/dark cycles and constant temperature (typically 25°C), 
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and transferred to fresh food every 3 days to avoid excessive sogginess 
caused by larval growth, which would cause adult flies to stick to the food 
and drown during oviposition and feeding. Temperature strongly influences 
the time-course of the survival: higher temperature (29°C) accelerates death 
and subjects flies to mild heat stress, whereas lower temperature slows 
down virus-induced mortality (Fig. 4e). 
Survival assays. Survival tests may be performed using replicate tubes 
within a single experiment, for example using three replicates with a minimum 
of 15 flies per replicate. This will give an indication of intra-experimental 
variability and prevents that unaccounted technical factors, such as food 
quality, affect the outcome of the assay. Survival assays should be repeated 
3 times to evaluate inter-experimental reproducibility. Survival data can be 
evaluated using Kaplan-Meier and Cox proportional hazard analyses. In 
Kaplan-Meier analyses, the log-rank test can be used to assess whether 
differences in survival are statistically significant, but it will not assess effect 
size. Difference in mean survival and associated 95% confidence intervals 
or standard errors may be reported as a quantitative measure of the effect of 
a genetic allele on survival. Cox proportional Hazard analyses (also known 
as Cox regression) estimate a hazard ratio (and associated 95% confidence 
interval) for the condition of interest relative to a reference condition, which 
can be reported as a measure of effect size. Other covariates, such as 
replicates within an experiment, repeats of the experiment, or sex, can be 
analyzed along with the parameter of interest and the reported hazard ratios 
then account for variation in covariates. Kaplan-Meier and Cox proportional 
hazard analyses of the survival experiments in Figure 4 are provided in 
Supplementary table 1. 
Viral load assessment. Multiple independent samples are analyzed to 
account for experimental variation (for example, 3 biological replicates of 
5 flies minimum; numbers can be adjusted according to the aim of the 
experiment). It is recommended to prepare a mock sample, to ensure 
that no other component in the fly lysate induces cell death that could be 
misinterpreted as virus-induced CPE. The end-point dilution assay requires 
viruses to replicate and cause CPE in cell culture. If those requirements are 
not met, additional techniques to quantify virus production are available: 
qRT-PCR assays, which quantifies viral RNA with greater sensitivity, but 
does not assess infectious virus, qPCR to quantify genome copies of DNA 
viruses, and western blot analyses to detect viral proteins (5, 11, 12, 15, 50). 
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Of note, the sensitivity limits of virus titration or western blots may not allow 
to readily or consistently detect small differences in viral titers (< 0.5 log). 
While differences in viral titers might appear mild in the whole organism, 
experiments using organ or tissue dissection (e.g. gut, or fat body) might 
unveil tissue-specific differences in viral load (12, 15). Organ dissection, and 
microscopy-based approaches may also be used as to evaluate tropism, 
and to determine sites with high level of infection (13, 15, 19, 20). 
Materials 
Reagents
• Drosophila stocks (w1118, Cinnabar Brown, and Oregon-R available from 
Bloomington Drosophila Stock Center, stock number: #3065, #264, #5, 
respectively) 
• Drosophila viruses, available upon request from academic laboratories 
• Drosophila S2 cells (Life technologies, cat. no. R690-07)
• Schneider’s Drosophila medium (Life technologies, cat. no. 21720)
• Penicillin (5,000 U/mL)-Streptomycin (5000 µg/mL) (Life technologies, 
cat. no. 15070)
• Fetal Bovine Serum (FBS), qualified, heat inactivated (Life technologies, 
cat. no. 10500-064)
• TaqMan reverse transcription reagents (Life technologies, cat. no. 
N8080234) 
• Standard PCR reagents: OneTaq DNA polymerase (New England 
Biolabs, cat. no M0480), dNTPs (New England Biolabs, cat. no N0447L), 
or equivalent reagents 
• Phusion High-Fidelity DNA Polymerase (New England Biolabs, cat. no. 
M0530)
• Custom oligonucleotides (described in Table 2) (Sigma-Aldrich) 
• DNA isolation kit (QIAamp DNA Blood Mini Kit) (Qiagen, cat. no. 51104)
• Illustra GFX PCR DNA and Gel Band Purification Kit (GE Healthcare, 
cat. No. 28-9034-70), or equivalent kit 
• Multipurpose agarose (Roche, 11388991001)
• Common fly food reagents: cornmeal and sucrose (Genesee Scientific 
cat. no. 62-100 and 62-112, or general store)
• Select Agar, powder (Life Technologies, cat. no. 30391)
• Isol-RNA lysis reagent (5 Prime, cat. no. 2302700)   
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CAUTION: Toxic upon skin contact of inhalation. Handle only under a 
chemical hood and wear protective equipment. 
• Good quality apple or grape juice (General store) 
• Baker’s yeast (Fermipan Red Dried Yeast, or any equivalent product)
• Methylparaben (Sigma-Aldrich, cat. no. 47889). Prepare 3% 
(w/v) methylparaben solution in 80% ethanol.     
CAUTION: Irritant upon contact, inhalation, or ingestion. Wear protective 
equipment. 
• Proprionic acid (Sigma-Aldrich, cat. no. 402907)  
CAUTION: Flammable. Irritant upon contact, inhalation, or ingestion. 
Handle only under a chemical hood and wear protective equipment. 
• Tetracycline (Sigma-Aldrich, Cat. no. 87128). Prepare tetracycline stock 
solution at 5 mg/mL in 80% ethanol.    
CAUTION: Irritant. Wear protective equipment. 
• 80% RNase free ethanol
• Isopropanol
• Sterile PBS 1x
• 10 mM Tris-HCl, pH 7.3
• 10 mM Tris-HCl, pH 8.2 
• 1 mM EDTA, pH 8.0
• 25 mM NaCl
• Proteinase K (20 mg/ml) (Ambion, Life technologies, cat. no. AM2564)
• TAE buffer 1x
• 80% (v/v) ethanol / 10% household bleach (v/v) solution 
• 50% household bleach (v/v) solution 
• Chloroform  
CAUTION: Irritant upon contact, inhalation, or ingestion. Handle only 
under a chemical hood and wear protective equipment. 
• Autoclaved milli-Q ultrapure water
• Demineralized water 
Equipment
• 96-well sterile cell culture plates with flat bottom (Sigma-Aldrich, cat.
no. CLS3596)
• 96-well sterile cell culture plates with round bottom (Sigma-Aldrich, cat.
no CLS3799) 
• Cell culture flasks (T25; Sigma-Aldrich, cat.no CLS3055 and T75; 
Sigma-Aldrich, cat.no CLS430725 )
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• Sterile 5 mL, 10 mL, 25 mL serological pipettes (Sigma-Aldrich, cat. no. 
CLS4051, CLS4101, CLS4251)
• Whatman Puradisc 30 syringe filters, cellulose acetate, 0.2 μm (Sigma-
Aldrich, cat. no. WHA10462200)
• BD Plastipak 50 mL sterile syringe (BD Medical Sciences, cat. no. 
300866)
• Large embryo collection cages (Genesee Scientific, cat. no. 59-101) and 
large replacement End caps (Genesee Scientific, cat. no. 59-103)
• Sterilin Standard 90mm Petri Dishes (Thermo Scientific, cat. no. 
101VR20)
• Narrow Fly Vials (Genesee Scientific, cat. no. 32-109)
• Cotton plugs (Genesee Scientific, cat. no. 51-101)
• Mesh nitex (filter for embryo collection), pore size 120 µm, open area 
49% (Genesee Scientific, cat. no. 57-102) 
• Filter paper (Whatman cellulose chromatography paper, Sigma-Aldrich, 
cat. no. WHA3030917)
• Cordless hand-operated motor (Sigma-Aldrich, cat. no. Z359971), 
to be used in combination with pellet pestles, blue polypropylene, 
autoclavable (Sigma-Aldrich, cat. no. Z359947)
• 1.5 mL Eppendorf tubes (Eppendorf, cat. no. 0030125150) and 50 mL 
centrifuge tubes (Corning, cat. no. 430829)
• Pasteur capillary pipette, length 230 mm (Hecht assistant, cat. no. 
567/2) 
• Flaming/Brown type micropipette puller (Sutter, cat. no. P-97)
• Injector (Nanoject II, Drummond Scientific company, cat. no. 3-000-
204) with foot switch (cat. no. 3-000-026)
• Glass capillaries (3.5’’, Drummond Scientific Company, cat. no. 3-000-
203-G/X)
• Paintbrush (size 0 or 1)
• Stereomicroscope (Zeiss, SteREO Discovery.V8)
• Fly pad on CO2 supply (Genesee Scientific, cat. no. 59-114) 
• Bunsen burner
• Fly incubator with l2h-light/dark cycle and adjustable temperature 
• Cell culture incubator with adjustable temperature 
• Laminar flow tissue culture hood
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Reagent setup
• Handling new fly stocks  
After receipt of new fly stocks, place them in quarantine outside the 
fly room. Wait until a critical amount of flies (about 30-50) is obtained. 
Monitor and, if needed, eliminate mites as previously described (31). 
Once confirmed to be mite-free, fly stocks can be transferred to the fly 
room and maintained using standard methods. 
• Yeast paste   
Mix 10 grams of dry baker’s yeast with 15-20 mL of demineralized water. 
Stir until the yeast is dissolved and add water until the paste has the 
consistency of peanut butter. Yeast paste can be stored for 3 days at 4°C. 
• Apple Juice-Agar medium (for 20 plates)  
Mix 6 grams of agar with 100 mL demineralized water. Boil until the agar 
is dissolved. Add 100 mL of apple juice. Boil again. While the mix cools 
down, dissolve 0.2 grams of methylparaben in 1 mL of 80% ethanol and 
add to the apple juice agar. Pour 10 mL of the medium in a Petri dish and 
let it dry for 1 hour. For use as egg-laying plates, deposit 1-2 grams of 
yeast paste on the center of the apple juice-agar plate. Before addition 
of yeast paste, plates can be stored at +4°C for up to 3 weeks. Once 
yeast paste has been added, plates can be stored at +4°C for 2 days. 
CAUTION: Content easily boils over and needs to be monitored carefully. 
CRITICAL: To avoid evaporation and degradation by heat, add the 
methylparaben only when the medium is lukewarm (50°C). 
• Fly food (for 30 tubes)  
Fly food should be made at least one day before use. Weigh dry 
ingredients: 2 grams agar, 8 grams dry baker’s yeast, 16 grams 
cornmeal, 33 grams sucrose. Blend and add, while stirring, to 300 mL 
of boiling demineralized water. Slowly cook the mixture for 5 min, and 
let cool down. When lukewarm (50°C), add 1 mL methylparaben stock 
solution and 0.75 mL propionic acid. For use in tetracycline treatment 
(step 13), fly food can be supplemented with 3 mL tetracycline stock 
solution at this point. Pour 10 mL of medium in each small fly vial, cover 
the vials with clean tissue or cheesecloth and let dry at room temperature 
(20°C) for a day. Fly food can be stored at +4°C for up to 3 weeks. 
CRITICAL: To avoid evaporation and degradation by heat, 
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add methylparaben, tetracycline and propionic acid only 
when the medium is lukewarm (50°C).     
CAUTION: Propionic acid is flammable and can cause skin corrosion. 
Wear protective equipment, and handle with care under a chemical 
hood. Once diluted in the fly food, it can be handled outside the hood. 
• Squishing buffer  
10mM Tris-HCl pH 8.2, 1mM EDTA, 25mM NaCl and 200 µg/
mL proteinase K added freshly      
• Supplemented Schneider’s Drosophila medium  
Supplement Schneider’s Drosophila medium with 10% heat-inactivated 
FBS and Penicillin (50 U/mL)-Streptomycin (50 µg/mL). Filter the FBS 
through a 0.2 µm filter using a sterile syringe. The medium can be stored 
at +4°C for 2 months. 
Equipment setup
• Injection needles   
Pull the capillaries to prepare injection needles using the Flaming/
Brown type micropipette puller with the following settings: Temperature: 
680, Pull: 50, Velocity: 50, Time: 200. Capillary needles may also 
be prepared on other models.       
CRITICAL: These settings are given as an example, they may need 
further optimization. 
• Oil-filling injection needles  
Prepare a Pasteur pipette for back-filling the injection needle by melting 
the Pasteur capillary using the flame of a Bunsen burner, and gently 
pull it apart to obtain a very thin end. Back-fill the injection needle with 
a non-compressible fluid (e.g. mineral oil) using the Pasteur pipette 
mounted with a bulb. Attach a bulb to the pipette and fill it with mineral 
oil. Insert the pipette into the capillary needle until it reaches the tip. 
Gently release the oil while slowly withdrawing the Pasteur pipette. Make 
sure not to form any bubbles in the capillary. Oil-filled injection needles 
can be stored for several months at room temperature in a petri dish.
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Procedure
Fly preparation: Egg bleaching 
Timing 1 day
1.  Transfer flies to egg-laying cages using CO2 anesthesia, place an apple 
juice plate (with yeast paste, see Reagent Setup) on top, and seal using 
the end cap. After the flies have recovered from anesthesia, place the 
cage in an incubator at 25°C for a minimum of 6-8 hours to overnight. 
2.  Collect eggs into a filter placed in demineralized water; the filter can be 
built using fine nylon mesh and a 50 mL Falcon tube (Fig. 2). Retrieve 
eggs from the apple juice-agar medium using a clean paintbrush. If 
only a few eggs (less than 20) are present on the apple juice-agar 
plate, place the dish under the stereoscope and pick eggs one-by-one 
with the brush and transfer them to the filter. If many eggs have been 
deposited on the agar, remove the yeast paste from the dish, add 3mL 
of demineralized water, and gently brush the surface to loosen the eggs 
without detaching the agar media. Pour the liquid into the filter.  
CRITICAL STEP: It is imperative that the brush is clean and does not 
contain eggs from previous collections to prevent genotypic mix-up and 
contamination (verify under a stereomicroscope). This is particularly 
important when collecting different genotypes in parallel. 
3.  Transfer the filter containing the eggs in a 50% household bleach 
and incubate at room temperature for exactly 10 min. This step 
dechorionates the eggs.       
CRITICAL STEP: Carefully time the treatment to 10 min. The treatment 
should be long enough for the chorion to dissolve, but excessive treatment 
will compromise embryo viability. Timing may need adjustment depending 
on the brand of household bleach. Successful dechorionation will remove 
the respiratory appendages of the egg, which can be visualized with the 
stereomicroscope.
4.  Transfer the filter to water and perform three 5-min washes. Dechorionated 
eggs tend to aggregate and float on the water surface. 
5.  Collect the eggs by gently withdrawing them from the water using a strip of 
filter paper of 1x5cm; fold the paper on one end and scoop out the eggs. 
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CRITICAL STEP Do not use a pipette, as dechorionated eggs will stick to the 
pipette tip. 
6.  Transfer the filter paper to a vial containing standard cornmeal-agar 
medium, and incubate at 25°C until adults emerge, about 10 days later. 
CRITICAL STEP: Ensure that the filter paper stays wet while the eggs 
develop by adding drops of water on it when needed.    
CRITICAL STEP: If substantial amounts of eggs (>100) have been 
collected, it is possible to shorten the protocol by transferring eggs directly 
to tetracycline-containing medium (step 13). RT-PCR and PCR screens 
for RNA viruses (Step 7) and Wolbachia (step 16) can then be performed 
after tetracyline treatment. Note that larvae seem to develop less well 
on tetracycline-containing medium; this shorter protocol is therefore not 
recommended for weaker stocks or when few eggs have been collected. 
Fly preparation: confirming absence of RNA viruses by RT-
PCR
Timing 1 day
7.  Freeze 5 newly emerged adult flies at -20°C, and extract RNA using 
Isol-RNA lysis reagent using the manufacturer’s instructions. Include a 
positive control, such as a non-bleached fly stock that is known to be 
persistently virus-infected. 
8.  Perform a reverse transcription (RT) reaction on 1 µg of RNA using TaqMan 
Reverse Transcription Reagents or equivalent reagents. Assemble the 
following reagents for each reaction:
Component Amount (μL) Final Concentration
10x RT Buffer 2 1x
25 mM MgCl2 4.4 5.5 mM
10mM dNTP Mix (2.5 mM each) 4 2 mM (0.5 mM each)
50 μM random hexamers 1 2.5 μM
RNase inhibitor (20 U/μL) 0.4 0.4 U/μL
Multiscribe RT (50 U/μL) 0.5 1.25 U/μL
Template 1 μg RNA, diluted in 7.7 μL RNase-free water
Total 20 μL (for 1 reaction)
9. Perform the RT reaction using the following conditions: 
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Cycle number Anneal Extend Inactivate RT enzyme
1 25°C, 10 min
2 48°C, 1h
3 95°C, 5 min
CRITICAL STEP: It is recommended to use random hexamers instead of 
poly-dT primers during complementary DNA (cDNA) synthesis, since not all 
viruses produce poly(A) tailed RNAs. 
10.  Perform a standard PCR on the cDNA using oligonucleotides targeting 
DCV, DAV, Nora virus and other viruses of interest, as well as the 
housekeeping gene Actin42A (See oligonucleotide sequences in Table 
2). Include a PCR reaction without template as a negative control. cDNA 
from non-bleached, virus-infected flies, or plasmid DNA containing viral 
sequences can be used as positive controls for PCR. Use the following 
set-up when using OneTaq polymerase; adapt when using other PCR 
reagents.
Component Amount (μL) Final Concentration
5x Reaction Buffer 10 1x
10mM dNTP Mix (2.5 mM each) 1 200 μM (50 μM each)
10 μM forward primer 1 0.2 μM
10 μM reverse primer 1 0.2 μM
Taq DNA Polymerase (5 U/μl) 0.25
Template (cDNA) 3
Nuclease-free water 33.75
Total 50 μL (for 1 reaction) 
11. Perform PCR using the following cycling conditions: 
Cycle number Denature Anneal Extend
1 94°C, 30 sec 
2-36 94°C, 30 sec 57°C, 30 sec 72°C, 50sec
37 72°C, 10 min 
12. Run 10 µL of each PCR product on a 1% agarose gel in TAE buffer (1x) 
and verify the absence of an amplification product for viral sequences. The 
Actin PCR should be positive for all samples. See Table 2 for expected sizes 
of the PCR products. 
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Fly preparation: Tetracycline Treatment 
Timing ≈25 days 
13.  Transfer the flies collected after bleaching (at Step 6) to standard 
cornmeal-agar fly food supplemented with tetracycline (see Reagent 
Setup) and let them lay eggs for 3 days. Remove the parents, and, 
optionally, keep them in a separate tube as back-up. Return the egg-
containing vials to an incubator set at 25°C.
14.  When adult F1 progeny eclose, transfer them to a fresh vial with 
tetracyline-containing food, and repeat the process outlined in step 13.
 
15.  When adult F2 progeny eclose, transfer them to conventional food. 
Withdraw 5 flies and transfer them to a 1.5 mL eppendorf tube and 
freeze at -20°C for confirmation of Wolbachia-free status by PCR assay 
(steps 16-18). Return the vials containing the adults to an incubator set 
at 25°C, and expand stocks for use in later experiments. See Table 3 for 
troubleshooting.
Fly preparation: confirming absence of Wolbachia by PCR
Timing 4 hours
16.  Make crude DNA extract from the frozen flies from step 15 by adding 
50 µL of squishing buffer (see Reagent Setup) and crushing flies using 
a pipet tip. Incubate the mixture at 37°C for 30 min and then inactivate 
Proteinase K at 95°C for 2 min. 
17.  Use 3 µL of extract in a 50 µL standard PCR reaction to detect Wolbachia 
using the oligonucleotide primers listed in Table 2; use the reaction 
setup tabulated at step 10 and the cycling conditions tabulated at step 
11. Include a negative control (no template), as well as an extract from 
Wolbachia-infected flies as a positive control. 
18.  Run 10 µL of each PCR product on a 1% agarose gel in TAE buffer (1x) 
and verify the absence of a Wolbachia amplicon (expected size 610 bp). 
See Table 3 for troubleshooting.
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Fly preparation: Sequencing of the pastrel locus 
Timing 1 day
19.  Extract DNA from ≈10 flies from step 15 using the QiAamp DNA Blood 
Mini extraction kit. Use between 50-100 ng of DNA as template in a 
PCR reaction with Phusion high-fidelity DNA polymerase or another 
high-fidelity DNA polymerase to amplify the pastrel locus. Include a PCR 
reaction for the housekeeping gene Actin42A to verify successful DNA 
isolation, and a PCR reaction without template as a negative control. 
Assemble the following reagents for each reaction:
Component Amount (μL) Final Concentration
5x Reaction Buffer 10 1x
10mM dNTP Mix (2.5 mM each) 1 200 μM (50 μM each)
10 μM forward primer 2.5 0.5 μM
10 μM reverse primer 2.5 0.5 μM
Phusion DNA Polymerase (2 U/μl) 0.5
Template (50-100 ng) variable 
Nuclease-free water Up to 50 μL
Total 50 μL (for 1 reaction) 
20. Perform PCR using the following cycling conditions:
Cycle number Denature Anneal Extend
1 98°C, 1 min
2-36 98°C, 10 sec 56°C, 30 sec 72°C, 90 sec
36 72°C, 10 min 
21.  Run 5 µL of the PCR products on a 1% agarose gel in TAE buffer (1x) to 
verify the presence of the amplicon (expected size 2629 bp). 
22.  Purify the PCR product using the Illustra DNA purification kit or 
equivalent reagents, and sequence the pastrel locus using the primers 
described in Table 2. Identify the nature of the 6 SNPs associated with 
viral resistance, as described previously (27) (Figure 3). If fly stocks are 
pastrel discordant, isogenize the genetic background using genetic 
crosses, or by sequential backcrosses to the control strain (13, 33).
72
Chapter 2
Fly preparation: Aging flies for injection 
Timing 3 days
23.  Three days before injection, collect newly eclosed 0 to 2-day-old flies, 
and place them in a new tube. Let them age for 3 more days to reach the 
age range of 3-5 days on the day of injection. All control groups must 
be prepared in parallel. Use 3 tubes of 15-20 flies for each experimental 
and control group.
Virus preparation: Preparation of virus stock 
Timing 3-6 days
24.  Infect S2 cells cultured to subconfluency in a T25 or T75 culture flask 
with the viral inoculum. If the titer of the viral isolate is known, infect 
cells with a low multiplicity of infection (MOI) of 0.01-0.1 to prevent the 
formation of defective interfering particles known to occur upon viral 
replication, notably with positive-sense RNA viruses (51, 52). Use 10 mL 
of medium in a T25 flask, or up to 45 mL in a T75 flask. 
25.  Monitor cell growth and morphology daily until the appearance of CPE, 
which is an indicator of viral replication and cell death. Harvest the cell 
culture supernatant, and centrifuge it for 10 min at 1,800 g. Transfer 
the supernatant to a new tube, and repeat the centrifugation step. 
Collect the supernatant and store in aliquots.   
PAUSE POINT: It is recommended to prepare large amounts of virus 
stocks, as they can be stored for prolonged periods of time at -80°C 
with minimal loss of infectivity. Store in aliquots of 20-50 µL.
Virus preparation: Titration by end-point dilution assay 
Timing 14 days
26.  Seed flat-bottom 96-well plates with 100 µL of S2 cell suspension at 
2.106 cells/mL. 
27.  Fill round-bottom 96-well plates with 180 µL of sterile PBS. Make 10-fold 
dilution series of virus suspension, by adding 20 µL of virus stock to the 
first well containing 180 µL of PBS, and diluting the suspension 10-fold 
at each step until the 12th well.
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28.  Add 25 µL of each viral dilution to 4 replicate wells in the plate containing 
S2 cells. 
29.  After 5 days, resuspend the cells and transfer 25 µL to a 96-well plate 
containing 100 µL of fresh Schneider’s medium per well. 
30.  After 9 more days, score CPE in each well, and calculate the viral titer 
using the Reed and Muench method. A ready-to-use calculation sheet 
has been published (53).
Virus preparation: Dilution for injection 
Timing 15 min
31.  Thaw an aliquot of virus stock on ice, and dilute to the appropriate 
concentration in 10 mM Tris-HCl, pH=7.3. To prevent a decrease of viral 
titers and experimental variation, avoid multiple freeze/thaw cycles by 
preparing the virus inoculum from fresh aliquots of virus stock for each 
experiment. 
Virus Injection 
Timing 1-4 hours, depending on the number of samples
32.  Prepare the needle for injection as described in section Equipment Setup. 
CRITICAL STEP. Change the needle for each virus dilution and for the 
mock control (10 mM Tris-HCl, pH=7.3). 
33.  Load the needle with the chosen inoculum. Extend the plunger of the 
microinjector by pressing the “empty” button until the audible signal, and 
then retract it 5 mm. Mount the oil-filled capillary needle on the plunger of 
the injector and screw it tight. View the needle through a stereomicroscope 
and break the tip using a thin forceps. The tip needs to be as thin as 
possible (≈ 0.05 mm in diameter), but should not bend upon injection. Fill 
the needle by dipping it in the viral suspension and pushing the “fill” button. 
CAUTION: the extended plunger is vulnerable. Handle with care to 
prevent damaging it.
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34.  Anesthesize flies using CO2, distribute them on the pad, and inject them 
with 50 nL of virus inoculum. Use option A for thoracic injection or option 
B for abdominal injection, according to the experimenter’s preference. 
Option A: thoracic injection.
  Inject the thorax at the slightly lighter-coloured region between 
the mesopleura and pteropleura (see Fig. 5a). Make sure that the 
inoculum enters and stays in the body cavity, and remove the needle 
from the body.
Option B: abdominal injection
  Inject the abdomen at the junction between the dorsal cuticle and 
ventral abdomen (see Fig. 5b). Make sure that the inoculum enters 
and stays in the body cavity, and remove the needle from the body.
35.  After injection, carefully transfer flies to a fresh vial. Place the vials in a 
horizontal position to prevent the flies from sticking to the medium while 
recovering from anesthesia. Once the flies have recovered, place the 
tube in an upright position in the incubator at the chosen temperature 
and analyze survival rates (steps 36-37) and viral load (steps 38-42). Both 
assays may be performed in parallel. See Table 3 for troubleshooting.
Follow-up studies: measuring survival rates 
Timing: 7-10 days, depending on the virus, inoculum, and 
sensitivity of the fly strain
36.  Prepare a scoring sheet to daily report the number of dead flies. Dead 
flies at day 1 are excluded from the analysis, since death is most likely 
due to lethal injury during injection.
37.  Count dead flies every day, and transfer flies to a fresh vial every 3 days. 
Symptoms of pathology (slower movement, swollen abdomen, arrest 
of egg production) may be monitored using the stereomicroscope. 
Stop monitoring the flies, including the mock controls, when 
all infected flies are dead or at a pre-defined time-point.  
CRITICAL STEP: When close to death, flies lie at the bottom of the tube 
and appear immobile, but they may still be moving. Close inspection 
using the stereomicroscope is recommended to score flies. See Table 
3 for troubleshooting.
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Follow-up studies: measuring viral load 
Timing: 14 days
  CRITICAL: Viral load is measured similarly to titration of the virus stock 
(steps 26-30), but requires additional sample preparation (step 38-41).
38.  Harvest 15 flies (from step 35) at a chosen time-point, and freeze three 
pools of 5 flies at -20°C. Numbers can be adapted according to the aim 
of the experiment. 
39.  Homogenize the flies in 300 μL sterile PBS using a hand-operated 
cordless motor mounted with pestles.      
CRITICAL STEP: From this step onwards, the samples should be kept 
on ice. 
40.  Centrifuge for 10 min at 12,000 g at 4°C and transfer the supernatant 
to a new tube.
41.  Repeat the centrifugation step, and transfer the supernatant to a new tube. 
PAUSE POINT. Samples can be stored for several months at -80°C for 
later use, or directly analyzed by end-point dilution assay. 
42. Proceed with the titration, as described in steps 26-30.
Timing 
Step 1-23: Fly preparation: Bleaching: 1 day, Tetracycline treatment: 25 
days (2 generations of ≈10-12 days each), SNP sequencing: 1 day, Aging: 3 
days. Total preparation: 25-30 days. 
Step 24-31: Virus preparation: Preparation of virus stock: 3-6 days, Titration: 
14 days. Total preparation: 17-20 days.
Step 32-35: Virus injection: Dilution for injection: 15 min, Needle preparation: 
15 min, Injection settings: 5 min, Injection: 1-4 hours. Total preparation: 2-5 
hours. 
Step 36-42: Follow-up studies: Survival studies: ≈ 10 days (depending 
on virus and inoculum), Titrations: 14 days. Total preparation: 15-24 days 
(depending on which time points are analyzed for titration).
76
Chapter 2
Troubleshooting
Step Problem Possible reason(s) Possible solution
15 There is no offspring on tetra-
cycline-containing medium
Flies need more time to deve-
lop on tetracycline medium
Incubate vials at 25°C, make 
sure the medium is humid 
enough (if needed, add a 
few drops of water) and wait 
at least 15 days to obtain 
progeny.
18 The fly stock is Wolbachia 
positive
Contamination at the PCR 
step (Step 17)
Inefficient antibiotic treatment 
(step 13-14)
Carefully repeat the PCR.
Prepare new medium, making 
sure that the antibiotic is 
added at the right temperatu-
re. Prevent contamination as 
described in Box 1.
35 Many flies died within 1 day 
following injection
Lethal injuries due to large 
needle sizes (step 34)
Lack of experience
Make sure that the capillary 
needles are thin and cause 
minimum damage to the flies. 
If needed, optimize the settings 
of the needle puller.
If the tip of the needle breaks 
during an experiment, replace 
with a new needle. 
Repeat the experiment. 
Injection is a skill that needs 
practice.
37 Poor food quality: desiccation 
of food and fungal growth.
Few flies in the tubes (for 
example, at the end of a 
survival assay)
Change tubes as often as ne-
cessary and carefully monitor 
food quality.
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Anticipated results
Analysis of tolerance and resistance in the fly is a multi-step process that 
starts with the preparation of fly strains of interest. Egg bleaching and 
tetracycline treatment will eliminate persistent virus and Wolbachia infections, 
which are common in Drosophila laboratory stocks. Sequencing the pastrel 
locus will uncover possible discordance between fly lines in SNPs that are 
genetically associated with resistance to virus infection. Variables, such 
as gender, age, and genotypic background should remain constant, given 
their possible influence on experimental outcomes. Finally, well-controlled 
infections that include mock infections and matched genetic controls, 
appropriate group sizes, and replicates are essential to obtain high-quality, 
reproducible datasets. 
It was recently proposed that host defense depends on a combination 
of resistance and tolerance mechanisms (1, 2). Resistance is mediated 
by cellular pathways that detect the pathogen and induce the expression 
of antiviral effectors that control its proliferation. As a consequence, it is 
expected that genetic inactivation of resistance mechanisms will lead to an 
increase in viral load, increased morbidity, and reduced survival. Typically, a 
fly mutant with a defect in resistance will succumb to systemic infection a few 
days earlier than a wild-type fly. Additionally, viral titers are expected to reach 
higher levels in resistance mutants, especially at the early stages of infection 
(10, 11, 13, 15). This may, however, depend on the strength of the allele (i.e. 
whether is it a null mutant, or merely a hypomorphic allele). Moreover, it is 
possible that some resistance mechanisms have tissue or cell type-specific 
functions, and differences in viral load may only be detectable in specific 
tissues (15) or for specific viruses. Alternatively, a resistance phenotype may 
be experimentally demonstrated by overexpression of an antiviral effector 
protein. It is then expected that virus replication is diminished, possibly until 
viral persistence or clearance, and that survival rates improve. 
Tolerance mechanisms limit detrimental effects of microbial infection 
on the host, such as direct tissue damage inflicted by the pathogen or 
immunopathology due to excessive immune responses. As a consequence, 
fly mutants with defects in tolerance are expected to show lower survival 
rates upon infection, without major changes in microbial load (12). It 
should be noted that specific cellular pathways may contribute to both 
resistance and tolerance in a pathogen-specific manner (54). Consequently, 
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phenotypes in survival assays may be more complex than suggested by a 
simple dichotomy between resistance and tolerance.
Host survival rates and viral loads are relatively straightforward read-outs, 
which, combined with the genetic tractability of Drosophila, already have 
yielded and will continue to provide important insights into antiviral defense. 
While powerful, these assays do not capture the complex pathological 
consequences of infection, and could be expanded with histological assays 
to study tissue morphology, as well as physiological and metabolic read-
outs (19, 20, 55). More recently, models to analyze complex physiological 
traits, such as gut-microbiota interactions, neuroinflammation, or hormonal 
regulation, have been developed in Drosophila (56), which may also be 
explored in the context of resistance and tolerance to virus infection. 
In-depth understanding of antiviral resistance and tolerance mechanisms is 
important for the development of novel therapeutic approaches in humans 
(57). The fruit fly and its ever-expanding experimental toolbox offer great 
promise for future studies. 
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Supplementary Information
Box 1: Tips for preventing contamination of fly stocks
• Keep fly pads and brushes clean by decontaminating weekly (or more 
frequently, depending on usage). Immerse the tools in a solution of 
80% ethanol and 10% bleach for 30 min. Rinse thoroughly with water, 
followed by a rinse in 80% ethanol. Re-use when fully dried. 
• Keep sets of brushes and pads for infection experiments separate from 
those for handling non-treated stocks.
• Always keep the workspace clean by wiping it with a 80% ethanol/10% 
bleach solution before and after each use. 
• Keep infected and non-infected fly stocks in separate incubators, if not 
separate fly rooms.
• Every 3 months, randomly select fly strains and verify that they are virus 
and Wolbachia-free by PCR assay. 
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Abstract 
Little is known about the tolerance mechanisms that reduce the negative 
effects of microbial infection on host fitness. Here, we demonstrate that 
the histone H3 lysine 9 methyltransferase G9a regulates tolerance to virus 
infection by shaping the response of the evolutionary conserved Jak-Stat 
pathway in Drosophila. G9a-deficient mutants are more sensitive to RNA 
virus infection and succumb faster to infection than wild-type controls, which 
was associated with strongly increased Jak-Stat dependent responses, but 
not with major differences in viral load. Genetic experiments indicate that 
hyperactivated Jak-Stat responses are associated with early lethality in 
virus-infected flies. Our results identify an essential epigenetic mechanism 
underlying tolerance to virus infection. 
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Author Summary 
Multicellular organisms deploy various strategies to fight microbial infections. 
Invading pathogens may be eradicated directly by antimicrobial effectors of 
the immune system. Another strategy consists of increasing the tolerance 
of the host to infection, for example, by limiting the adverse effects of the 
immune response. The molecular mechanisms underlying this novel concept 
remain largely uncharacterized. Here, we demonstrate that the epigenetic 
regulator G9a mediates tolerance to virus infection in Drosophila. We found 
that G9a-deficient flies succumb faster than control flies to infection with RNA 
viruses, but that the viral burden did not significantly differ. Unexpectedly, 
mutant flies express higher levels of genes that are regulated by the Jak-
Stat signaling pathway, which in other studies was found to be important 
for antiviral defense. Exploiting the genetic toolbox in Drosophila, we 
demonstrate that Jak-Stat hyperactivation induces early mortality after virus 
infection. Precise control of immune pathways is essential to ensure efficient 
immunity, while preventing damage due to excessive immune responses. 
Our results indicate that G9a, an epigenetic modifier, dampens Jak-Stat 
responses to prevent immunopathology. Therefore, we propose epigenetic 
regulation of immunity as a new paradigm for disease tolerance. 
Epigenetic regulation of immune tolerance
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Introduction 
Efficient immunity against pathogens requires the coordinated activation 
and repression of genes within multiple signaling networks. Insufficient 
immune activation results in high microbial burden, severe pathogenesis, 
and high mortality from infection; overly strong immune responses may lead 
to tissue damage, immunopathology, and auto-inflammatory diseases. The 
inevitable tradeoff between immunity and immunopathology necessitates 
tightly regulated induction and resolution of immune responses. This is 
achieved by negative regulatory circuits within and among immune signaling 
cascades and by complex cellular and molecular programs that terminate 
inflammation (1, 2).
It was recently proposed that host defense depends on a combination of 
resistance mechanisms, which lower or eliminate pathogen burden, and 
tolerance mechanisms (3, 4). Tolerance reduces the negative effects of 
an infection on host fitness, which could be either direct damage inflicted 
by the pathogen itself or adverse effects of the immune response on host 
tissues. Little is known about the molecular basis for tolerance, but it likely 
involves regulatory mechanisms that control the magnitude of the immune 
response (3, 4). 
The fruit fly Drosophila melanogaster is a powerful model to genetically and 
functionally dissect innate immunity. Past studies found that the evolutionarily 
conserved NF-ĸB pathways Toll and Immune Deficiency (Imd) mediate the 
humoral response against bacteria and fungi (5). Defense against viruses, 
in contrast, requires the constitutively expressed RNA interference (RNAi) 
pathway (6). In addition, the RNA viruses Drosophila C virus (DCV), Cricket 
paralysis virus (CrPV), and Drosophila X virus (DXV) activate the Janus 
Kinase-Signal transducers and activators of transcription (Jak-Stat) pathway 
that orchestrates a transcriptional response to fight the infection (7, 8). 
The evolutionarily conserved Jak-Stat pathway controls important 
developmental and homeostatic processes, including hematopoiesis and 
immunity (9, 10). Deficiencies in Jak-Stat pathway genes cause serious 
immune disorders and increase susceptibility to infections (11-13), whereas 
hyperactivated Jak-Stat responses are associated with autoimmune 
diseases and carcinogenesis in humans (13, 14). Also in insects, the 
Jak-Stat pathway needs to be tightly controlled. The Jak-Stat pathway 
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is required for efficient antiviral immunity in fruit flies and Aedes aegypti 
mosquitoes (15). For example, loss-of-function fly mutants for the Jak kinase 
hopscotch (hop) support high levels of virus replication and show increased 
mortality rates upon infection with the RNA viruses DCV and CrPV (7, 8). 
Yet, hyperactivation of the Jak-Stat pathway in Drosophila can have serious 
consequences, such as the formation of lethal hematopoietic melanotic 
tumors in hop gain-of-function mutants (16).
Spatiotemporal regulation of immune responses occurs via a variety of 
mechanisms. At the transcriptional level, chromatin structure is a major 
determinant of gene expression. Histone-modifying enzymes deposit 
covalent modifications on specific amino acid residues of histone 
tails that alter the structure of chromatin and its accessibility to the 
transcriptional machinery. Histone H3 lysine 9 dimethylation (H3K9me2) 
is commonly regarded as a marker for heterochromatic genomic 
regions and transcriptional repression. Yet, G9a, one of the three H3K9 
methyltransferases in Drosophila, mediates H3K9 dimethylation in vivo, but 
is associated with euchromatic regions (17). Loss of G9a does not affect 
heterochromatin formation or global heterochromatic H3K9me2 levels in 
flies and mice (18, 19), but G9a fly mutants show loss of H3K9 dimethylation 
at about 5% of the euchromatic genome (20). Moreover, H3K9me2 can be 
associated with actively transcribed genes (21) and its presence does not 
globally correlate well with gene repression, unlike other repressive marks 
such as H3K27me2 and H3K27me3 (20, 22). These observations suggest 
that H3K9me2 is not solely associated with stably repressed genes, and 
that G9a might regulate defined sets of euchromatic genes. 
A previous study revealed that G9a controls genes that are involved in 
processes that require tight and dynamic regulation and high transcriptional 
plasticity, including neuronal processes, stress responses, and immunity 
(20). These observations prompted us to study the role of G9a in antiviral 
defense. Here, we report that G9a mutant flies are hypersensitive to RNA virus 
infection and that their inducible immune responses are highly dysregulated. 
We show that G9a and the Jak-Stat pathway epigenetically and genetically 
interact to modulate immune defense. Genetic hyperactivation of Jak-Stat 
signaling causes early lethality after viral infection, thus phenocopying loss 
of G9a. Together, our results uncover an epigenetic mechanism for tolerance 
that shapes Jak-Stat pathway activity in response to virus infection.
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Results 
Reduced survival of G9a mutant flies after RNA virus infection 
To investigate the role of G9a in Drosophila antiviral defense, we used the 
loss-of-function allele G9aDD2 and its wild-type genetic background control 
(hereafter referred to as G9a-/- and G9a+/+) (20). Since the H3K9me2 mark 
is essential for the establishment of heterochromatin and proper gene 
regulation, we first assessed the overall fitness of G9a-deficient flies. G9a 
mutants were viable, fertile, and showed no obvious defects in development, 
confirming previous observations (20, 23). Moreover, the average life span of 
G9a-/- flies was slightly longer than that of wild-type controls (mean survival 
= 105.8 days and 87,8 days, respectively; P < 0.001) (Fig. 1A). 
We challenged wild-type and mutant flies with DCV, a positive-sense RNA 
virus from the Dicistroviridae family, by intra-thoraxic injection. G9a mutants 
were more sensitive to infection than their wild-type controls, with a mean 
survival of 3.6 and 6.9 days for G9a-/- and G9a+/+ female flies, respectively (P 
< 0.001; Fig. 1B). Male G9a-deficient flies were also more sensitive to DCV 
infection than control flies, indicating that hypersensitivity to virus infection 
was not sex-dependent (Fig. S1A). 
To analyze whether G9a-/- flies were also more sensitive to other virus 
infections, we challenged flies with a panel of viruses with different genome 
organization and genetic makeup. Upon challenge with another Dicistrovirus, 
Cricket paralysis virus (CrPV), the mean survival of G9a mutants was 3.4 
days, compared to 7.3 days for wild-type flies (P < 0.001; Fig. 1C). Similarly, 
when infected with Flock House Virus (FHV), a positive-sense virus of the 
Nodaviridae family, G9a mutants succumbed faster than wild-type flies to 
infection (mean survival = 7.9 days and 13.1 days, respectively; P < 0.001; 
Fig. 1D). Also upon challenge with the dsRNA virus Drosophila X Virus (DXV, 
member of the Birnaviridae), G9a mutant flies displayed higher lethality rates 
compared to wild-type controls (mean survival 7.6 days and 13.6 days, 
respectively, P < 0.001; Fig. 1E). To analyze whether G9a mutants are also 
more sensitive to DNA virus infection, we challenged flies with Invertebrate 
iridescent virus 6 (IIV-6). As we observed before, IIV-6 infected wild-type 
flies survived for prolonged periods of time and mortality only became 
apparent in the later stages of the infection (>25 days post infection) (24). In 
contrast to their hypersensitivity to RNA virus infection, survival rates of G9a 
mutants after IIV-6 infection were similar to wild-type levels (mean survival 
= 33.6 days and 34.4 days, respectively; P = 0.2; Fig. 1F). Of note, mock 
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infection with Tris buffer did not affect the survival rate of G9a mutants for 
up to 40 days (Fig. 1F). Flies carrying another loss-of-function allele, G9aDD3, 
exhibited the same phenotype and succumbed more rapidly than their wild-
type controls to DCV, but not to IIV-6 infection (Fig. S1B-S1D). As G9a 
mutants displayed increased sensitivity against all RNA viruses tested, we 
used the model RNA virus DCV for follow-up studies. 
A
20 40 60 80 100 120 140
0
20
40
60
80
100
Time (days)
S
ur
vi
va
l (
%
)
G9a+/+
G9a-/-
5 10 15 20 25 30 35 40
0
20
40
60
80
100
S
ur
vi
va
l (
%
)
B
Time (days)
Mock; G9a +/+
Mock; G9a -/-
IIV-6; G9a+/+
IIV-6; G9a-/-
C
G
G9a+/+
G9a -/-
G9a -/-; C564-Gal4
G9a -/- ; C564-Gal4>UAS-G9a
G9a -/- ; UAS-G9a
1 2 3 4 5 6 7 8 9 10 11 120
20
40
60
80
100
S
ur
vi
va
l (
%
)
G9a+/+
G9a-/-
Time (days)
DCV
CrPV
IIV-6
2 4 6 8 10 12 14 16
0
20
40
60
80
100
S
ur
vi
va
l (
%
)
FHV
 G9a+/+
 G9a-/-
2 4 6 8 10 12 14 16 18
0
20
40
60
80
100
S
ur
vi
va
l (
%
)
Time (days)
DXV
 G9a+/+
 G9a-/-
D
E F
Time (days)
Mock; G9a +/+
Mock; G9a -/-
DCV; G9a+/+
DCV; G9a-/-
1 2 3 4 5 6 7 8 9 10 1112 13
0
20
40
60
80
100
Time (days)
S
ur
vi
va
l (
%
)
1 2 3 4 5 6 7 8 9 10 111213
0
20
40
60
80
100
Time (Days)
S
ur
vi
va
l (
%
)
94
Chapter 3
Fig. 1 |  G9a mutants have a normal life span but are hypersensitive to RNA virus 
infection. (A) Life span of non-infected female wild-type (G9a+/+) or G9a 
mutant (G9a-/-) flies at 20°C. (B-F) Survival of wild-type or G9a mutants 
infected with (B) DCV, (D) CrPV, (D) FHV, (E) DXV, (F) IIV-6, and Tris buffer 
as a control (mock). (G) Survival of wild-type or G9a mutant flies expressing 
a G9a transgene in the fat body using the UAS/Gal4 system upon DCV 
infection (1,000 TCID50 units). The fat body-specific C564 driver line (C564-
Gal4) was used to drive expression of the transcription factor Gal4, which 
binds to the Upstream Activating Sequence to induce expression of a G9a 
transgene (UAS-G9a). Flies expressing only the C564-Gal4 driver or the 
UAS-G9a responder construct were included as controls. Mock infections 
were performed in all experiments (B-G), and no difference in survival was 
observed between wild-type or G9a mutant flies, as shown in panel B and 
F. All survival data are available in S1 Dataset. Data represent means and 
s.d. of five (A) or three (B-G) biological replicates of at least 15 female flies 
(A-F), or 15 male flies (G) per replicate for each genotype. Data are from one 
experiment representative of at least 3 (B,C,F,G), or 2 (D,E) independent 
experiments. 
Fat body specific expression of G9a rescues hypersensitivity 
to virus infection 
To confirm the role of G9a in antiviral defense, we performed genetic rescue 
experiments by expression of a G9a transgene in the mutant background 
using the UAS/Gal4 system. We were unable to recover adult flies expressing 
the G9a transgene under control of the drivers actin-Gal4, daughterless-
Gal4 and tubulin-Gal4, suggesting that ubiquitous overexpression of G9a 
is detrimental to fly development. The fat body, an organ that is involved 
in metabolism and immunity (5), is a major target organ of DCV (25). We 
therefore used a fat body driver (C564-Gal4) to induce tissue-specific 
expression of the G9a transgene. Early lethality of infected G9a mutants 
(mean survival = 3.1 days) was rescued to control levels by fat body-specific 
G9a expression in the G9a-deficient background (mean survival = 5.6 days, 
compared to 6.3 days for G9a+/+; P = 0.482; Fig. 1G). Survival of genetic 
control flies that only express the C564-Gal4 driver or the UAS-responder 
in the G9a-/- background remained significantly different from wild-type flies 
(mean survival = 4.1 and 3.8 days, respectively, P < 0.001 for both), indicating 
that the observed rescue was dependent on functional expression of the 
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G9a transgene (Fig. 1G). The rescue was tissue specific, since expression 
of G9a in other tissues, such as hemocytes (using the hemolectin-Gal4 
driver), or glia (using the repo-Gal4 driver) did not rescue the phenotype 
of G9a mutants (Fig. S2A-S2B). These experiments indicate that G9a is 
required specifically in the fat body during virus infection. Moreover, these 
experiments genetically segregate the role of G9a in antiviral defense from 
its function in other organs (20). 
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Fig. 2 |  Loss of G9a does not affect viral loads upon DCV infection.   
(A,B) Wild-type or G9a mutant flies were inoculated with DCV and viral titers 
were determined over time in (A) whole flies, and (B) dissected fat bodies. Data 
represent means and s.d of three independent experiments. Each experiment 
contained three biological replicates of 5 female flies (A), or 10 fat bodies (B) per 
replicate for each genotype. (C,D) DCV RNA levels over the course of 3 days 
post-infection analyzed by RT-qPCR in (C) whole flies or (D) fat bodies of wild-
type and G9a mutant flies. DCV RNA levels were normalized to transcript levels 
of the housekeeping gene Ribosomal protein 49 and are calculated relative to 
the viral RNA levels in flies harvested immediately after inoculation (t0). Data 
represent means and s.d. of three biological replicates of 5 female flies (C) or 
10 fat bodies (D) per replicate for each genotype. Data in panel C and D are 
from one experiment representative of 2 independent experiments. *P < 0.05 
(Student’s t-test).
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Reduced tolerance of G9a mutants to RNA virus infection
To analyze whether the reduced survival of G9a mutants is due to a defect 
in resistance or to reduced tolerance to infection, we analyzed viral load 
over time. No differences in infectious viral titers were observed between 
G9a-/- and G9a+/+ flies during the first 3 days post-infection (dpi) (Fig. 2A). 
Since G9a was specifically required in the fat body during DCV infection 
(Fig. 1G), we analyzed viral titers in dissected fat bodies of virus-challenged 
flies. Virus titers in G9a-/- flies were slightly higher than in wild-type flies, 
but no significant difference was observed at any time point (Fig. 2B). To 
confirm these data, we measured viral RNA levels in whole flies and fat 
bodies by quantitative RT-PCR (RT-qPCR). Consistent with the results from 
the titration, we did not detect significant differences in DCV RNA levels in 
wild-type and mutant flies over three days post-infection. In the fat body, we 
observed a modest 3-fold increase in viral RNA at 1 dpi (P = 0.014), but not 
at the other time points (Fig. 2C and 2D).
Together, our results demonstrate that G9a mutants are more sensitive to 
DCV infection, but that this is not associated with a major and generalized 
increase in viral titers. Moreover, the modest increase in viral load at 1 dpi 
in the fat body seems insufficient to explain the strongly reduced survival 
upon virus infection. We conclude that G9a mutant flies exhibit defects in 
tolerance to RNA virus infection.
The antiviral RNAi pathway is functional in G9a mutants 
RNA interference (RNAi) is a major antiviral pathway in Drosophila (6). Given 
the hypersensitivity of G9a-/- flies to virus infection, we analyzed whether this 
pathway is functional in mutant flies. To this end, we first monitored RNAi 
activity using an in vivo sensor assay, in which the inhibitor of apoptosis 
thread (th) is silenced by expression of an RNAi-inducing hairpin RNA (thRNAi) 
(26, 27). Expression of thRNAi using the eye-specific driver (GMR-Gal4) leads 
to severe apoptosis in the developing eye. Consequently, adult thRNAi flies 
display a reduced eye size, roughening of the eye surface, and loss of 
pigmentation (Fig. S3A). This phenotype is fully dependent on the RNAi 
pathway, since the phenotype is lost in mutants lacking the central catalytic 
component of the pathway, Argonaute 2 (AGO2) (26, 27). We expressed 
the thRNAi hairpin in the eye of G9a-/- and G9a+/+ flies and analyzed the 
phenotype. Both in G9a-/- and G9a+/+ flies, expression of thRNAi resulted in 
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strong RNAi-induced eye phenotypes (Fig. S3A). These results suggest that 
G9a-/- mutant flies have no major defect in RNAi. 
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Fig. 3 |  Hyperactivation of the Jak-Stat pathway by virus infection of G9a mutants.  
(A,B) Expression of inducible immune genes at 24 hours after DCV infection 
(TCID50 = 10,000) determined by RT-qPCR in (A) whole flies, and (B) fat 
bodies of wild-type or G9a mutant flies. Expression of the gene of interest was 
normalized to transcript levels of the housekeeping gene Ribosomal protein 
49 and expressed as fold change relative to mock infection (Tris buffer). Data 
are means and s.d. of three independent pools of (A) 30 female flies and 
(B) 30 fat bodies for each genotype. (C,D) Basal expression levels of the 
indicated genes measured by RT-qPCR on 3 to 5-day-old unchallenged wild-
type and G9a mutant female flies (C) or fat bodies (D). Basal expression levels 
are expressed as dCt values (difference between Ct of the gene of interest 
and the Ct of Ribosomal protein 49). (E-I) Expression of inducible Jak-Stat 
dependent immune genes at (E-H) 24 hpi or (I) 7 dpi with 10,000 TCID50 units 
of (E) CrPV, (F) DXV, (G) FHV or (H,I) 14,000 TCID50 units of IIV-6. Data are 
means and s.d. of three independent pools of at least 15 female flies (C,E-I) 
or at least 10 fat bodies (D) per genotype. Data are from one experiment 
representative of 3 (A,B,E), and 2 (C,D) independent experiments. *P < 0.05; 
** P < 0.01; *** P < 0.001 (Student’s t-test).
To further evaluate the efficiency of the RNAi response of G9a mutants, 
we adapted a luciferase-based RNAi sensor assay that we routinely use 
in Drosophila S2 cells (27, 28), to adult flies. Flies were subjected to in vivo 
transfection with firefly and Renilla luciferase reporter plasmids along with 
either firefly luciferase-specific dsRNA or control dsRNA, and three days 
later, efficiency of silencing was assessed in whole fly lysates. As controls, 
we included Ago2 null mutants and their wild-type controls (w1118). As 
expected, silencing was abolished in Ago2-/- flies, confirming that loss of 
FLuc expression was RNAi dependent (Fig. S3B, left panel). Efficiency 
of silencing was similar in G9a-/- and G9a+/+ flies (Fig. S3B, right panel), 
indicating the RNAi pathway is fully proficient in G9a mutant flies.
Hyperactivation of the Jak-Stat pathway in G9a mutants 
upon virus infection
Since the RNAi pathway was fully functional in G9a-/- flies, we next analyzed 
whether inducible immune responses were intact in these flies. Virus 
infection of Drosophila activates the Jak-Stat pathway to induce expression 
of downstream genes, such as virus induced RNA-1 (vir-1) (7, 8). In addition, 
the NF-kB pathways Toll and IMD have been implicated in the response to 
99
Epigenetic regulation of immune tolerance
3
virus infections in some studies (29-31). We measured expression of vir-
1, the stress-induced genes Turandot A and M (TotA and TotM), and the 
antimicrobial-like peptide Listericin as markers for Jak-Stat activation. To 
monitor activation of the Toll and IMD pathways, we measured expression of 
genes encoding the antimicrobial peptides Drosomycin (Drs), Metchnikowin 
(Mtk), Diptericin (Dpt). In addition, we measured expression of Vago, which 
is induced in DCV infection via an unknown signaling pathway (25).
We monitored expression of these genes by RT-qPCR at 24 hours after 
DCV infection (hpi) in whole flies (Fig. 3A) and isolated fat bodies (Fig. 3B). 
As observed before (7, 8), DCV infection induced expression of the Jak-Stat 
dependent genes vir-1, TotA, and TotM, but not of NF-kB dependent Drs, Mtk, 
and Dpt genes. Strikingly, in G9a-/- flies we noted a much higher induction 
of Jak-Stat dependent genes than in wild-type flies, but no induction of NF-
kB dependent genes (Fig. 3A). In the fat body, even stronger overactivation 
of Jak-Stat dependent pathway genes was observed in G9a mutants (Fig. 
3B). However, basal expression levels of these genes did not differ between 
non-challenged G9a+/+ and G9a-/- flies (Fig. 3C and 3D), suggesting that 
G9a is not required for steady-state repression of these genes, but that it 
mitigates their inducibility in response to viral infection. 
We also monitored expression of the Jak-Stat dependent genes upon 
infection with 3 other RNA viruses: CrPV, DXV and FHV (Fig. 3E-3G). As 
observed upon DCV infection, a strong upregulation of vir-1, TotA, and TotM 
was found in G9a mutants compared to wild-type flies. Upon infection with 
the DNA virus IIV-6, we detected only slight expression of these genes (1 
to 4-fold, at 24 hpi and 7 dpi, when the replication plateau is reached), and 
expression levels were not significantly different between wild-type and G9a 
mutant flies (Fig. 3H and 3I). We note that those viruses that induce higher 
Jak-Stat activation also induce higher mortality rates in G9a mutants (Fig. 
1B-1F). Our results are in line with a previous report showing that DCV, CrPV, 
DXV, and FHV, but not IIV-6, induce expression of the Jak-Stat dependent 
genes vir-1 or TotM (7). In that study, DXV induces strong TotM expression, 
and DCV, CrPV and FHV induce mainly vir-1 expression, whereas under our 
experimental conditions, TotA and TotM are induced at higher levels than 
vir-1 for all viruses. 
Jak-Stat deficient flies were reported to display higher viral load and 
increased mortality upon DCV and CrPV infection (7, 8), suggesting that 
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the Jak-Stat pathway controls expression of antiviral effectors. Our data 
suggest that robust induction of Jak-Stat dependent genes is not sufficient 
for efficient host defense, which is in line with previous observations (8). 
Moreover, the G9a phenotype seems counter-intuitive, since the antiviral 
Jak-Stat pathway is strongly activated in G9a mutant flies, yet they are 
hypersensitive to virus infection. 
G9a mutants display an altered transcriptional response to 
virus infection
To analyze the transcriptional response to viral infection at a genome-
wide scale, we performed transcriptome analyses by next-generation 
sequencing (RNA-seq). We infected wild-type or G9a mutant flies with DCV, 
and collected whole flies or dissected fat bodies at 24 hpi (Fig. 4A). At this 
time point, flies do not yet exhibit pathological symptoms, such as reduced 
locomotion and abdominal swelling. 
We first determined the number of differentially expressed genes (≥ 2-fold) 
upon DCV infection in whole fly (Fig. 4B) or fat body (Fig. 4C) relative to 
mock-infected flies. We noted that only a limited number of genes were 
induced upon DCV infection in whole wild-type flies (n = 31), whereas many 
more genes were induced in the fat body (n = 129), possibly because the 
fat body is a major immune organ and a target organ for DCV (25). In G9a 
mutants, significantly more genes were induced upon DCV infection than in 
wild-type flies, both in whole flies and in dissected fat bodies (n = 74, P < 
0.0001 and n = 548, P < 0.0001, respectively, Pearson’s chi-squared test). 
We also observed a large number of genes that were downregulated upon 
DCV infection. These genes followed the same trends as the virus-induced 
genes, with greater number of genes affected in G9a mutants both in whole 
fly and fat body. These observations are in agreement with the results from 
Fig. 3 and suggest that the transcriptional response to virus infection is 
dysregulated in G9a mutants. 
Only a limited number of genes were induced by DCV in both wild-type and 
G9a mutant flies (13 and 28 genes in whole fly and fat body, respectively; 
Fig. 4D and 4E). This core set of virus-induced genes consisted of genes 
involved in stress responses such as heat shock proteins (Hsp70 family, 
Hsp68) and the Jak-Stat dependent Turandot proteins (TotM, TotX, TotC), 
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as well as other Jak-Stat dependent genes, Diedel (32) and Suppressor of 
Cytokine Signaling 36E (Socs36E ) (8), and genes of unknown function (Fig. 
S4A and S4B). 
Jak-Stat dependent genes are enriched in the G9a 
transcriptome
 
We focused our subsequent analyses on the genes that were differentially 
expressed (≥2-fold) in G9a mutants, based on the prediction that if G9a 
represses genes by depositing H3K9me2 marks, direct target genes are 
most likely de-repressed in G9a mutants. To analyze whether specific 
biological processes are dysregulated in G9a mutants, we analyzed Gene 
Ontology (GO) terms of genes that were expressed at least 2-fold higher 
in DCV-infected G9a mutant flies over infected wild-type flies. In the whole 
fly dataset, we observed significant enrichment for GO terms, such as 
“response to abiotic stimulus” and “response to stress” (within the ancestral 
GO term “response to stimulus”) and “immune response” (ancestral GO 
term “immune system process”) (Fig. 4F, Fig. S4C). GO term analysis on 
the fat body dataset identified several additional processes, including 
“reproduction” and “locomotion” (Fig. 4G, Fig. S4D). Using Pscan (33) to 
predict transcription factor binding sites in the promoter regions of the 
differentially expressed genes, we observed, in addition to the TATA-box 
binding motif, strong enrichment of Stat binding sites, and target sites of 
the JNK cascade transcription factor, AP-1 (Fig. 4H and 4I). In accordance, 
we noted among the categories “response to stress” and “immune system 
processes” genes of the Jak-Stat and c-Jun N-terminal Kinase (JNK) 
signaling pathways, which included pathways components (dPIAS, Socs36E 
for Jak-Stat; Hemipterous, Gadd45, Jra, Kay for JNK) as well as some of 
their downstream targets (Socs36E, vir-1, CG13559, CG1572 for Jak-Stat; 
Puckered and Rab-30 for JNK) (34). 
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Fig. 4 |  RNA sequencing and transcriptome analysis of wild-type and G9a mutant 
flies following DCV infection. (A) Experimental workflow. Three to five-day-old 
female flies were infected with DCV or mock-infected with Tris buffer as a 
control and TotAl RNA was extracted for next-generation sequencing from 
whole flies or dissected fat bodies at 24 hpi. (B,C) Number of differentially 
expressed genes in (B) whole flies or (C) fat bodies of wild-type (G9a+/+) or 
mutant (G9a-/-) flies upon virus infection normalized to their respective mock 
control. Numbers of genes with ≥2-fold change are shown. (D,E) Venn 
diagrams representing the overlap of DCV-induced genes (relative to mock) 
between wild-type and G9a mutant flies in (D) whole flies or (E) fat bodies. 
(F-I) Gene ontology (GO) and predicted transcription factor binding sites 
of genes that are expressed at ≥2-fold higher levels in DCV infected G9a 
mutants than in infected wild-type flies. (F,G) All significantly enriched GO 
terms of level 2 are shown (P < 0.05 in a hypergeometric test with Benjamini 
& Hochberg correction). (H,I) Pscan was used to predict transcription factor 
binding sites in the 500-bp region upstream of the transcription start site 
using the TRANSFAC database. Significantly enriched transcription factors 
compared to the genome-wide mean are shown (P < 0.05 in a z-test). Data 
are from whole flies (F,H) or dissected fat bodies (G,I). 
G9a targets genes of the Jak-Stat pathway 
Our results indicate that the transcriptional response to infection is highly 
dysregulated in the absence of G9a and that Jak-Stat pathway components 
and downstream targets are among the genes that are derepressed in G9a 
mutants. We then asked whether these derepressed Jak-Stat genes are 
direct targets of G9a, or whether they are affected indirectly.
A previous study identified putative G9a target sites by comparing genome-
wide H3K9me2 profiles obtained by chromatin immunoprecipation (ChIP) 
followed by next generation sequencing in wild-type and G9a mutant larvae 
(20). Interestingly, these predicted targets are enriched for the GO term 
“Jak-Stat cascade” (P = 0.0011, 2.3-fold enrichment). We therefore selected 
Jak-Stat genes that fulfilled three criteria for further analysis: i) harboring a 
reported loss-of-methylation site in G9a mutants, ii) previously shown to be 
involved in defense responses, iii) being upregulated in the transcriptome 
sets of challenged G9a mutants. This set of five genes consisted of pathway 
components and regulators (domeless, dPIAS, Socs36E ), as well as 
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the downstream targets vir-1 and TotM (10, 35-38). Using RT-qPCR, we 
confirmed that all five predicted G9a target genes show over-induction in 
response to virus infection in G9a mutant fat bodies (domeless, dPIAS, 
Socs36E, Fig. 5A; vir-1, TotM, Fig. 3B). For none of these genes, a difference 
in basal expression was observed in the absence of viral infection, indicating 
that these genes are only derepressed upon viral infection in G9a mutants 
(Fig. 5B, Fig. 3D).
We next analyzed G9a-dependent targeting of these Jak-Stat genes by 
H3K9me2 ChIP followed by qPCR (ChIP-qPCR) in dissected fat bodies 
of wild-type and G9a mutants. We designed qPCR primers in the loss-of-
methylation regions observed in ChIP-seq, as shown (domeless in Fig. 5C; 
dPIAS, Socs36E, vir-1, TotM in Fig. S5A-S5J). We found that Socs36E and 
domeless were significantly depleted of H3K9me2 in the fat body of G9a 
mutants at previously predicted G9a target sites (20) (Fig. 5D). Not all G9a 
targets sites could be confirmed, possibly because ChIP-seq and ChIP-
qPCR have been performed at different developmental stages and tissues 
(whole larvae versus adult fat body, respectively). Although we could not 
confirm direct targeting by G9a of dPIAS, vir-1 and TotM using ChIP-PCR, 
we did observe higher expression of these genes in infected G9a mutants. 
Upregulation of these genes could be a secondary effect resulting from the 
dysregulation of pathway components, such as domeless and Socs36E, in 
G9a mutants, rather than from direct epigenetic regulation by G9a. Taken 
together, these observations suggest that G9a epigenetically regulates a 
subset of Jak-Stat genes in the adult fat body to shape their transcriptional 
response to virus infection. 
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Fig. 5 |  G9a targets genes of the Jak-Stat pathway.   
(A) Expression levels of domeless, dPIAS, and Socs36E at 24 hpi in fat bodies 
of 3 to 5-day-old female wild-type or G9a mutant flies challenged with DCV 
(10,000 TCID50 units). Data are expressed as fold change relative to mock 
infection (Tris buffer). (B) Basal expression levels of Jak-Stat genes measured 
by RT-qPCR on fat bodies of 3 to 5-day-old unchallenged female wild-type 
and G9a mutant flies. Basal expression is presented as dCt (difference 
between Ct of the gene of interest and the Ct of Ribosomal protein 49). (C) 
Representative example of a G9a target locus within the domeless gene, 
defined as a genomic region in which the H3K9me2 mark is present in wild-
type flies, but not in G9a mutants, in a previous study (20). Blue and red plots 
represent sequence reads in H3K9me2 ChIP-seq analyses of wild-type and 
G9a mutants, respectively (20). Gene structure is indicated with boxes for 
exons, lines for introns, and gray boxes for untranslated regions. The arrow 
represents the position of the amplicon generated by qPCR after Chromatin-
Immunoprecipitation (ChIP-qPCR). (D) H3K9me2 ChIP-qPCR on fat bodies of 
wild-type or G9a mutant flies. Fold enrichment is the percentage of input of the 
gene of interest normalized to that of a reference gene with very low H3K9me2 
marks (moca). Specificity control experiments for ChIP-qPCR experiments are 
shown in Fig. S5E-S5J. Data are means and s.d. of (A,B) three independent 
pools of at least 10 fat bodies, or (D) three independent pools of 80 female fat 
bodies, for each genotype. Data are from one experiment representative of 2 
(A,B) or 6 (D) independent experiments. *P < 0.05 (Student’s t-test). 
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Fig. 6 |  Genetic interaction between G9a and the Jak-Stat pathway.   
(A,B) Survival upon DCV infection (1,000 TCID50 units) of wild-type or G9a 
mutant and wild-type flies overexpressing (A) a dominant negative version 
of the domeless receptor (domeΔCyt), or (B) the negative regulator of Jak-
Stat signaling Socs36E. The UAS/Gal4 system was used to drive transgene 
expression. Gal4 is expressed under control of the actin promoter (Act-
Gal4) to drive ubiquitous expression of the UAS-domeΔCyt and UAS-Socs36E 
transgenes. Control flies expressing only the Act-Gal4, the UAS-domeΔCyt, 
or the UAS-Socs36E transgenes were included as controls (see S5A and 
S5B Dataset). Mock infections where performed along the experiments and 
are shown in Fig. S6A - S6B. (C,D) Expression of TotA and vir-1 upon DCV 
infection of wild-type or G9a mutant flies, expressing (C) domeΔCyt, or (D) 
Socs36E. Expression of the gene of interest (by RT-qPCR) was normalized 
to transcript levels of the housekeeping gene Ribosomal protein 49 and 
expressed as fold change relative to mock infection (Tris buffer). Data are 
means and s.d. of three independent pools of at least 15 male flies for each 
genotype. (A,B) A representative experiment of two independent experiments 
is shown. Differences in expression of TotA and vir-1 were evaluated with a 
Student’s t-test (*P < 0.05; ** P < 0.01; *** P < 0.001). 
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G9a regulates tolerance through modulation of Jak-Stat 
pathway activity
Our data suggest that G9a regulates Jak-Stat responses to prevent 
excessive expression of downstream target genes. We performed genetic 
epistasis tests to analyze the relationship between G9a and the Jak-Stat 
pathway. Epistasis is defined as a genetic interaction in which a mutation 
in one gene masks the phenotype of a mutation in another gene. We 
hypothesized that if G9a mediates viral tolerance through dampening Jak-
Stat-induced transcription, inactivation of the Jak-Stat pathway would 
mask the hypersensitivity of G9a mutants to virus infection. Alternatively, if 
G9a confers tolerance to DCV infection in a Jak-Stat independent manner, 
simultaneous loss of G9a and Jak-Stat function would result in more 
dramatic hypersensitivity to virus infection. 
To test our hypothesis, we combined the mutant G9a allele with a dominant 
negative allele of the Jak-Stat pathway receptor domeless (domeΔCyt) under 
control of a UAS enhancer (39). We drove expression of domeΔCyt in the 
background of G9a mutants and wild-type controls using the ubiquitous actin-
Gal4 driver and challenged flies with DCV. As expected (8), overexpression 
of domeΔCyt increased mortality rates in a G9a+/+ background. Remarkably, 
the difference in survival between G9a-/- and G9a+/+ flies was masked in 
the Jak-Stat impaired genetic background (Fig. 6A). Moreover, mortality 
rates of double mutant flies (G9a-/- and Jak-Stat deficient) were similar to 
those of flies in which either G9a or Jak-Stat was inactivated. Therefore, our 
data suggests a genetic interaction between G9a and the Jak-Stat pathway 
receptor, domeless. Additionally, we found that domeΔCyt negated the over-
induction of TotA and vir-1 in DCV-infected G9a mutants, demonstrating 
that G9a regulates these genes in a Jak-Stat dependent manner (Fig. 6C).
To confirm these results with another Jak-Stat loss-of-function allele, we 
performed a second epistasis experiment using a fly strain overexpressing 
the negative regulator of the Jak-Stat pathway Socs36E under control of the 
UAS sequence (40). Similar to the experiment with domeΔCyt, overexpression 
of Socs36E masked the hypersensitivity phenotype of G9a mutants to virus 
infection, suggesting a genetic interaction between G9a and Socs36E (Fig. 
6B). Again, as expected, Socs36E overexpression significantly reduced 
expression of TotA and vir-1 (Fig. 6D). In both assays, mock infections 
were performed in parallel, confirming that differences in survival cannot 
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be attributed to the injury caused by the injection itself (Fig. S6Aand S6B). 
As the DCV inoculum of 1,000 TCID50 induced high mortality rates in G9a 
mutants, as well as in Jak-Stat deficient flies, it remained possible that we 
may have missed higher mortality rates in flies carrying both mutations. 
Therefore, we repeated the epistasis experiments using a lower inoculum 
of 100 TCID50, and confirmed that combining Jak-Stat inactivation with G9a 
loss-of-function did not yield higher mortality rates than in single mutants 
(Fig. S6C-S6D). 
In both cases, inhibition of Jak-Stat signaling in wild-type flies masked 
the effect of a G9a null mutation upon viral challenge, indicating a genetic 
interaction between G9a and the Jak-Stat components. Taken together, 
these results suggest that G9a regulates viral tolerance through modulation 
of Jak-Stat pathway activity.
Jak-Stat hyperactivation induces early mortality after virus 
infection  
Our results suggest that G9a buffers Jak-Stat dependent responses to 
prevent excessive expression of Jak-Stat dependent genes. We hypothesize 
that hyperactivation of the Jak-Stat response induces immunopathology 
that causes increased mortality of G9a mutants upon virus infection. This 
hypothesis predicts that ectopic activation of the Jak-Stat pathway results 
in increased rates of mortality upon virus infection. 
To test this prediction, we activated the Jak-Stat pathway in adult flies by 
ubiquitous expression of Unpaired (Upd), a ligand for the domeless receptor, 
and subsequently infected flies with DCV. Since the Jak-Stat pathway has 
important functions in development, we used the temperature sensitive 
Gal80ts allele (41) to induce ubiquitous Upd expression in adult flies by 
transferring them from 18-20°C (non-permissive temperature) to 29°C 
(permissive temperature) (Fig. 7A). We confirmed by RT-qPCR that Upd 
as well as the Jak-Stat target gene TotA were strongly induced at 3 days 
after the shift to 29°C (Fig. 7B). We next challenged Upd-overexpressing 
adult flies with virus. Strikingly, flies with a hyperactivated Jak-Stat pathway 
succumbed earlier to DCV infection (mean survival = 3.3 days) than genetic 
control flies expressing only the UAS-Upd transgene or the tubulin-Gal4, 
tubulin-Gal80ts drivers (mean survival = 5.5 days for both, P < 0.001) (Fig. 
7C). Moreover, irrespective of the genotype, mock infection did not induce 
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mortality, excluding the possibility that incubation at 29°C is a stressor 
that triggers early lethality. We conclude that ectopic Jak-Stat activation 
phenocopies loss of G9a, indicating that immune hyperactivation may 
underlie the hypersensitivity of G9a mutant flies to DCV infection. 
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Fig. 7 |  Hyperactivation of the Jak-Stat pathway renders flies hypersensitive to virus 
infection. (A) Experimental set-up. Expression of the Upd transgene was 
induced specifically in adult flies using the Gal4/Gal80ts system. Gal80ts 
is a temperature-sensitive allele of the Gal80 inhibitor that binds Gal4 to 
prevent activation of gene expression at 20°C. At 29°C, Gal80ts is degraded, 
allowing Gal4 to bind to the Upstream Activating Sequences (UAS) to induce 
gene expression. Flies were reared at 20°C, and 0 to 3-day-old adults were 
conditioned at 29°C for 3 days prior to viral challenge. (B) Expression levels 
by RT-qPCR of Upd and TotA in flies carrying the temperature-dependent 
Upd overexpression system (UAS-Upd; tubulin-Gal4/Gal80ts) after 3 days 
conditioning at 29°C. The Gal4 and Gal80ts transgenes were combined with 
the UAS-Upd by standard genetic crosses at 20°C and 0 to 3-day-old adult 
offspring was cultured for 3 days at 20°C or at 29°C before RNA levels were 
analyzed by RT-qPCR. Transcript levels of Upd and TotA were normalized to 
RNA levels of the housekeeping gene Ribosomal protein 49, and expressed 
as fold change relative to control flies carrying only the UAS-Upd transgene. 
(C) Survival of flies carrying the temperature-dependent Upd overexpression 
system (UAS-Upd; tubulin-Gal4/Gal80ts) and genetic control flies upon 
DCV infection (1,000 TCID50= units) at 29°C. Data are means and s.d. of 
three independent pools of at least 10 male flies for each genotype. Data in 
(C) are from one experiment representative of 2 independent experiments. 
Differences in expression of Upd and TotA were evaluated with a Student’s 
t-test (*P < 0.05; ** P < 0.01; *** P < 0.001).
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Discussion 
Disease tolerance was recently defined as a defense strategy that reduces 
the negative impact of infection on host fitness, without a concomitant 
reduction of pathogen burden (3, 4). The concept of tolerance (also 
termed resilience) provides an exciting, novel perspective on pathogen-
host interactions in metazoans. A few examples of tolerance to bacterial 
or viral infections have been described in flies (42-48), but the mechanisms 
of tolerance remain largely unknown. In this study, we elucidate a novel 
epigenetics-based mechanism for tolerance. We provide evidence that the 
histone methyltransferase G9a contributes to tolerance by regulating the 
antiviral Jak-Stat signaling pathway. 
G9a mutant flies are hypersensitive to RNA virus infection. Transcriptome 
analyses indicate that Jak-Stat pathway genes are highly upregulated upon 
DCV challenge in G9a mutants, whereas their basal levels prior to viral 
infection are normal. This phenotype, like others reported previously (49, 
50), seems paradoxical: the antiviral Jak-Stat pathway is strongly activated, 
yet G9a flies are hypersensitive to infection, showing that immune induction 
per se is not sufficient for efficient host defense. We propose that increased 
expression of Jak-Stat dependent genes causes immunopathology, 
eventually resulting in earlier mortality upon virus infection. In support of this 
hypothesis, we demonstrated that G9a limits the strength of the immune 
response through Jak-Stat and that ectopic hyperactivation of Jak-Stat 
signaling triggered early lethality after DCV infection, thus phenocopying 
the G9a phenotype. Therefore, we propose that epigenetic regulation by 
G9a dampens Jak-Stat signaling to avoid immune hyperactivation and 
subsequent mortality. 
G9a seems to be required for tolerance to RNA viruses, but not to DNA viruses. 
G9a mutants induce higher expression of the Jak-Stat dependent genes vir-1, 
TotA, and TotM and show increased lethality rates upon infection with four RNA 
viruses (DCV, CrPV, FHV, and DXV). A previous study found that these viruses 
all induce either vir-1 or TotM to some extent, but that a resistance phenotype 
for Jak-Stat mutants (higher lethality rates in combination with increased viral 
load) was only observed after DCV and CrPV infection (7). Thus, whereas Jak-
Stat is only required for resistance to DCV and CrPV infection, our results 
suggest that all RNA viruses activate the Jak-Stat pathway and that precise 
epigenetic control of the pathway is required to prevent immunopathology.
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Like in mammals, hyperactivation of immune pathways in Drosophila 
is detrimental for fitness and survival. For instance, overexpression of 
antimicrobial peptides or loss of negative regulators such as Caudal or 
the catalytic peptidoglycan receptor proteins (PGRP-LB and PGRP-SCs) 
triggers severe tissue pathology in the gut that are reminiscent of chronic 
inflammatory syndromes in mammals (49, 51). The mechanism by which 
Jak-Stat overactivation triggers lethality remains to be determined, but 
may involve expression of potentially toxic gene products that require 
tight regulation. Moreover, we cannot exclude that additional derepressed 
genes upon loss of G9a contribute to increased mortality of mutant flies. 
Alternatively, the G9a phenotype might be caused by defects in cell growth, 
differentiation, tissue homeostasis or apoptosis, which are also under control 
of the Jak-Stat pathway. We do note, however, that an external infectious 
stimulus, i.e. virus infection, was required to cause increased mortality upon 
genetic hyperactivation of the Jak-Stat pathway, and that G9a mutants 
appear to develop normally, thus excluding more generalized defects.
Our transcriptome analysis uncovered that, in addition to the Jak-Stat 
pathway, a multitude of pathways are activated by virus infection, many of 
which are of interest for follow-up studies. We observed a strong activation 
of the JNK pathway upon DCV infection. In accordance, predicted binding 
sites for the AP-1 complex, the transcriptional module of the JNK pathway, 
were highly enriched in promoters of genes upregulated upon DCV infection 
in G9a mutant fat bodies. Whether Stat and AP-1 associate upon virus 
infection to regulate immune genes cooperatively, as previously described 
in lipopolysaccharide stimulated Drosophila cells (52, 53), is an interesting 
question for future investigation. 
Our study makes an important contribution to understanding tolerance 
mechanisms beyond Drosophila. Two EHMT/G9a paralogs exist in 
mammals, EHMT1/GLP and EHMT2/G9a (20). They form a heterodimeric 
complex, and loss of either protein results in nearly identical phenotypes 
(54). We analyzed published microarray data of mice in which the G9a and 
GLP genes were inactivated in forebrain neurons and observed enrichment 
for the GO term “immune response”, and over-representation of NF-kB 
binding sites in differentially regulated genes, suggesting that G9a also 
regulates immune signaling cascades in mammals (Fig. S7). Indeed, a 
previous study suggested that the G9a-dependent H3K9me2 mark is an 
epigenetic determinant of the interferon response in murine and human 
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cells (55). In that study, the abundance of H3K9me2 at the promoters of the 
Interferon-β (Ifnβ) gene and Interferon stimulated genes (ISG) correlates with 
expression levels of these genes in different cell types, but deficiency in G9a 
did not affect basal gene expression. Pharmacological inhibition or genetic 
ablation of G9a increased Ifnβ and ISG expression in mouse fibroblasts and 
rendered these cells resistant to viral infection. 
Our results demonstrate that the role of G9a in controlling the responsiveness 
to immune challenge is evolutionarily conserved. Moreover, while the in vitro 
cell culture model suggested that loss of G9a would be beneficial to the 
antiviral response of the host (55), our data show that loss of G9a disrupts 
tolerance mechanisms at the organismal level, and is therefore detrimental 
for survival. This seems to better match the observations in humans. 
Heterozygous loss of EHMT1/GLP causes Kleefstra syndrome (OMIM number 
610253). This rare disorder is characterized by developmental delay and 
severe intellectual disability. Interestingly, up to 60% of Kleefstra syndrome 
patients suffer from recurrent infections; yet, these patients do not suffer 
from primary immune deficiencies (56). Whether defects in tolerance explain 
this aspect of the clinical presentation of Kleefstra syndrome remains an 
interesting hypothesis. 
Materials and Methods 
Fly strains and husbandry 
Flies were reared on standard cornmeal-agar media at 25°C on a light/dark 
cycle of 12h/12h. G9aDD2 mutants were generated previously by mobilization 
of the P-element KG01242 located in the 5’ UTR of the gene (20). G9aDD2 
has been used throughout the main text and is referred to as G9a-/-. A 
precise transposon excision line, referred to as G9a+/+, has been generated 
in the same genetic background and serves as a control in all experiments. 
An independent null allele, G9aDD3, has been generated by mobilization of 
the same P element and contains a deletion of 1850 bp that spans the 
translation start site (20) (Fig. S1B). The following fly stocks and alleles 
have been described before: UAS-G9a (ref. (20)), C564-Gal4 fat body driver 
(ref. (57)), Hml-gal4 hemocyte driver (ref. (58)), UAS-domeΔCyt (ref. (8, 37)), 
UAS-Socs36E (ref. (59)), UAS-Upd (ref. (59)), tubulin-Gal4, tubulin-Gal80ts 
(ref. (60)), and Argonaute 2414 (ref. (61)). The driver lines armadillo-Gal4 and 
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repo-Gal4 were obtained from the Bloomington Stock Center. In vivo RNAi 
experiments were performed by crossing GMR-Gal4, UAS-thRNAi/CyO male 
flies (26) with G9a+/+or G9a-/- virgins. The eye phenotype was monitored in 
two to four-day-old male F1 offspring lacking the CyO balancer. Upd was 
conditionally overexpressed by crossing tubulin-Gal4, tubulin-Gal80ts with 
UAS-Upd flies. Flies were reared at 20°C until hatching. Zero to three-day-old 
F1 offspring were then incubated at 29°C for 3 days prior to viral challenge, 
and cultured at 29°C throughout the remainder of the experiment. 
Virus infection 
Fly stocks were raised for two generations on standard fly flood containing 
0.05 mg/ml tetracycline hypochloride (Sigma) to clear Wolbachia infection. 
Absence of Wolbachia was verified by PCR on DNA of whole flies using 
Wolbachia-specific primers, as described previously (24). Persistent virus 
infections were cleared by bleaching embryos, and absence of DCV, DAV 
and Nora virus was verified by RT-PCR, as previously described (24). 
Virus stocks were prepared as described (24). Three to five-day-old flies were 
anesthetized with CO2 and injected with virus suspension using a Nanoject 
II injector (Drummond) in the thorax, between the mesopleura and the 
pteropleura. Virus suspensions in 10 mM Tris-HCl, pH 7.3 contained 1,000 
median tissue culture infectious dose (TCID50) of DCV and CrPV; 14,000 
TCID50 of IIV-6; 3,000 TCID50 of FHV and 2,000 TCID50 of DXV for all survival 
experiments. 10,000 TCID50 of DCV was used in experiments in which 
transcriptional responses were analyzed. Flies were cultured at 25°C and 
transferred to fresh food every 3 days. Survival was monitored daily; lethality 
at day 1 was attributed to the injection procedure and subtracted from the 
survival analysis. Unless noted otherwise, three pools of 10 to 15 flies were 
injected per condition with independent dilutions of virus stock. Fat body 
tissues were isolated by careful dissection of the abdominal carcasses of 
adult flies and removal of the gut and reproductive system. This procedure 
recovers cuticle-associated fat body with minor contamination by muscular 
and epidermal tissues (62). 
Virus titration
Drosophila S2 cells (Invitrogen) were cultured at 25°C in Schneider’s 
Drosophila Media (Gibco) supplemented with 10% heat-inactivated Fetal 
Calf Serum (PAA), 50 U/mL Penicillin and 50 μg/mL Streptomycin (Gibco). 
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DCV titers were determined by end-point dilution, as described previously 
(24). Briefly, 2.104 cells were seeded in 96-well plates and ten-fold dilutions 
of fly homogenate were inoculated in quadruplicate. Cells were transferred 
to fresh medium at day 5, and cytopathic effect (CPE) was monitored until 
day 14. Viral titers were calculated according to the method of Reed and 
Muench (63). 
RNA analysis 
RNA was isolated from flies using Isol-RNA lysis Agent (5-Prime), treated 
with DNase I (Ambion), and cDNA synthesis was performed on 1 μg RNA 
using TaqMan Reverse Transcription Reagents (Applied Biosystems) 
according to the manufacturer’s instructions. qPCR was performed on a 
LightCycler 480 using SYBR Green I Master Mix (Roche). The qPCR program 
was the following: 95°C for 5 min, and 45 cycles of 95°C for 5s, 60°C for 
10s, 72°C for 20s. Expression of the gene of interest was normalized to 
transcript levels of the housekeeping gene Ribosomal protein 49 (Rp49). 
The following primers were used for qPCR: 
Rp49 forward, 5’- ATGACCATCCGCCCAGCATAC-3’;
Rp49 reverse, 5’-CTGCATGAGCAGGACCTCCA-3’; 
Vago forward, 5’- CAGCCAAGCGATTCCTTATC-3’;
Vago reverse, 5’- CTCATACAGTGGGCAGCATC-3’; 
vir-1 forward, 5’-ATTACTCCGAATTCGAAGCTTCC-3’;
vir-1 reverse, 5’- CGAATTCTTCACGCTCCTTC-3’; 
Listericin forward, 5’-TTGCGGCCATTCTGGCCATG-3’, 
Listericin reverse, 5’- TTTACGTCCCCAACTGGAAC-3’; 
TotA forward, 5’- CCCTGAGGAACGGGAGAGTA-3’; 
TotA reverse, 5’- CTTTCCAACGATCCTCGCCT-3’; 
TotM forward, 5’- ACCGGAACATCGACAGCC-3’; 
TotM reverse, 5’- CCAGAATCCGCCTTGTGC-3’; 
Drosomycin forward 5’-GTACTTGTTCGCCCTCTTCG-3’; 
Drosomycin reverse, 5’- ACAGGTCTCGTTGTCCCAGA-3’; 
Metchnikowin forward 5’- TACATCAGTGCTGGCAGAGC-3’; 
Metchnikowin reverse, 5’- AATAAATTGGACCCGGTCTTG-3’; 
Diptericin forward, 5’- TGTGAATCTGCAGCCTGAAC-3’; 
Diptericin reverse, 5’- GCTCAGATCGAATCCTTGCT-3’; 
DCV forward, 5’- TTGCCATTGCACCACTAAAA -3’; 
DCV reverse, 5’- AAAATTTCGTTTTAGCCCAGAA -3’; 
Domeless forward, 5’- AGCTCTGATCCGGATTGTTG-3’; 
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Domeless reverse, 5’-ATCTCACCGCATTCACCAAG-3’; 
dPIAS forward, 5’-AACTGCCCTGTATGCGACAA-3’;
dPIAS reverse, 5’-ACACCTCCTGGAAGTAGCCA-3’; 
Socs36E forward, 5’-GTTGCTGCTCCCATTGAAAG-3’; 
Socs36E reverse, 5’-GCAAAAGTCGGAGTGTGAGAG-3’; 
In vivo RNAi reporter assay 
RNAi competency of adult flies was analyzed using a reporter assay that 
was adapted from a previously published method in S2 cells (27, 28). In vivo 
plasmid transfection was based on a method described for Aedes aegypti 
mosquitoes (64, 65). Three to five-day-old female flies were injected in the 
abdomen with a 100 nl suspension containing a 1:1 mixture of Schneider’s 
Drosophila Media (Gibco) and Lipofectamine 2000 (Invitrogen) complexed 
with 80 ng pMT-GL3 (encoding firefly luciferase, FLuc), 50 ng pMT-Ren 
(encoding Renilla luciferase, RLuc) and 1 ng FLuc-specific or non-specific 
control dsRNA. After incubation for 3 days at 25°C, flies were homogenized 
with a Douncer in passive lysis buffer (Promega). Supernatant was collected 
after 10 min centrifugation at 16,000 × g and transferred to a new tube, 
followed by centrifugation for 5 min at 16,000 × g. 25μL of fly lysate was 
used to measure FLuc and RLuc activity using the Dual Luciferase assay 
reporter system (Promega). Ratios of FLuc/Rluc were calculated for each 
sample, and data are presented as fold silencing relative to the non-specific 
dsRNA control (GFP). 
Chromatin immunoprecipitation followed by qPCR
 
Eighty dissected fat bodies were homogenized in PBS with a douncer and 
crosslinked with 3.7% formaldehyde for 30 minutes at room temperature. 
The cross-linking reaction was quenched by addition of 1.25 mM glycine, 
and the samples were washed with 1 mL PBS and resuspended in a buffer 
containing 150 mM Tris-HCl (pH 7.5), 600 mM KCl, 150 mM NaCl, 10 
mM EDTA, 1 mM EGTA, 1.5 mM spermine (Sigma) and 5 mM spermidine 
(Sigma). Tissue was further homogenized using a QiaShredder column, 
and cells were lysed by adding the same buffer supplemented with 2% 
Triton-X100. Nuclei were pelleted by centrifugation at 6,000 rpm for 10 min, 
and resuspended in 250 μL incubation buffer (0.75% SDS, 5% Triton-X100, 
750 mM NaCl, 5mM EDTA, 2.5 mM EGTA, 50 mM Tris pH 8.0, 0.4% BSA, 
1x protease inhibitor cocktail complete (Roche)). After nuclei purification, 
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chromatin was sonicated at 4°C using a Bioruptor sonicator (Diagenode) 
for 30 minutes at high power with cycles of 30 seconds ON, and 30 s 
OFF. Anti-H3K9me2 (ab1220, Abcam), anti- H3 (ab1791, Abcam), anti-V5 
(R960-20, Invitrogen) antibodies, and Prot A/G beads (Santa Cruz) were 
used to capture antibody-bound chromatin overnight at 4°C on a rotating 
wheel. Chromatin was eluted and de-crosslinked for 4 hours at 65°C in 
416 μL elution buffer containing 0.2 M NaCl, 1% SDS and 0.1 M NaHCO3. 
DNA was then isolated using phenol/chloroform, precipitated overnight at 
-20°C with 1 mL 100% ethanol, 5 μg linear acrylamide, 0.1 M NaAc, pH 5.2. 
The pellet was washed with 70% ethanol and resuspended in water. Non-
immunoprecipitated DNA was isolated in parallel from purified nuclei and 
used as an input control in qPCR. 
qPCR was performed on a LightCycler 480 using SYBR Green I Master Mix 
(Roche) using the following qPCR program: 95°C for 10 min, and 40 cycles 
of 95°C for 15s, 60°C for 1 min. The percentage of immunoprecipitated DNA 
relative to the input was calculated after qPCR. Fold enrichment in H3K9me2 
positive DNA was calculated by normalizing the percentage of input of the 
gene of interest to the euchromatic control gene previously shown to lack 
H3K9me2, moca (66). We confirmed in our conditions that H3K9me2 marks 
are indeed nearly absent on moca in both wild-type flies and G9a mutants. 
Also, we show that histone H3 levels are identical between G9a mutant 
and wild-type flies, both on moca and domeless. Using an aspecific IgG 
isotypic control antibody, we verified very low aspecific background binding 
to chromatin (Fig. S5E-J). 
Primers for qPCR were designed in regions previously shown to be depleted 
of H3K9me2 in G9a mutants by ChIP-sequencing (20). Sequences are as 
follows: 
Socs36E forward, 5’-GAAATCCGATGTGCTGAAG-3’; 
Socs36E reverse, 5’-ACATGGGGGTGTTTTACAGG-3’; 
Domeless forward: 5’-CACGTGGATCCAAAATACCC-3’; 
Domeless reverse, 5’-GATTGCGATTCCGAGAACTG-3’; 
dPIAS forward, 5’- CACTGACTCAACCACGCTTC-3’; 
dPIAS reverse, 5’-CCGTAAAAGGTGAACCGAAA-3’; 
vir-1 forward, 5’- TTGTTCTGGGGCAGAGAAAG-3’; 
vir-1 reverse, 5’- ATCGCTTCATGTCAGTGTCC-3’;
TotM forward, 5’-TTCGGGACGGTCACAGATAG-3’; 
TotM reverse, 5’-TCTCGAAAAACCCCTGTAGC-3’; 
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RNA sequencing 
Thirty whole flies or 100 fat bodies of three to five-day-old flies were collected 
at 24 hours after infection with 10,000 TCID50 of DCV. Samples were frozen 
on dry ice and stored at -80°C before RNA was isolated using Isol-RNA 
Lysis reagent as described above. The cDNA library was prepared with the 
Illumina TruSeq mRNA kit and single-end sequencing was performed on an 
Illumina HiSeq 2000 (Baseclear BV, Leiden, the Netherlands). RNAseq was 
performed on a single biological replicate, and should be considered an 
exploratory analysis. 
The FastQ sequence reads were generated in the Illumina Casava pipeline 
version 1.8.0. Initial quality assessment was based on data passing the 
Illumina Chastity filter. Reads containing only adapters or PhiX control 
sequences were removed by filtering protocols developed by Baseclear 
BV. The second quality control on the remaining reads was performed with 
FastQC quality control tool 0.10.0. Reads were mapped to the reference 
genome (Drosophila melanogaster R5/dm3, released in April 2006, UCSC 
Bioinformatics) using TopHat version 1.4.0. Differential expression between 
two datasets was analyzed with the Genomatix analysis suite (using DESeq 
1.0.6). Gene Ontology enrichment was analyzed using GoToolBox (67), 
with a hypergeometric test with Benjamini & Hochberg correction. Level 
2 GO terms are shown in Fig. 4, and level 3 GO terms in Fig. S4. Fold 
enrichment is the ratio of the GO term frequency in the G9a datasets to the 
genome-wide GO term frequency. Promoter binding-sites for transcription 
factors were predicted with Pscan (33) on the 500-bp region upstream of 
the transcriptional start site using the TRANSFAC database. Venn diagrams 
were generated using Biovenn (68). The RNA-Seq data are available at the 
NCBI Gene Expression Omnibus under series accession number GSE56013.
Statistical Analysis 
Kaplan-Meier analyses and log-rank tests, as implemented in SPSS 
Statistics (version 20, IBM), were used to evaluate whether differences in 
survival were statistically significant. For all other experiments, Unpaired two-
tailed Student’s t-tests and Pearson’s chi-squared test, as implemented in 
Graphpad Prism version 6, were used to determine statistical significance. 
P-values below 0.05 were considered statistically significant. 
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Fig. S1 | Hypersensitivity of G9a mutants to RNA virus infection is not sex-dependent, 
or allele-specific. (A) Survival of male, wild-type or G9a mutant flies upon DCV 
infection, or Tris buffer control (mock). The mean survival is 8.9 days for wild-
type flies, and 5.1 days for G9a mutants (P < 0.001). (B) Structure of the G9a 
locus. Boxes represent exons (5’ and 3’-untranslated regions in gray, and coding 
sequence in white). The KG01242 P-element insertion site that was used to 
generate the G9aDD3 allele is depicted by dashed lines. Size and location of the 
G9a deletion in the G9aDD3 allele are indicated. (C,D) Survival of wild-type or 
G9aDD3 mutants infected with (C) DCV, (D) IIV-6, or with Tris buffer as a control 
(mock). Upon DCV infection (C), the mean survival is 6.9 days for wild-type flies, 
and 4.4 days for G9aDD3 mutants (P < 0.001). Data represent means and s.d. of 
three biological replicates of 15 male flies (A) or 20 female flies (C,D) per replicate 
for each genotype. A representative experiment of 3 independent experiments 
is shown.
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expressing a G9a transgene in (A) hemocytes or (B) glial cells upon DCV 
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Upstream Activating Sequences to induce expression of the G9a transgene 
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Fig. S3 |  G9a mutants have a functional RNAi response. (A) Eye phenotype of wild-
type or G9a mutant flies (3 to 5-day-old) expressing an RNAi-inducing 
inverted repeat RNA targeting the Drosophila Inhibitor of Apoptosis thread 
(thRNAi). As controls, eyes of wild-type and G9a mutant flies not expressing 
the inverted repeat are shown. Five representative images are shown for 
each genotype. (B) In vivo RNAi reporter assay in adult flies. Fluc and RLuc 
reporter plasmids were transfected along with FLuc specific dsRNA or non-
specific control dsRNA in G9a-/- and AGO2-/- mutant flies and their wild-
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type controls (G9a+/+ and w1118, respectively). Reporter gene activity was 
measured at three days after transfection and fold silencing by Fluc dsRNA 
relative to control GFP dsRNA was calculated. Results are expressed as 
percentage of silencing relative to wild-type flies (w1118 and G9a+/+). Bars 
represent means and s.d. of three pools of five flies for each genotype. Data 
are from one experiment representative of two (A) and three (B) independent 
experiments.
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Acf1,Shroom,didum,Arpc3A,T_cp1,insc,WASp,fs(1)Ya,cpb,RfC4,
chic,Klp10A,Arc_p34,CG7033,polo,egh,Src64B,Hsp70Bc,crb,raps,
osk,moody,Hrs,Cct5,Top2,Hsp70Ab,Cortactin,Fs(2)Ket,Hsp70Ba,
Tcp_1zeta,CycB,HmgD,CG5525,Syx13,Hsp70Aa,Pak3,Hsp70Bb
CG3509,capt,ena,Gap1,Grip84,Rcd2,Cctgamma,nod,puc,Sop2,
sle,pbl,toc,Hsp70Bbb,wisp,CG31352,ball,alphaTub67C,p130CAS
CycA,Act5C,G_ialpha65A,cal1,gnu,spas,Su(var)2_10,Tcp_1eta
Art4,trbl,mus209,Vrp1,loco,armi,otu,Arp66B
GO:0019953 sexual reproduction 2,20 8,10E-09
e(y)3,Eip75B,didum,fs(1)Ya,piwi,Nc,fs(1)M3,RhoL,zpg,pgc,exu,
orb,Fas3,polo,egh,Src64B,BicC,Jra,stai,crb,osk,Hrs,ovo,Cortactin
aPKC,kay,Fs(2)Ket,Tre1,Cp15,capt,spz,Cp19,lok,Grip84,puc,Sop2
brat,Arp66B,sl,toc,Cbl,wisp,yl,ball,alphaTub67C,Act5C,Pi3K92E
gnu,Mcm6,Ptp61F,mus209,loco,swa,armi,otu,chic
GO:0009607 response to biotic stimulus 4,22 3,95E-08
Eip75B,CecC,AttB,Rel,Jra,AttC,kay,CecA1,pirk,key,spirit,TepIII,Def
spz,vir_1,dos,CecA2,AttA,mus209,PEK
GO:0006955 immune response 3,73 2,91E-07
Eip75B,CecC,dnr1,AttB,Rel,Jra,AttC,kay,CecA1,pirk,key,spirit,Def,
spz,vir_1,dos,CecA2,AttA,mus209,Sp7
GO:0022607 cellular component assembly 2,26 4,34E-07
Acf1,Arpc3A,WASp,MED20,cpb,exu,chic,l(2)gl,Arc_p34,orb,polo,
Src64B,Jra,crb,osk,moody,Hrs,aPKC,Fs(2)Ket,CG1890,mys,Cp15
CG3509,spz,Cp19,ena,Grip84,nod,puc,Sop2,Arp66B,pbl,wisp,
alphaTub67C,G_ialpha65A,Mcm6,Gli,mus209,loco,swa,armi
GO:0007275 multicellular organismal development 1,49 1,76E-06
rdx,tim,Acf1,Eip75B,cdi,didum,insc,WASp,stc,Su(dx),CG34449,piwi
Nc,bchs,cpb,fs(1)M3,RhoL,Hsp26,Socs36E,exu,chic,l(2)gl,bif,orb
Fas3,polo,apt,egh,AnnIX,Src64B,Jra,stai,crb,raps,osk,moody,Pak
ovo,mex1,aPKC,B4,blow,kay,Eip63E,Mmp1,Ets21C,CecA1,CG6194
CycB,HmgD,mys,nmo,Cp15,Myo31DF,vri,Hsp27,capt,spz,Cp19
dos,CG10641,ena,Gap1,pot,puc,Sop2,brat,Arp66B,sle,pbl,toc,
Mes_4,cad,Cbl,vap,alphaTub67C,Pka_C3,p130CAS,CycA,Hsp68
Act5C,Pi3K92E,G_ialpha65A,l(2)gd1,dhd,mthl5,CG1943,NijA,
Su(var)2_10,Alh,per,Art4,Gli,trbl,Ptp61F,Vrp1,PR2,scb,loco,chn,swa
armi,veg,tamo,otu
GO:0030029 actin filament-based process 3,57 2,09E-06
Arpc3A,WASp,cpb,chic,Arc_p34,Src64B,moody,Fs(2)Ket,Pak3,capt,
ena,puc,Sop2,Arp66B,pbl,G_ialpha65A,Vrp1,loco
GO:0007049 cell cycle 2,00 2,55E-06
T_cp1,insc,fs(1)Ya,RfC4,chic,l(2)gl,Klp10A,CG7033,bif,polo,raps,
Cct5,Fim,Top2,kay,Tcp_1zeta,CycB,CG5525,Syx13,lok,Gap1,Grip84
Rcd2,Cctgamma,nod,puc,Sop2,brat,Arp66B,pbl,toc,mtrm,wisp,
ball,alphaTub67C,CycA,G_ialpha65A,dhd,cal1,gnu,Tcp_1eta,Gli,trbl
Ptp61F,mus209,otu
GO:0048856 anatomical structure development 1,51 2,93E-06
rdx,Acf1,Eip75B,Shroom,didum,insc,WASp,stc,Su(dx),piwi,Nc,bchs
cpb,fs(1)M3,RhoL,Socs36E,exu,chic,l(2)gl,Arc_p34,bif,orb,Fas3,
polo,apt,egh,AnnIX,Src64B,Jra,stai,crb,raps,osk,moody,Pak,ovo,fz4
Lap1,mex1,Cortactin,aPKC,B4,blow,kay,Eip63E,Fs(2)Ket,Mmp1,
Ets21C,CecA1,CG6194,HmgD,mys,nmo,Cp15,Myo31DF,vri,capt
spz,Cp19,dos,CG10641,ena,Gap1,pot,puc,Sop2,brat,Arp66B,sle,
pbl,cad,Cbl,vap,alphaTub67C,Pka_C3,p130CAS,CycA,Act5C,
Pi3K92E,G_ialpha65A,l(2)gd1,CG1943,NijA,Mcm6,Su(var)2_10,Alh,
Gli,trbl,Ptp61F,mus209,Vrp1,PR2,scb,loco,chn,swa,armi,veg
GO:0070271 protein complex biogenesis 4,24 3,79E-06
Arpc3A,WASp,cpb,chic,l(2)gl,Arc_p34,Hrs,Fs(2)Ket,CG1890,spz,
nod,Sop2,Arp66B,alphaTub67C
GO:0065008 regulation of biological quality 2,06 4,15E-06
Eip75B,Arpc3A,WASp,piwi,bchs,cpb,RhoL,chic,CG17018,l(2)gl,
Arc_p34,synj,egh,Src64B,crb,raps,osk,Pak,Hrs,Cortactin,Fs(2)Ket
Snap24,CycB,rtGEF,Syx13,mys,capt,ena,Ir,puc,Sop2,Arp66B,pbl
p130CAS,Act5C,CG4199,Pi3K92E,dhd,Gli,Ptp61F,Vrp1
D (1/3)
Fig. S4 D(1/3) | See legend on p. 129.
128
Chapter 3
GO ID TERM Fold Enrichment P-Value Gene list 
GO:0033036 macromolecule localization 2,10 3,30E-05
tim,insc,Su(dx),exu,chic,l(2)gl,orb,polo,egh,crb,raps,osk,Hrs,SH3PX1
Lap1,aPKC,Fs(2)Ket,CycB,Syx13,pbl,CG3529,wisp,p130CAS
Act5C,G_ialpha65A,l(2)gd1,Rab30,Ptp61F,loco,swa,armi,tamo
GO:0051716 cellular response to stimulus 2,74 4,65E-05
DNApol_iota,RfC4,Rel,Src64B,Hsp70Bc,Jra,Pak,Hsp70Ab,kay,
Hsp70Aa,Hsp70Bb,lok,puc,Gadd45,Hsp70Bbb,Pi3K92E,mus209
PEK, Hsp70Ba
GO:0051301 cell division 2,95 7,54E-05
insc,WASp,piwi,chic,polo,raps,aPKC,CycB,Syx13,brat,pbl,
alphaTub67C,CycA,Act5C,G_ialpha65A,loco
GO:0009628 response to abiotic stimulus 2,63 7,88E-05
tim,Hsp26,CG7650,Hsp70Bc,Hsp70Ab,Hsp70Ba,nmo,Hsp70Aa,
Hsp70Bb,Hsp27,Hsp23,Hsp70Bbb,Hsp68,CG7130,Hsf,pain,Fst,
per,CG4461
GO:0051641 cellular localization 1,90 9,90E-05
tim,CG8026,insc,bchs,exu,chic,l(2)gl,synj,orb,polo,raps,osk,Hrs
SH3PX1,Top2,Fs(2)Ket,Snap24,CycB,Syx13,CG3476,ena,nod,Sop2
Arp66B,CG3529,wisp,alphaTub67C,p130CAS,Act5C,G_ialpha65A
l(2)gd1,loco,swa,armi,tamo
GO:0007154 cell communication 1,52 0,0001684
WASp,RhoGAP92B,Su(dx),Rgl,bchs,CG12290,por,RfC4,RhoL,
CG5522,dx,Socs36E,l(2)gl,CG6954,synj,Socs44A,CG5916,Rel,apt,
Src64B,Jra,stai,raps,moody,Pak,Hrs,SH3PX1,fz4,aPKC,step,kay
rho_4,Snap24,rtGEF,Syx13,mys,Tre1,nmo,key,spirit,stet,spz,dos,lok
Gap1,puc,Gadd45,pbl,sl,Cbl,vap,Pi3K92E,G_ialpha65A,l(2)gd1,
mthl5,Rab30,spas,Su(var)2_10,per,PEK,loco,CG3077
GO:0034330 cell junction organization 5,49 0,0001896 l(2)gl,crb,moody,aPKC,G_ialpha65A,Gli,loco
GO:0043933 macromolecular complex subunit organization 2,22 0,0002413
Acf1,Arpc3A,WASp,MED20,cpb,chic,l(2)gl,Arc_p34,Src64B,Hrs,
Fs(2)Ket,CG1890,CG3509,capt,spz,ena,nod,Sop2,Arp66B,
alphaTub67C,spas,Mcm6
GO:0008219 cell death 2,35 0,0008588
Eip75B,stv,Nc,l(2)gl,RnrS,Mmp1,CecA1,CG6194,Tre1,lok,puc,RnrL
viaf,GlcT_1,Art4,PR2
GO:0007059 chromosome segregation 2,57 0,0011556
RfC4,Klp10A,bif,polo,Fim,Top2,CycB,Gap1,nod,toc,mtrm,CycA,
Gli
GO:0007155 cell adhesion 2,40 0,0013598
RhoL,pes,Fas3,egh,Pak,Cad96Ca,Mmp1,mys,ImpL2,pbl,NijA,
CG31004,scb,CG11320
GO:0051674 localization of cell 1,89 0,0017345
Shroom,RhoL,pgc,bif,Fas3,egh,BicC,stai,Pak,Hrs,Cortactin,kay,
mys,Tre1,ena,puc,pbl,sl,Cbl,NijA,Ptp61F,scb
GO:0008283 cell proliferation 2,43 0,0018392
insc,l(2)gl,orb,polo,crb,raps,aPKC,brat,CycA,Pi3K92E,
G_ialpha65A,loco,otu
GO:0007623 circadian rhythm 3,57 0,0026428 tim,E23,CrebB_17A,B4,vri,to,per
GO:0030030 cell projection organization 1,69 0,0047927
Acf1,WASp,bchs,cpb,Arc_p34,bif,Fas3,egh,Pak,ovo,Ets21C,
HmgD,mys,vri,ena,Sop2,Arp66B,pbl,p130CAS,NijA,Gli,Ptp61F,scb
GO:0043062 extracellular structure organization 2,72 0,0064233 WASp,bchs,fs(1)M3,Src64B,Cortactin,aPKC,Mmp1,rtGEF
GO:0016271 tissue death 2,89 0,0076443 Eip75B,Nc,l(2)gl,Mmp1,CecA1,CG6194,PR2
GO:0044238 primary metabolic process 1,12 0,0087563
DNApol_iota,rdx,tim,e(y)3,Acf1,Eip75B,cdi,Arpc3A,T_cp1,CG15220
Pez,stc,stv,CG11674,Su(dx),fs(1)Ya,piwi,MED20,Nc,bchs,cpb,
por,RfC4,CG18278,ple,CG7433,CG10254,CG15817,Arc_p34,
CG7033,CG10376,CG5493,scaf6,bif,orb,CrebB_17A,CG32479,
CG13704,Rel,polo,RnrS,CG8334,apt,dUTPase,CG30059,Src64B,
CG14645,Aats_asp,CG6428,Neu3,BicC,CG6283,Uro,Jra,Pabp2,osk,
Pak,Cct5,CG3194,ovo,CG30090,Top2,Cad96Ca,aPKC,CG8690,kay
Eip63E,fu12,Mmp1,Ets21C,CG14125,CG30360,Tcp_1zeta,CG6194
CG11669,CG5525,CG4267,Amy_d,Mur18B,nmo,Pak3,key,Muc68D
RPA2,vri,spirit,Hsp27,Hydr2,CG32412,CG6277,CG9772,ena,
CG32369,lok,Cctgamma,nod,puc,CG9646,Sop2,Peritrophin_15a
brat,Arp66B,sl,toc,cad,Cbl,CG9743,RnrL,wisp,yl,ball,Pka_C3,
CG5909,Hsp68,Ipk2,CG3074,Pi3K92E,l(1)G0045,CG8258,
CG31278,CalpB,CG7130,Hsf,gnu,CG34056,spas,Mcm6,Amy_p,
Su(var)2_10,Tcp_1eta,Alh,per,Art4,RpS5b,Wsck,trbl,Ptp61F,mus209,
Sp7,PR2,PEK,LvpH,chn,slif,armi,veg,CG15100,CG6733,CG16997,
Aats_pro,GATAd,otu
D (2/3)
Fig. S4 D(2/3) | See legend on p. 129.
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GO ID TERM P-ValueFold enrichment Gene list 
GO:0007028 cytoplasm organization 2,64 0,011672 exu,chic,orb,osk,yl,swa,armi
GO:0007568 aging 2,64 0,011672 Nc,bchs,Hsp26,Hsp27,puc,Hsp68,mthl5
GO:0043170 macromolecule metabolic process 1,10 0,0189024
DNApol_iota,rdx,tim,e(y)3,Acf1,Eip75B,cdi,Arpc3A,T_cp1,CG15220
Pez,stc,stv,CG11674,Su(dx),fs(1)Ya,piwi,MED20,Nc,bchs,cpb,
por,RfC4,CG10254,CG15817,Arc_p34,CG7033,CG10376,scaf6,
orb,CrebB_17A,CG32479,CG31704,Rel,polo,RnrS,CG8334,apt,
Src64B,CG14645,Aats_asp,Neu3,BicC,Jra,Pabp2,osk,Pak,Cct5,
ovo,CG30090,Top2,Cad96Ca,aPKC,kay,Eip63E,Mmp1,Ets21C,
CG14125,Tcp_1zeta,CG6194,CG5525,Mur18B,nmo,Pak3,key,
RPA2,vri,spirit,Hsp27,CG32412,CG9772,ena,CG32369,lok,
Cctgamma,nod,puc,CG9646,Sop2,Peritrophin_15a,brat,Arp66B,toc,
Mes_4,cad,Cbl,RnrL,wisp,yl,ball,Pka_C3,CG5909,Hsp68,CG3074,
l(1)G0045,CG8258,CG31278,CalpB,CG7130,Hsf,gnu,CG34056,
spas,Mcm6,Su(var)2_10,Tcp_1eta,Alh,per,Art4,RpS5b,Wsck,trbl,
Ptp61F,mus209,Sp7,PR2,PEK,chn,armi,veg,CG15100,CG6733,
CG16997,Aats_pro,GATAd,otu,Muc68D
GO:0008037 cell recognition 3,00 0,0193569 WASp,Fas3,Sop2,Arp66B,p130CAS
GO:0006323 DNA packaging 2,58 0,0200953 Acf1,fs(1)Ya,RfC4,Top2,CG3509,Su(var)2_10
GO:0007610 behavior 1,43 0,0209123
tim,ple,CrebB_17A,Fas3,egh,Src64B,osk,moody,aPKC,tun,nmo,
vri,Pino,homer,vap,Pi3K92E,to,spas,pain,per,Spn,scb,armi
GO:0065009 regulation of molecular function 1,95 0,0246646 Acf1,Nc,CG5916,RnrS,kay,lok,Cbl,RnrL,viaf
GO:0007624 ultradian rhythm 31,00 0,0323123 per
GO:0006807 nitrogen compound metabolic process 1,61 0,0345726
CG18278,ple,CG7433,CG5493,CG30059,Aats_asp,CG6428,Uro,
CG3194,CG15100,CG6733,Aats_pro
GO:0009605 response to external stimulus 1,65 0,0353895 tim,CG7650,Rel,Fas3,kay,nmo,puc,to,NijA,pain,per
GO:0009719 response to endogenous stimulus 2,77 0,042065 Eip75B,l(2)gl,Pi3K92E,Art4
GO:0044237 cellular metabolic process 1,03 0,0427624
DNApol_iota,rdx,tim,e(y)3,Acf1,Eip75B,cdi,Arpc3A,T_cp1,CG15220
Pez,stc,CG11674,Su(dx),fs(1)Ya,piwi,MED20,bchs,cpb,por,RfC4
CG18278,ple,CG7433,CG10254,CG15817,Arc_p34,CG7033,
CG10376,CG5493,synj,scaf6,orb,CrebB_17A,CG32479,Rel,polo,
RnrS,CG8334,apt,dUTPase,CG30059,Src64B,Aats_asp,CG6428,
BicC,Uro,Jra,Pabp2,osk,Pak,Cct5,CG3194,ovo,Top2,Cad96Ca,
aPKC,kay,Eip63E,fu12,Ets21C,CG13090,Tcp_1zeta,CG6194,
CG5525,nmo,Pak3,key,RPA2,vri,spirit,Hsp27,Def,spz,CG9772,ena,
lok,Cctgamma,nod,puc,Sop2,brat,Arp66B,sl,cad,Cbl,RnrL,wisp,yl,
ball,Pka_C3,Hsp68,Ipk2,Pi3K92E,l(1)G0045,CG8258,CG31278,
CG7130,Hsf,gnu,CG34056,spas,Mcm6,Tcp_1eta,Alh,per,Art4,RpS5b,
Wsck,trbl,Ptp61F,mus209,Sp7,PR2,PEK,LvpH,chn,armi,veg,
CG15100,CG6733,Aats_pro,GATAd,otu
GO:0016044 membrane organization 1,37 0,0528068
T_cp1,Su(dx),synj,polo,Jra,crb,Hrs,blow,TepIII,CG6479,brat,Arp66B
Act5C,Vrp1,scb
GO:0003008 system process 1,20 0,0559107
WASp,bchs,l(2)gl,synj,CG7650,CrebB_17A,Fas3,apt,Src64B,crb,
osk,Pak,Hrs,aPKC,tun,Snap24,rtGEF,Syx13,Tre1,spas,pain,per,
scb,armi
D (3/3)
Fig. S4 |  DCV-induced transcriptome in G9a mutants.   
(A,B) List of genes that are expressed ≥2-fold upon DCV infection (relative 
to mock) in both wild-type and G9a mutant flies in (A) whole flies or (B) fat 
bodies. (C,D) Gene ontology (GO) analysis of genes that are expressed at 
≥2-fold higher levels in DCV infected G9a mutants than in infected wild-
type flies. All significantly enriched GO terms of level 3 are shown (P < 
0.05 in a hypergeometric test with Benjamini & Hochberg correction), with 
their respective fold enrichment (defined as the ratio of the frequency in the 
dataset to the genome-wide frequency). Data are from whole flies (C) or 
dissected fat bodies (D)
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Fig. S5 |  Primer location and specificity controls for ChIP-qPCR.   
(A-D) Schematic representation of G9a target loci within the Socs36E 
(A), TotM (B), vir-1 (C) and dPIAS (D) genes, defined as genomic regions 
in which the H3K9me2 mark is present in wild-type flies but not in G9a 
mutants, in a previous study (20). The arrow represents the position of 
the amplicon generated by qPCR after Chromatin-Immunoprecipitation 
(ChIP-qPCR). Blue and red plots represent H3K9me2 levels in wild-type 
and G9a mutants, respectively. (E-J) ChIP-qPCR in the moca (E,G,I) and 
domeless (F,H,J) loci, performed on fat bodies of wild-type or G9a mutant 
flies with aspecific anti-IgG control (E,F), anti-H3 (G,H), and anti-H3K9me2 
(I,J) antibodies. Data are presented as percentage of input, calculated by 
dividing the signal obtained after IP by the signal obtained from the input. 
The results indicate that there is very low aspecific binding of chromatin to 
the control IgG antibody (E,F), and that H3 levels are similar on the moca 
and domeless loci of wild-type flies and G9a mutants (G,H). Moreover, 
these results show that the moca locus is depleted of H3K9me2 marks 
both in wild-type and G9a mutant flies (I), and that the domeless locus is 
depleted of H3K9me2 in G9a mutants (J). Data are means and s.d. of three 
independent pools of 80 female fat bodies for each genotype. **P < 0.01 
(Student’s t-test).
132
Chapter 3
0 1 2 3 4 5 6 7 8 9 10 11 12 13
20
40
60
80
100
Time (Days)
Su
rv
iva
l (
%
)
0 1 2 3 4 5 6 7 8 9 10 11 12 13
20
40
60
80
100
Time (Days)
Su
rv
iva
l (
%
)
G9a+/+
G9a -/-
G9a+/+; Act >
G9a -/- ; Act >
DomeΔCyt
DomeΔCyt
C D
0 1 2 3 4 5 6 7 8 9 10 11 12
20
40
60
80
100
Time (Days)
Su
rv
iva
l (
%
)
0 1 2 3 4 5 6 7 8 9 10 11 12
20
40
60
80
100
Time (Days)
Su
rv
iva
l (
%
)
A B
G9a+/+
G9a -/-
G9a+/+; Act >
G9a -/- ; Act >
DomeΔCyt
DomeΔCyt
G9a+/+
G9a -/-
G9a+/+ Socs36E; Act >
G9a -/- Socs36E; Act >
G9a+/+
G9a -/-
G9a+/+ Socs36E; Act >
G9a -/- Socs36E; Act >
Fig. S6 |  Genetic interaction between G9a and the Jak-Stat pathway.   
(A,B) Survival upon mock infection of wild-type or G9a mutant and wild-
type mutant flies overexpressing (A) domeΔCyt, or (B) Socs36E. These mock 
infections were run in parallel to the experiments of Fig. 6A and 6B. (C,D) 
Survival upon DCV infection (100 TCID50 units) of wild-type or G9a mutant 
flies overexpressing (C) domeΔCyt, or (D) Socs36E, as described in Fig. 6. 
Control flies expressing only the Act-Gal4, the UAS-domeΔCyt, or the UAS-
Socs36E transgenes and mock infections were included as controls (see 
S11 Dataset). Data are means and s.d. of three independent pools of at 
least 15 male flies for each genotype.
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Abstract 
Innate immunity is the first line of defence against pathogens and is essential 
for survival of the infected host. The fruit fly Drosophila melanogaster is an 
emerging model to study viral pathogenesis, yet antiviral defence responses 
remain poorly understood. Here, we describe the heat shock response, 
a cellular mechanism that prevents proteotoxicity, as a component of 
the antiviral immune response in Drosophila. Transcriptome analyses of 
Drosophila S2 cells and adult flies revealed strong induction of the heat 
shock response upon RNA virus infection. Dynamic induction patterns 
of heat shock pathway components were characterized in vitro and in 
vivo following infection with different classes of viruses. The heat shock 
transcription factor (Hsf ), as well as active viral replication, were necessary 
for the induction of the response. Hsf-deficient adult flies were hypersensitive 
to virus infection, indicating a role of the heat shock response in antiviral 
defence. In accordance, transgenic activation of the heat shock response 
prolonged survival time after infection and enabled long-term control of virus 
replication to undetectable levels. Together, our results establish the heat 
shock response as an important constituent of innate antiviral immunity in 
Drosophila. 
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Introduction 
Innate immunity is a complex, heritable line of defence shared by all metazoans 
(1). Innate immune pathways of the fruit fly Drosophila melanogaster are 
evolutionary conserved with those of mammals (1), and the wide range of 
genetic tools available in this system have been instrumental in the discovery 
of fundamental aspects of antimicrobial immunity (2). Over the past decade, 
the fly model has also been used for the discovery and characterization of 
antiviral immune pathways (3, 4), yet, the host response to virus infection in 
insects remains incompletely understood. 
In mammals, sensing of viral infections is mediated by pattern recognition 
receptors that recognize virus-associated molecules. For example, viral 
double-stranded RNA is recognized by Toll- or RIG-I-like receptors, leading 
to the activation of the NF-ĸB and IRF3/IRF7 transcription factors that induce 
the expression of antiviral type I interferons and other proinflammatory 
cytokines (5, 6). Type I interferons activate the Jak-Stat pathway to induce 
expression of a wide array of antiviral effectors in infected and non-infected 
cells (5, 6). Also in Drosophila, antiviral immunity is mediated by the Jak-Stat 
pathway, through the activation of general stress-induced genes, as well as 
the virus-specific gene vir-1, whose function remains to be determined (7, 8). 
Other evolutionary conserved antiviral mechanisms have recently been 
described. Autophagy, a highly conserved catabolic pathway that responds 
to nutrient starvation, mediates immunity against a range of viruses in flies 
and mammals (9, 10). RNA interference (RNAi) is a broadly active antiviral 
mechanism in insects. Sensing of viral double-stranded RNA by Dicer-2 
precedes its cleavage into small interfering RNAs (siRNAs), which, in 
association with the Argonaute-2 containing RNA induced silencing complex 
(RISC), mediate degradation of complementary viral RNA molecules (4, 11). 
In mammals, RNAi has been reported to have antiviral activity in specific cell 
lineages (12, 13). 
The heat shock response is a cellular pathway that is activated by a myriad of 
stressors, including extreme temperature, chemicals, and physical injuries, 
which are all associated with the accumulation of damaged proteins. These 
stimuli lead to the activation of heat shock transcription factors (Hsf ) in a 
multi-step process that includes trimerization and translocation of Hsf to 
chromosomal target loci, among which are promoters of genes encoding 
138
Chapter 4
heat shock proteins (Hsp) (14). The Drosophila genome encodes a single 
Hsf, which relocates upon activation from the nucleoplasm to regulatory 
regions of Hsp genes and triggers their rapid transcription (15, 16). Heat 
shock proteins are molecular chaperones that mediate protein folding and 
re-folding, modulate entry into proteasomal and autophagic degradation 
pathways, or interact with metabolic stress sensors, thereby preventing 
global cellular stress and proteotoxicity (17, 18). There are several families 
of heat shock proteins, classified by their molecular mass and sequence 
conservation. The main constituents are Hsp90/Hsp100 (called Hsp83 in 
Drosophila), Hsp70, Hsp40, and the small Hsps. Small heat shock proteins, 
such as Hsp23, Hsp26 and Hsp27 in Drosophila, range in size from 10 to 
40 kDa, and have, in contrast to the ubiquitous Hsp70 and Hsp90, distinct 
developmental, tissue, and subcellular expression patterns (17). 
In addition to abiotic stresses, microbial infections may also induce the heat 
shock response (19). In mammals, fever activates the heat shock response, 
which then functions through several mechanisms, including direct inhibition 
of pathogen growth or cytoprotection of host cells. Fever may also induce 
bacterium-encoded Hsps and both host and pathogen-derived Hsps can 
activate the immune response of the host (20, 21). However, the heat shock 
response can also be exploited by pathogen for their own replication (22). 
For instance, Hsp70 participates in entry of rotaviruses into host cells (23), 
uncoating of adenoviruses in the cytoplasm (24), and folding and maturation 
of picornavirus capsid proteins (25). Whether the benefit of heat shock 
responses can be attributed to either the host or the pathogen seems to 
depend on the nature and context of their interaction (22). As most of these 
observations originate from studies in cell culture systems, the importance 
of the heat shock response in vivo remains to be elucidated. 
In this study, we investigated the role of the cellular heat shock response 
upon viral infection in Drosophila. Analyses of in vitro and in vivo 
transcriptome data revealed strong induction of the heat shock response 
upon viral challenge. Hsf-deficient flies that lack the heat shock response 
were hypersensitive to virus infection. Conversely, transgenic activation of 
the response resulted in prolonged control of virus replication and reduced 
virus-induced mortality. Taken together, our results indicate that the heat 
shock response is an important component of antiviral defence in flies. 
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Materials and Methods
Fly strains and husbandry 
Flies were raised on standard cornmeal-agar medium at 25°C in a light/dark 
cycle of 12h/12h. The Hsf4 mutant was obtained from the Drosophila Genetic 
Resource Center (stock no. 108-256) and the Hsf4; Hsf+ rescue line from the 
Bloomington Stock Center (stock no. 5490, described in ref. (26)). CnBw, 
which is the genetic background for those lines, was used as the wild-
type control in all experiments. The following fly lines have been described 
previously: Hml-Gal4 (ref. (27)), C564-Gal4 (ref. (28)), UAS-Hsp70 (ref. (29)), 
UAS-Hsf (ref. (16)). The HsfRNAi line expressing a short hairpin targeting 
Hsf, and the driver Act-Gal4 were obtained from the Bloomington Stock 
Center (stock no. 27070 and 4414, respectively). The genetic background 
of wild-type flies used for RNA sequencing is y1w1, and has been described 
previously as EHMT+ (ref. (30)) or G9a+/+ (ref. (31)). In vivo RNAi experiments 
were performed by crossing GMR-Gal4, UAS-thRNAi/CyO virgins (32) with 
HsfRNAi male flies or with control flies containing the attP landing site used to 
introduce the RNAi-inducing transgene (y1v1; attP2; Bloomington stock no. 
36303). The eye phenotype was assessed in three to five-day-old female F1 
offspring lacking the CyO balancer. 
Virus infection 
Drosophila S2 cells (Invitrogen) were maintained in Schneider’s Drosophila 
medium (Gibco) containing 10% heat-inactivated Fetal Bovine Serum 
(Gibco), 50 U/mL Penicillin and 50 μg/mL Streptomycin (Gibco). Cells were 
seeded in 6-well plates at a density of 2.5 x 106 cells/mL in 2 ml medium, 
and infected with Drosophila C Virus (DCV), Cricket paralysis virus (CrPV), or 
Invertebrate iridescent virus (IIV-6) at an MOI (Multiplicity of Infection) of 10. 
After removal of the medium, S2 cells were incubated with virus inoculum 
in 0.5 mL of fresh Schneider’s medium for an hour, and the inoculum was 
subsequently replaced with 2 mL of fresh medium. Cells were harvested in 
1 mL of Isol-RNA Lysis Reagent at given time points. UV-inactivated virus 
stocks were generated by exposing the virus inoculum to a total of 24,000 
mJ of UV light in eight intervals of 90 sec in a GS Gene linker UV Chamber 
(Bio-Rad).
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Fly stocks were cleared of Wolbachia and persistent virus infections as 
described previously (33-35). Three to five-day-old flies were injected 
intrathoraxically with a Nanoject II injector (Drummond) after anesthesia 
with CO2. Injection doses were 1,000 median tissue culture infectious dose 
(TCID50) units of DCV and CrPV, and 14,000 TCID50 units of IIV-6 in 10 mM 
Tris-HCl, pH 7.3. Survival was assessed daily and flies were transferred to 
fresh food every 3 days. Lethality at day 1 was attributed to the injection 
procedure and excluded from the survival analysis. Unless noted otherwise, 
three pools of 10 to 15 flies were injected per condition with independent 
dilutions of virus stock. 
Virus titration
Viral titers were determined by end-point dilution, as described previously 
(33). In short, ten-fold dilutions of fly homogenates were used to inoculate 
2 x 104 S2 cells (Invitrogen) per well in 96-well plates in quadruplicate. After 
5 days, cells were transferred to fresh medium, and cytopathic effect (CPE) 
was monitored until day 14. Viral titers were calculated using the method of 
Reed and Muench (36). 
In vivo RNAi reporter assay 
RNAi competency of adult flies was analysed using a reporter assay, as 
described previously (34). Briefly, three to five-day-old female flies were 
injected in the abdomen with a 100 nl suspension containing a 1:1 mixture of 
Schneider’s Drosophila Medium (Gibco) and Lipofectamine 2000 (Invitrogen) 
complexed with Firefly luciferase (Fluc) and Renilla luciferase (Ren) reporter 
plasmids, and Fluc specific or non-specific control dsRNA (GFP). After 
incubation for 3 days, Fluc and Ren activity was measured in fly homogenate 
using the Dual Luciferase assay reporter system (Promega). Fluc over Ren 
ratios were calculated for each sample, and data are presented as fold 
silencing relative to the non-specific dsRNA control. 
RNA analysis
RNA was isolated from S2 cells or flies using Isol-RNA lysis Agent (5-Prime). 
cDNA synthesis was performed on 1 μg RNA, pre-treated with DNase I 
(Ambion), using TaqMan Reverse Transcription reagents (Applied Biosystems) 
according to the manufacturer’s instructions. qPCR was performed with 
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SYBR Green I Master Mix on a LightCycler 480 (Roche). The qPCR program 
was the following: 95°C for 5 min, followed by 45 cycles of 95°C for 5s, 60°C 
for 10s, 72°C for 20s. Expression of the gene of interest was normalized to 
transcript levels of the housekeeping gene Ribosomal protein 49 (Rp49), 
and fold change relative to mock infection was calculated using the ΔΔCt 
method (37). Rp49 Ct values were stable in all conditions and experiments. 
The primers used for qPCR analysis are provided in Supplementary table 
S1. 
Microarray 
S2 cells were infected with DCV (MOI=10) or mock infected (Schneider’s 
medium), and 3 biological replicates were collected at 8 and 24 hours 
post-infection (hpi). RNA was extracted with the RNeasy Mini Kit (Qiagen) 
followed by on-column DNaseI treatment, according to the manufacturer’s 
instructions. RNA was labelled using the GeneChip WT Terminal Labelling 
kit (Affymetrix), and hybridized on an Affymetrix Drosophila GeneChip 
microarray 2.0 for 17 hours at 45°C in the Affymetrix hybridization oven at 60 
rpm. The arrays were washed and stained on a Fluidics station 450 according 
to Affymetrix protocol FS450_0001 and analysed on a GeneChip scanner 
3000 7G. Partek software was used for RMA background correction and 
statistical analyses. An Analysis of Variance (ANOVA) was performed on the 
three conditions followed by a post-hoc analysis comparing the individual 
conditions to each other. P-values were corrected for multiple testing by a 
step-up False Discovery Rate (FDR). Gene induction was calculated relative 
to a mock infection at 8 hpi. The dataset is available at the NCBI Gene 
Expression Omnibus under series accession number GSE57434. 
RNA sequencing
Thirty female flies (3-5 days old) were collected at 24 hpi with 10,000 TCID50 
units of DCV or CrPV, and RNA was isolated using Isol-RNA Lysis reagent 
as described above. Procedures for library preparation, sequencing, and 
data analyses have been published (34). The RNA-Seq data are available at 
the NCBI Gene Expression Omnibus under accession number GSE56013.
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Western Blotting
S2 cells in 6-well plates were infected with DCV at an MOI of 10 as described 
above. Cells were harvested at different time points by resuspension in PBS 
(Phosphate Buffer Saline) buffer and centrifugation for 5 minutes at 2,000 
x g. Supernatant was discarded and the cell pellet was resuspended in 
Laemmli sample buffer (4% SDS, 20% glycerol, 120mM Tris-HCl pH=6.8, 
0.02% bromophenol blue). The samples were separated on a 12.5% SDS-
PAGE gel and transferred to a nitrocellulose membrane (pore size 0.2 μm, 
Bio-Rad). The membrane was incubated with rat anti-Hsp70 antibody 
(SMC-230D, StressMarq), followed by an incubation with and IRDye 
680-conjugated goat anti-rat IgG antibody (LI-COR). The proteins were 
visualized with an Odyssey infrared imager (LI-COR). 
Statistical analysis
Unpaired two-tailed Student’s t-tests and Wilcoxon rank-sum tests, as 
implemented in Graphpad Prism version 6, were used to compare differences 
in gene expression and log-transformed viral titers, and single-fly viral RNA 
levels, respectively. Survival assays were assessed using Kaplan-Meier 
analyses and log-rank tests, as implemented in SPSS Statistics (version 
20, IBM). P-values below 0.05 were considered statistically significant. 
Enrichment of Gene Ontology terms was analysed in GoToolBox (38), using 
the hypergeometric test with Benjamini & Hochberg correction.
Results
The heat shock response is induced in DCV-infected 
Drosophila S2 cells
To identify novel factors or processes involved in antiviral defence in 
Drosophila, we generated transcriptional profiles of DCV-infected Drosophila 
S2 cells at 8 and 24 hours post-infection (hpi) using Affymetrix GeneChip 
microarrays (Fig. 1a). S2 cells are likely derived from hematopoietic tissues 
and have macrophage-like properties; they can therefore be described as 
hemocyte-like (39). Even though S2 cells support efficient DCV replication, 
we noted that only a limited number of genes were significantly induced by 
DCV infection relative to mock (n=16 and n=20 at 8 and 24 hpi, respectively, 
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Fig 1b, Supplementary Figure S1). Overlap of the upregulated genes at 
both time points revealed that 6 genes, all encoding members of the heat 
shock protein family (Hsp70Ab, Hsp70Ba, Hsp22, Hsp23, Hsp26, Hsp27), 
were consistently induced upon infection (Fig. 1c). Accordingly, Gene 
Ontology (GO) term analysis showed that terms such as “chromosome 
organization”, “response to temperature stimulus” or “cellular response to 
stress” were significantly enriched at 8 and 24 hpi (Fig. 1d and 1e). Likewise, 
prediction of transcription factor binding sites in the promoter regions of 
the upregulated genes detected strong enrichment of heat shock factor 
(Hsf) binding motifs at both time points (Fig. 1f and 1g). In addition, the 
TATA box and the binding motif for Chorion factor 2 were enriched at both 
time points, suggesting that genes under control of these elements are also 
activated upon viral challenge. Additionally, we observed that relatively few 
genes were downregulated at 8 and 24 hpi (n=24 and n=19, respectively, 
Fig. 1b, Supplementary Figure S2) and GO term analysis showed that 
these genes are involved in reactive oxygen species production and cellular 
catabolic processes, suggesting metabolic deregulation upon viral infection 
(Supplementary Figure S2). Overall, these results suggest that DCV 
infection strongly induces the heat shock response in Drosophila S2 cells. 
The heat shock response is induced upon DCV and CrPV 
infection in vivo
To analyze the global transcriptional response to virus infection in vivo, we 
generated genome-wide transcriptomes of DCV-infected wild-type flies at 
24 hpi by next-generation sequencing (RNAseq). In addition, we included 
another member of the Dicistroviridae family, Cricket paralysis virus (CrPV) 
(Fig. 2a). Consistent with our observations in S2 cells (Fig. 1), only few 
genes were up- (n=31) or down-regulated (n=14) after DCV infection (Fig. 
2b and Supplementary Figure S3). In contrast, CrPV infection altered 
the expression of many more genes (n=71 up, n=64 down, Fig. 2b and 
Supplementary Figure S4). 
A core set of 13 genes was expressed at >2-fold higher level over mock in 
both DCV- and CrPV-infected flies (Fig. 2c). These genes included the Jak-
Stat dependent and stress-induced genes encoding Diedel and Turandot 
(Tot) proteins, induction of which has been reported before in DCV infection 
(8, 34, 40). Another immune gene that was induced by both DCV and CrPV 
was the peptidoglycan-recognition protein PGRP-SC1a, which is essential 
for Toll signalling in the context of antibacterial responses (41).
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Figure 1 |  Microarray analysis of DCV-infected Drosophila S2 cells.   
(a) Overview of the experimental workflow. S2 cells were infected with DCV 
(MOI=10) or mock-infected with Schneider’s medium, and RNA was extracted 
at 8 and 24 hours post-infection (hpi) for microarray analyses. Figure drawn 
by S.H. Merkling. (b) Number of differentially expressed genes at 8 and 24 
hpi (fold change ≥2 relative to mock infection). (c) Venn diagram representing 
the overlap between differentially induced genes after DCV infection at 8 and 
24 hpi. (d,e) Gene ontology (GO) analysis of the genes that are upregulated 
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≥2-fold at (d) 8 hpi and (e) 24 hpi. All significantly enriched level 4 GO terms 
are shown (P < 0.05 in a hypergeometric test with Benjamini & Hochberg 
correction). (f,g) Enrichment of predicted transcription factor binding sites 
amongst genes induced ≥2-fold at (f) 8 hpi and (g) 24 hpi. The 500-bp region 
upstream of the transcriptional start site was analysed in Pscan, using the 
Transfac database. All transcription factors that are significantly enriched 
over the genome-wide mean are shown (P < 0.05 in a z-test).
The putative function of the other core genes in host defence has not been 
evaluated, but they are interesting candidates for follow-up studies. Heat 
shock proteins were absent from this core set, as they were induced by DCV 
only (Fig. 2c). Accordingly, GO terms such as “chromosome organization” 
or “response to temperature stimulus” were significantly enriched among 
the genes up-regulated by DCV (Fig. 2d), but were absent amongst genes 
up-regulated by CrPV (Fig. 2e). In line with these observations, analysis of 
transcription factor binding motifs in DCV-induced genes revealed strong 
enrichment of the Hsf motif (Fig. 2f), which was absent in the CrPV dataset 
(Fig. 2g). Other binding motifs, such as Chorion factor 2 and Mitochondrial 
transcription factor A were enriched in both DCV and CrPV datasets, 
suggesting that multiple signalling pathways are activated upon viral 
challenge. The genes that were downregulated upon DCV or CrPV infection 
were enriched for GO terms such as extracellular matrix and cytoskeleton 
organization, as well as lipid metabolism (Supplementary Figure S3 and 
S4). Together, these data suggest that a conserved transcriptional response 
is induced upon RNA virus infection, complemented with a virus-specific 
response, as previously suggested (7). Together, our transcriptome analyses 
indicate that DCV, but not CrPV, infection induces the heat shock response 
in vivo. 
Dynamics of the heat shock response upon viral infection in 
S2 cells
To validate our results obtained by microarray profiling (Fig. 1) and RNA 
sequencing (Fig. 2), and to analyze the dynamics of the heat shock response, 
we performed quantitative RT-PCR (RT-qPCR) on Drosophila S2 cells (Fig. 3) 
or adult flies (Fig. 4) infected with the RNA viruses DCV and CrPV. To test if 
the heat shock response was specific to RNA virus infection, we included the 
DNA virus Invertebrate iridescent virus 6 (IIV-6) in our experiments.
146
Chapter 4
b c
d e
DCV
CrPV
18
58
13
0 20 40 60
lipid localization
response to temperature stimulus
eye pigmentation
cellular response to stress
chromosome organization
defense response
macromolecule catabolic process
Fold enrichment 
0 10 20 30 40
detection of biotic stimulus
humoral immune response
defense response
macromolecule catabolic process
carbohydrate metabolic process
biopolymer metabolic process
Fold enrichment 
Transcription 
factor P-value P-value
Transcription 
factor
TATA 1.14e-16
MT-TFA 5.68e-08
FTZ 0.029
CF2-II 0.0355
BCD 0.0426
TATA 8.27e-08
HSF 7.15e-07
CF2-II 0.001
BRCZ4 0.011
MT-TFA 0.043
Nu
m
be
r o
f g
en
es
Up-regulated
DCV
CrPV
Down-regulated
80
60
40
20
20
40
80
60
0
DCV
DCV
CrPV
CrPV
CrPV
DCV
RNA sequencing24 hpi
a
71
64
31
14
CG6639
Lsd-1
Lcp65Ag1
Lcp65Ag2
Lcp65Ag3
Socs36E
ninaD
CG9616
lectin-37Da
CG6508
CG12517
Diedel
TotX
TotM
TotC
TotA
CG11459
Cys
CG14205
CG1773
CG31704
CG42737
PGRP-SC1a
CG42868
f g
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and CrPV infection. (d,e) Gene ontology analysis of the genes that are 
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upregulated by (d) DCV or (e) CrPV at 24 hpi. All significantly enriched level 
4 GO terms are shown (P < 0.05 in a hypergeometric test with Benjamini 
& Hochberg correction). (f,g) Enrichment of predicted transcription factor 
binding sites amongst genes induced ≥2 fold at 24 hpi with DCV (f) or 
CrPV (g). The 500-bp region upstream of the transcriptional start site was 
analysed in Pscan, using the Transfac database. All transcription factors 
that are significantly enriched over the genome-wide mean are shown 
(P < 0.05 in a z-test).
We first infected S2 cells with DCV and measured expression levels of the 
genes encoding heat shock transcription factor (Hsf) and the heat shock 
proteins Hsp70, Hsp23, and Hsp26 (Fig. 3a). 
Modest induction of heat shock protein mRNAs was noted at 8 hpi (2 to 
7-fold over mock), but very high expression was measured at 24 hpi (45 to 
50-fold). In contrast, expression of Hsf was slightly elevated (3-fold) at both 
time points (Fig. 3a). 
As we only analysed DCV-infected S2 cells in our microarray analysis, we 
also tested whether other viruses induce a heat shock response in those 
cells. After CrPV infection, modest induction of heat shock genes was 
observed: Hsp23 was induced 6-fold at 8 hpi, whereas other Hsps and Hsf 
were only induced 2-fold (Fig. 3b). We chose to analyze gene expression 
at 16 hpi, as cytopathic effect (CPE) is already visible at 24 h after CrPV 
infection and non-specific RNA degradation may occur at that time point. 
Strikingly, the heat shock response was no longer induced at 16 hpi with 
CrPV (Fig. 3b), perhaps due to general inhibition of cellular transcription by 
CrPV, similar to observations in mammalian picornavirus infections (42).
Next, we asked whether the DNA virus IIV-6 triggers a heat shock response. 
As the replication rates of IIV-6 are lower than the ones of DCV or CrPV, 
we analysed gene expression at 24, 48, and 72 hpi. Expression of the heat 
shock genes was low at 24 hpi (<2-fold), but was induced at 8 to 11-fold at 
48 hpi. However, the response no longer persisted at 72 hpi, which may be 
due to virus-induced shutdown of host transcription(43) (Fig. 3c). 
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Figure 3 |  The heat shock response is dynamic and requires viral replication in 
Drosophila S2 cells. Expression of the genes encoding the heat shock 
proteins Hsp70, Hsp23, Hsp26, and the Heat shock transcription factor 
(Hsf) was monitored at the indicated time points by RT-qPCR after infection 
with (a) DCV, (b) CrPV or (c) IIV-6 (MOI=10). (d) S2 cells were inoculated 
with UV-inactivated viruses and gene expression was measured at 24, 16 
or 48 hpi with DCV, CrPV and IIV-6, respectively. Expression of the gene of 
interest was normalized to the housekeeping gene Ribosomal protein 49 
and expressed as fold change relative to mock infection. Data are mean 
and s.d. of three independent infections. Student’s t-tests were used to 
compare virus-infected samples to mock infections (*P < 0.05, **P < 0.01, 
***P < 0.0001). Dotted lines mark the threshold of 2-fold change.
Similarly, expression of Hsf was slightly induced at 24 hpi (2-fold), peaked 
in expression at 48 hpi (4-fold), before returning to basal levels at 72 hpi 
(Fig. 3c). 
Finally, we tested whether active viral replication was required for heat shock 
induction. After treatment of S2 cells with UV-inactivated viral particles, the 
heat shock response remained at basal levels, even at time points with the 
dc
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highest expression upon viral infection (24h for DCV, 16h for CrPV and 48h 
for IIV-6) (Fig. 3d). These results indicate that viral replication is essential for 
the induction of the heat shock response.
To confirm that the heat-shock response was not only induced at a 
transcriptional level, we measured levels of Hsp70 in DCV-infected S2 
cells by Western Blotting (Fig. S5), and found induction of Hsp70 at 16 
and 24 hpi. Those results were consistent with the data obtained by RT-
qPCR and confirmed the induction of Hsp70 proteins upon virus challenge 
in Drosophila S2 cells. 
Overall, our results demonstrate that the heat shock response to virus 
infection is dynamic in magnitude and time. Interestingly, induction of the 
heat shock response does not correlate with viral RNA loads, as no robust 
induction was detected at late time points of CrPV and IIV-6 infections, 
during which higher viral loads are present. This is possibly linked to the 
global inhibition of host transcription by those viruses (43, 44). 
Dynamics of the heat shock response upon viral infection in 
adult flies 
We analysed the dynamics of the heat shock response in vivo after systemic 
infection of adult wild-type flies with DCV, CrPV, or IIV-6. Upon DCV infection, 
we detected a moderate upregulation of Hsp23 and Hsp70 (4 and 10-fold 
over mock), but not of Hsp26, Hsp27 or Hsf. More robust levels of Hsp23 
and Hsp70 (10 to 30-fold) were measured at 48 hpi, whereas other genes 
remained at basal levels (Fig. 4a). CrPV infection did not induce the heat 
shock response at 24 hpi, confirming the outcome of the transcriptome 
analysis by RNA-seq (Fig. 2). However, strong upregulation of Hsp23 (14-
fold) and Hsp70 (51-fold) was apparent at 48 hpi (Fig. 4b). Given the lower 
replication kinetics of IIV-6, we analysed IIV-6 infected flies at 7 dpi when 
viral loads increased exponentially, and at 14 dpi when titers reached a 
plateau (33). 
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Figure 4 |  The heat shock response is virus-specific and Hsf-dependent in vivo. 
 Female wild-type flies (a, b, c) or Hsf4 mutant flies (d) were infected with 
(a, d) DCV, (b) CrPV or (c) IIV-6. The expression levels of the genes encoding 
heat shock proteins and Heat shock factor (Hsf) were analysed by RT-
qPCR at the indicated time points (a, b, c), and at 24h for DCV in panel 
d. Expression of the gene of interest was normalized to the housekeeping 
gene Ribosomal protein 49 and presented as fold change relative to mock 
infection. Data are mean and s.d. of three independent experiments. 
Student’s t-tests were used to compare virus-infected samples to mock 
infections (*P < 0.05, **P < 0.01, ***P < 0.0001). Dotted lines mark the 
threshold of 2-fold change. 
However, we detected low levels of heat shock transcripts relative to mock at 
these time points (Fig. 4c). Thus, although IIV-6 induced transient Hsp expression 
in S2 cells (Fig. 3c), we were unable to observe a heat shock response in the 
entire animal. This result suggests that the pathway may not be activated in vivo, 
or that it is induced in specific cell types, such as hemocytes, which would not 
be detectable by performing RT-qPCR on entire adult flies. Finally, similar to our 
observations in cells, no significant upregulation of the Hsf transcription factor 
was observed upon DCV, CrPV or IIV-6 infection at the analysed time points. 
a b
c d
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A previous study found that a subset of heat shock genes could be induced 
by the JNK pathway and the transcription factor FOXO in response to 
oxidative stress (45). We thus asked whether the heat shock response to 
virus infection was solely dependent on Hsf activation. To that end, we 
exploited the temperature-sensitive Hsf4 mutant fly, which expresses a 
mutant Hsf protein with reduced DNA-binding activity, but is viable at 25°C 
and below (26). No heat shock genes were induced in Hsf4 mutant flies upon 
DCV infection at 24 hpi, whereas the response was very strong in wild-
type flies at this time point (Fig. 4d). This is also consistent with previous 
observations that Hsp70 induction upon heat stress is Hsf-dependent (26). 
In conclusion, the heat shock response is induced by RNA virus infection in 
vivo and is dependent on the canonical heat shock transcription factor Hsf.
The heat shock response is antiviral in Drosophila
In order to establish whether the heat shock response is important for 
antiviral defence, or merely a secondary effect of infection-induced stress, 
we challenged Hsf4 mutant flies with several viruses and monitored survival 
over time. We included as genetic control the Hsf4 mutant carrying a single 
wild-type Hsf transgene under its own regulatory elements (Hsf4; Rescue). 
Upon DCV challenge, Hsf4 mutants succumbed faster to infection than wild-
type flies (mean survival = 2.2 and 5.5 days, respectively; P < 0.001). The Hsf4 
mutants carrying a rescue construct exhibited a partial rescue of survival 
(mean survival = 3.5; P < 0.001 compared to Hsf4, Fig. 5a). Similarly, Hsf4 
mutants died prematurely upon CrPV infection (mean survival = 3.1 and 6.2 
days for mutant and control flies, respectively; P < 0.001). Expression of the 
Hsf transgene rescued the mean survival time close to wild-type levels (5.2 
days; P < 0.001 when compared to Hsf4) (Fig. 5b). Finally, we also observed 
a higher susceptibility of Hsf4 mutants to IIV-6 infection compared to wild-
type flies (P < 0.001), whereas the Hsf rescue line remained at wild-type 
levels (Fig. 5c). However, we noted that Hsf4 mutants also had a reduced life 
span in mock infections. It is therefore not possible to draw firm conclusions 
about the role of Hsf in IIV-6 infection, as the increased mortality upon IIV-
6 infection could be a reflection of the decreased life span of the mutants 
(Fig. 5c). 
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Figure 5 |  Hsf-deficient flies are hypersensitive to RNA virus infection.    
(a-c) Survival of wild-type flies, Hsf4 mutants, and Hsf4 mutants carrying 
a single Hsf transgene (Hsf4; Rescue) upon (a) DCV, (b) CrPV, and (c) 
IIV-6 infection. (d,e) Survival of flies expressing an RNAi-inducing hairpin 
targeting Hsf in the fat body upon (d) DCV and (e) CrPV infection. The fat 
body-specific C564 driver line (C564-Gal4) was used to drive expression 
of the transcription factor Gal4, which binds to the Upstream Activating 
Sequence to induce expression a short hairpin targeting Hsf (UAS-HsfRNAi). 
Flies expressing the C564-Gal4 driver, but not the UAS responder, were 
included as controls. Mock infections (Tris buffer) were performed along all 
experiments, and no mortality was noticed over the time course analysed. 
(f,g) Viral titers of wild-type and Hsf4 mutant flies inoculated with (f) DCV 
or (g) CrPV over time. The dashed line represents the detection limit of 
the titration. Data represent mean and s.d. of three biological replicates 
of at least 15 female flies for each genotype (a-e) or mean and s.d. of 
three independent experiments, each consisting of 3 replicates of at 
least 5 female flies for each genotype (f,g). Differences in viral titers were 
assessed on log-transformed data with a Student’s t-test (*P < 0.05). 
Statistical analyses for survival assays (a-e) are discussed in the main text. 
To confirm the results obtained with Hsf4 mutants, we attempted to reduce 
Hsf levels by ubiquitous expression of an RNAi-inducing hairpin RNA (HsfRNAi) 
using the Actin-Gal4 driver. However, no viable offspring was obtained, 
consistent with the lethality associated with Hsf null alleles (26). We therefore 
reduced Hsf expression specifically in the fat body using the C564-Gal4 
transgene to drive HsfRNAi (50% knock-down efficiency, Supplementary 
Figure S6). These flies showed increased mortality rates compared to 
control flies both upon infection with DCV (mean survival = 4.2 and 6.0 days; 
P < 0.001) and CrPV (mean survival = 5.5 and 7.8 days; P < 0.001) (Fig. 
5d and 5e). In conclusion, impairing the heat shock response using a Hsf 
loss-of-function allele and gene knockdown results in increased sensitivity 
to viral infection, suggesting that the heat shock response is important for 
antiviral defence. 
 
Next, we asked whether the increased sensitivity of Hsf4 mutants to viral 
infections was accompanied by higher viral replication rates. Moderate 
differences in viral titers were observed between wild-type and mutant 
flies during the 2 day time-course following DCV infection, with a 10-fold 
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difference on the first day, which did not reach statistical significance 
(Fig. 5f). Upon CrPV infection, a small, but significant, increase in viral 
titers was observed at 1 dpi (10-fold, P < 0.05) (Fig. 5f). In conclusion, we 
demonstrate that the hypersensitivity of Hsf4 mutants to viral infections is 
accompanied by a modest increase in viral titers. 
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Figure 6 |  RNAi and inducible immune pathways are functional in Hsf-deficient flies. 
(a) Eye phenotype of 5 to 7-day-old flies expressing a hairpin RNA 
targeting the Drosophila Inhibitor of Apoptosis thread (thRNAi) and Heat 
shock factor (HsfRNAi). The genetic background of the HsfRNAi line was 
used as a control (Ctrl). No eye phenotype was observed in control and 
HsfRNAi flies that do not expressing the thRNAi transgene. Five representative 
images are shown for each genotype. (b) In vivo RNAi reporter assay. 
Reporter plasmids encoding Firefly (Fluc) and Renilla (Ren) luciferase were 
transfected along with Fluc specific dsRNA or non-specific control dsRNA 
in Hsf4 and Dcr2-/- mutant flies and their wild-type controls (CnBw and 
y1w1, respectively). Reporter gene activity was measured in fly lysates 
at three days after transfection. Fold silencing by Fluc dsRNA relative 
to control dsRNA was calculated and presented as the percentage of 
silencing relative to wild-type controls (see Fig. S6 for Fluc/Ren ratios of all 
samples). Bars represent mean and s.d. of three pools of five flies for each 
genotype. (c) Expression of inducible immune genes at 24 hpi with DCV 
(TCID50 = 10,000) determined by RT-qPCR in wild-type or Hsf4 mutant 
flies. Expression of the gene of interest was normalized to transcript levels 
of the housekeeping gene Ribosomal protein 49 and expressed as fold 
change relative to mock infection (Tris buffer). Data are mean and s.d. of 
three independent pools of 15 female flies for each genotype. Student’s 
t-tests were used to compare the difference s in expression between wild-
type and mutant flies (*P < 0.05).
b c
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RNAi and inducible immune pathways are functional in Hsf-
deficient flies
RNAi is one of the major antiviral pathways in Drosophila (4, 11) and its 
interaction with heat shock components has previously been demonstrated. 
For instance, the Hsc70/Hsp90 chaperone machinery participates in RISC 
assembly, and Hsp70 is transcriptionally regulated by the RNAi machinery 
(46-49). We therefore tested whether the RNAi pathway is fully functional 
in Hsf mutants. We first assayed RNAi activity using an in vivo sensor 
assay (34) that is based on silencing of the inhibitor of apoptosis thread 
(th) by expression of an RNAi-inducing hairpin RNA (thRNAi) (32, 50). Severe 
apoptosis in the developing eye is triggered by expression of thRNAi under 
control of the eye-specific driver GMR-Gal4, resulting in reduced eye 
size, roughening of the eye surface, and loss of pigmentation in adult flies 
(Fig. 6a). This phenotype is absent in mutant flies missing the central catalytic 
component of the pathway, Argonaute 2 (AGO2), indicating that it is fully 
dependent on the RNAi pathway (32, 50). We concomitantly expressed the 
thRNAi and HsfRNAi hairpins in the eye and monitored the resulting phenotypes. 
As controls, we included control flies that do not express HsfRNAi, but have 
the same genetic make-up, as well as flies that do not express thRNAi. Both in 
HsfRNAi and control flies, expression of thRNAi resulted in an RNAi-induced eye 
phenotype (Fig. 6a), which was absent in the control flies devoid of thRNAi. 
These results thus suggest that HsfRNAi mutant flies do not have a defect in 
RNAi activity. 
Additionally, we used a luciferase-based RNAi sensor assay to confirm the 
efficiency of the RNAi response in Hsf4 adult flies (50, 51). Three days after 
in vivo transfection with Firefly (Fluc) and Renilla luciferase reporter plasmids 
together with either Fluc-specific dsRNA or control dsRNA, silencing 
efficiency was measured in fly lysates. Dicer-2 null mutants and their wild-
type controls (y1w1) were included to verify that silencing of Fluc expression 
was RNAi-dependent (Fig. 6b, left panel). In contrast to Dicer-2 mutants, 
silencing capacity was intact in Hsf4 flies (Fig. 6b, right panel), confirming 
that RNA interference is fully functional in Hsf4 mutant flies.
Virus infection activates a number of evolutionary conserved immune 
pathways in Drosophila. Upon virus infection, the Jak-Stat pathway 
mediates induction of virus induced RNA-1 (vir-1), and genes encoding 
Turandot proteins A and M (TotA and TotM) (7, 8). The NF-ĸB pathways 
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Toll and Imd regulate expression of genes encoding antimicrobial peptides, 
such as Drosomycin, Metchnikowin, and Diptericin upon bacterial challenge, 
and in some cases, upon viral infections (52-54). Vago is induced by DCV 
infection through an unknown signalling pathway (55). To assess whether 
these virus-induced genes were regulated by the heat shock response, 
we measured their expression levels by RT-qPCR at 24 hours after DCV 
infection of adult wild-type and Hsf4 mutant flies (Fig. 6c). Consistent with 
previous observations, Jak-stat-dependent genes, especially vir-1 and TotM, 
were induced by virus infection. Vir-1 was induced to higher levels in Hsf4 
mutants than in wild-type flies (7.9-fold and 3.6-fold over mock, respectively, 
P < 0.05), likely caused by higher viral replication levels. TotM induction 
was slightly lower in Hsf4 mutants (6 and 4-fold in wild-type and mutant, 
respectively), whereas TotA and Vago, as well as antimicrobial peptides 
were not induced or only to low levels (<2-fold over mock) (Fig. 6c). Overall, 
no major differences were observed between wild-type and Hsf4 mutant 
flies, indicating that inducible responses to virus infection are not regulated 
by the heat shock response, and that differences in survival of Hsf mutants 
cannot be explained by defects in known immune pathways. 
Transgenic activation of the heat shock response reduces 
viral load
Host defence has been proposed to rely on resistance mechanisms that 
reduce pathogen load and tolerance mechanisms that reduce infection-
inflicted damage, but are not directly associated with control of pathogen 
load (56, 57). As Hsf4 mutant flies are more sensitive to infection and support 
mildly higher virus replication than control flies, our data suggest that the 
heat shock response contributes to resistance to viral infection. To further 
support this conclusion, we used overexpression studies to deduce whether 
the heat shock response confers tolerance or resistance to infection. If the 
heat shock response mediates resistance by driving expression of antiviral 
effectors, it is expected that transgenic activation of the response would 
reduce viral replication and prolong survival upon infection. 
We tested this hypothesis by ubiquitously overexpressing Hsf or Hsp70 
using the Actin-Gal4 driver. As controls, we included flies expressing either 
the Actin-Gal4 driver (Act-Gal4>+) or the UAS-Hsp70 responder (UAS-
Hsp70>+). Upon DCV infection, we observed lower mortality rates in Hsp70-
overexpressing flies compared to control flies (mean survival time of 7.6 
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and 5.1 days, respectively; P < 0.001; Fig. 7a). Consistently, mortality rates 
of flies overexpressing Hsf significantly decreased upon DCV infection, 
compared to Act-Gal4>+ controls (mean survival time of 12.5 and 7.6 days, 
respectively; P < 0.001; Fig. 7b). 
Interestingly, we observed that a subset of the Hsf-overexpressing flies did 
not succumb to infection. At 17 dpi, about 40% of the flies were still alive 
and did not exhibit symptoms of pathology, such as abdominal swelling 
or reduced locomotion. This intriguing observation could indicate that the 
flies were refractory to the virus, or that virus replication was suppressed to 
non-pathogenic levels or even fully eradicated. To address this question, we 
analysed in parallel to the survival assay the viral RNA load by RT-qPCR in 
single flies at different time points after infection (1, 2, 4 and 7 dpi), and at 17 
dpi on the protected flies (Fig. 7c). At 1 dpi, DCV RNA was detectable at low 
levels, both in control flies and in Hsf-overexpressing flies. At 2 and 4 dpi, viral 
loads increased dramatically in both groups, with Hsf-overexpressing flies 
showing a broad distribution of viral loads, and the control group showing a 
more homogeneous distribution. At 7 dpi, all Hsf-overexpressing flies were 
still alive and harboured significantly lower viral loads than control flies. In the 
control group, 55% of the flies already died (Fig. 7b); the remaining flies were 
moribund and contained very high viral loads (Fig. 7c). Yet, some of the Hsf-
expressing flies remained heavily infected, and these likely correspond to 
the population that would succumb to infection after that time. In the group 
of flies that were protected from infection until day 17, most flies had very 
low viral loads that were close to, or even below the level of detection (Fig. 
7c), indicating that overexpression of Hsf leads to long-term suppression of 
virus replication. 
These experiments demonstrate that overexpression of Hsp70 or Hsf confers 
resistance to viral infection, indicating that the heat shock response has 
antiviral activity in Drosophila. Overexpression of Hsf even enables control of 
viral loads to undetectable levels in a subpopulation of infected flies, raising 
the exciting possibility that these flies have fully cleared the infection. 
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Figure 7 |  Transgenic activation of the heat shock response protects against viral 
infection. (a,b) Survival of flies overexpressing (a) Hsp70 or (b) Hsf. The 
ubiquitous driver line (Actin-Gal4) was used to drive expression of (a) Hsp70 
or (b) Hsf. Flies expressing only the Actin-Gal4 driver or the responders 
UAS-Hsp70 or UAS-Hsf were included as controls. Mock infections 
(Tris buffer) were performed along all experiments, and no mortality was 
noticed over the analysed time course. (c) Viral RNA load was measured 
by RT-qPCR in single flies over time. The experiment was performed 
simultaneously with the survival of panel (b). Ten flies were analysed for 
each time point and genotype. DCV RNA levels were normalized to the 
housekeeping gene Ribosomal protein 49 and presented as fold change 
over the viral RNA levels in flies harvested immediately after inoculation. A 
Wilcoxon rank-sum test was used to compare differences in viral load (**P 
< 0.01). Data represent mean and s.d. of three biological replicates (a,b) 
of at least 15 female flies for each genotype. 
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Discussion
 
Inducible antiviral defence mechanisms remain poorly defined in insects. 
By combining transcriptome analyses and functional studies in vivo, we 
show in this study that RNA virus infection induces the heat shock response 
in a dynamic and Hsf-dependent manner. Hsf loss-of-function and Hsf 
knockdown reduce resistance to viral challenge in adult flies. Conversely, 
overexpression of Hsf induces resistance to infection. Thus, the heat shock 
response has direct antiviral activity in Drosophila. 
The mechanism underlying the antiviral activity of the heat shock response 
remains unknown. The Hsf transcription factor may induce expression of 
direct antiviral effectors. Strikingly, transgenic activation of the heat shock 
pathway by Hsf overexpression induces long-term control of viral replication, 
in some flies even to undetectable levels, raising the possibility of complete 
virus eradication. Similarly, overexpression of Hsp70 also confers resistance 
to infection, albeit not as strongly as Hsf overexpression. These results 
suggest that Hsp70 itself has antiviral activity, but that Hsf induces additional 
downstream effectors that mediate antiviral immunity. Alternatively, the heat 
shock response may function as an alert system that primes the immune 
system to deploy more rapid and efficient immune responses. For example, 
it has recently been suggested in mammalian systems that damaged 
cells release heat shock proteins, which function as damage-associated 
molecular patterns (DAMPs) that activate immune cells through binding to 
Toll-like-receptors (58-60). 
The heat shock signalling cascade has been characterized in depth in 
Drosophila, in which it was first discovered with the “puffing” pattern of 
polytene chromosomes upon heat treatment (61). The well-described 
heat shock response, combined with an extensive genetic toolbox, makes 
Drosophila a good model to further study the activation of the heat shock 
response and putative downstream effector mechanisms in antiviral defence. 
For example, it would be of interest to analyze whether heat shock proteins 
are secreted in the hemolymph and whether they signal infection systemically. 
Putative target loci bound by Hsf have recently been characterized by genome-
wide analyses (62-64). Epigenetic marks present on the chromosomal 
landscape influence Hsf binding to heat shock element (HSE) target sites. 
Prior presence of active chromatin marks, such as H3K4 acetylation, are 
determinants of binding (64). Chromatin immunoprecipitation combined 
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with genome tiling and cDNA microarrays provided a map of the in vivo 
binding sites of the Hsf in Drosophila embryos or Kc cells (62, 63). These 
studies identified as Hsf target sites, chaperone-encoding genes, as well as 
many genes with other cellular functions, including metabolic and stress-
related genes, which are typically activated upon starvation or oxidative 
stress. These analyses suggest that a core set of downstream effectors can 
be induced by different stress responses and that Hsf forms a signalling hub 
to coordinate these responses. 
The molecular mechanisms underlying the activation of the heat shock 
response upon viral infection remain elusive. Studies in mammalian infection 
models suggest multiple possibilities. In line with the chaperone function 
of heat shock proteins, the heat shock response could result from the 
accumulation of large amounts of unfolded viral proteins in the cytoplasm 
(22). In addition, some components of the innate antiviral immune response, 
such as MDA-5, have aggregation properties that are potent heat shock 
inducers (65, 66). Their accumulation in the cytoplasm upon infection, which 
is required for their signalling function, could be a trigger for the heat shock 
response. In addition, it was recently proposed that Dicer-2 and AGO2, two 
components of the RNAi pathway, regulate expression of transcriptionally 
active, euchromatic loci, such as Hsp70 (46). Intriguingly, many insect viruses 
including DCV and CrPV encode suppressors of RNAi (4, 67-69). Possibly, 
these proteins could interfere with RNAi-mediated suppression of Hsp70, 
and the heat shock response would therefore act as a counter-counter-
defence mechanism that is activated when the pathogen interferes with the 
primary defence system. A similar concept has recently been discovered in 
plants (70). 
Translocation of the heat shock transcription factor to the nucleus and binding 
to chromosomal target loci is an essential step in activation of the heat 
shock pathway (71). Surprisingly, only few studies report Hsf translocation 
upon viral infection, one in adenovirus infection of HeLa cells, and another in 
vaccinia virus infection of human macrophages (72, 73). The translocation of 
Hsf is difficult to assess, as it can have a nuclear localization at steady state 
conditions (14). Live multi-photon imaging of Drosophila salivary glands 
revealed that upon activation, Hsf translocates from the nucleoplasm to 
chromosomal loci (16). Hsf translocation can be used as a read-out for the 
activation of the heat shock response that, although technically challenging, 
would be worth investigating in virus infected cells. For instance, it would 
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be of interest to determine whether Hsf translocation could be visualized 
in adult flies, and whether Hsf translocation occurs only in infected cells, 
or also in non-infected cells, and whether tissue specific target loci can be 
defined. 
As the heat shock response exerts antiviral function, it is likely that viruses 
have evolved counter-defence strategies to impede it. All steps of the heat 
shock pathway (activation, Hsf translocation, binding to target promoters, 
as well as expression and function of downstream effectors) are potential 
targets for interference by viruses. Strikingly, our results indicate that 
CrPV is a modest inducer of heat shock genes in S2 cells and, in vivo, the 
response seems to be delayed, but stronger, in comparison to DCV. This 
is consistent with previous observations that CrPV inhibits the heat shock 
response to elevated temperatures in vitro at early time points after infection 
(44). It would be of interest to map this activity to individual viral proteins, 
and to assess the in vivo course of infection of virus mutants with defects 
in this activity. Studying the complex interactions between the heat shock 
pathway and virus infection will yield fundamental insights into cellular 
defence mechanisms, and may uncover new targets for the treatment of 
viral infection. 
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Supplementary Figures
Probeset ID Flybase ID Gene name Fold change  
1631628_s_at FBgn0033520 Peroxiredoxin 2540 32,26
1639571_s_at FBgn0013276 Heat shock protein 70Ab; Heat shock protein 70Aa 20,84
1626821_s_at FBgn0013277 Heat shock protein 70Ba 7,15
1632841_x_at FBgn0013278 Heatshock protein 70Bc; Heat shock protein 70Bb 7,15
1641055_at FBgn0001224 Heat shock protein 23 7,13
1635044_at FBgn0001225 Heat shock protein 26 6,63
1635263_at FBgn0033519 Dmel_CG11825 5,94
1627613_at FBgn0014865 Metchnikowin 4,39
1634366_at FBgn0052185 Dmel_CG32185 2,94
1629061_s_at FBgn0001223 Heat shock protein 22; Heat shock gene 67Bb 2,88
1640881_at FBgn0035343 Dmel_CG16762 2,58
1628117_at FBgn0001226 Heat shock protein 27 2,48
1640405_at FBgn0010497 lethal (2) 01810 2,23
1625265_at FBgn0035189 Dmel_CG9119 2,19
1638301_at FBgn0034010 Dmel_CG8157 2,18
1634640_at FBgn0031693 Probable cytochrome P450 4ac1 2,05
Probeset ID Flybase ID Gene name Fold change  
1639571_s_at FBgn0013276 Heat shock protein 70Ab; Heat shock protein 70Aa 26,25
1641055_at FBgn0001224 Heat shock protein 23 15,34
1635044_at FBgn0001225 Heat shock protein 26 9,91
1629061_s_at FBgn0001223 Heat shock protein 22; Heat shock gene 67Bb 6,67
635666_at FBgn0053906 Histone H2B 4,47
1628117_at FBgn0001226 Heat shock protein 27 3,59
1626821_s_at FBgn0013277 Heat shock protein 70Ba 3,33
1632023_s_at FBgn0039911 Dmel_CG1909 2,85
1640231_a_at FBgn0034493 Dmel_CG8908 2,81
1627129_at FBgn0000253 Calmodulin 2,69
1629261_at FBgn0020660 Eukaryotic initiation factor 4B 2,43
1637786_s_at FBgn0085820 Dmel_CR41610 2,35
1641609_at FBgn0005630 longitudinals lacking 2,30
1624070_at FBgn0010408 Ribosomal protein S9 2,18
1641593_at FBgn0053969 Dmel_CG33969 2,12
1635210_a_at FBgn0003137 Papilin 2,05
1631797_at FBgn0029521 Odorant receptor 1a 2,05
1639005_x_at FBgn0053272 Dmel_CG33272 2,03
1625387_s_at FBgn0025615 Torsin-like protein 2,02
1627679_at FBgn0040371 Dmel_CG12470 2,00
Supplementary Figure S1
a. Up-regulated, 8 hpi
b. Up-regulated, 24 hpi
Figure S1 |  List of upregulated genes (> 2-fold over mock) in DCV-infected Drosophila 
S2 cells at (a) 8 hours and (b) 24 hpi. Probe set ID is the unique identifier 
given by Affymetrix to the probes on a microarray. 
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Probeset ID Flybase ID Gene name Fold change 
1633989_at FBgn0037290 Dmel_CG1124 3,57
1635227_at FBgn0001258 Ecdysone-inducible gene L3 3,01
1639737_at FBgn0085359 Dmel_CG34330 2,90
1635852_at FBgn0010194 Wnt oncogene analog 5 2,76
1634964_at FBgn0038565 Dmel_CG7794 2,62
1629479_a_at FBgn0020303 fledgling of Klp38B 2,56
1636275_a_at FBgn0260964 Vesicular monoamine transporter 2,54
1624725_at FBgn0037565 Dmel_CG9626 2,54
1632491_at FBgn0052985 Dmel_CG32985 2,41
1624591_at FBgn0031784 Dmel_CG9222 2,40
1635000_at FBgn0034603 Dmel_CG9480 2,22
1641552_at FBgn0010019 Cytochrome P450-4g1 2,20
1626442_at FBgn0031971 Dmel_CG7224 2,19
1628032_a_at FBgn0051092 Dmel_CG31092 2,19
1626849_at FBgn0031723 Dmel_CG7251 2,17
1637257_at FBgn0027601 Dmel_CG9009 2,17
1637632_at FBgn0031636 Dmel_CG12194 2,13
1623949_s_at FBgn0052816 Dmel_CG32816 2,09
1639105_at FBgn0065110 pickpocket 10 2,07
1637544_s_at FBgn0085436 Dmel_CG34407 2,06
1639537_at FBgn0028863 Dmel_CG4587 2,02
1625761_a_at FBgn0035049 Matrix metalloproteinase 1 2,01
1631441_s_at FBgn0035539 Dmel_CG7447 2,00
1628494_a_at FBgn0024315 Putative inorganic phosphate cotransporter 2,00
Probeset ID Flybase ID Gene name Fold change 
1626442_at FBgn0031971 Dmel_CG7224 4,33
1626846_s_at FBgn0031914 Dmel_CG5973 3,58
1635227_at FBgn0001258 Ecdysone-inducible gene L3 3,29
1635635_a_at FBgn0065097 small non-messenger RNA 357 3,27
1631628_s_at FBgn0033520 Peroxiredoxin 2540 3,09
1632719_at FBgn0000279 Cecropin C 2,98
1629479_a_at FBgn0020303 fledgling of Klp38B 2,70
1639737_at FBgn0085359 Dmel_CG34330 2,58
1623635_at FBgn0031701 Turandot M 2,29
1630361_at FBgn0002945 naked cuticle 2,26
1633989_at FBgn0037290 Dmel_CG1124 2,17
1626892_at FBgn0086251 deadlock 2,16
1631408_at FBgn0029123 SoxNeuro 2,14
1624725_at FBgn0037565 Dmel_CG9626 2,13
1633770_at FBgn0037646 Dmel_CG11967 2,12
1625840_at FBgn0037265 Uncharacterized protein CG12001 2,04
1635263_at FBgn0033519 Dmel_CG11825 2,03
1635852_at FBgn0010194 Wnt oncogene analog 5 2,02
1641722_at FBgn0016715 Rhythmically expressed gene 2 2,01
Supplementary Figure S2
a. Down-regulated, 8 hpi
b. Down-regulated, 24 hpi
0 10 20 30 40 50 60 70
fusome organization
oxygen and reactive oxygen species metabolic process
cellular catabolic process
Fold enrichment 
c
Figure S2 |  List of downregulated genes (>2-fold over mock) in DCV-infected 
Drosophila S2 cells at (a) 8 hours and (b) 24 hpi. (c) Gene ontology 
analysis of downregulated genes at 24 hpi. All significantly enriched level 
4 GO terms are shown (P < 0.05 in a hypergeometric test with Benjamini 
& Hochberg correction) No significant enrichment was found at 8 hpi.
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Symbol Fold change
TotX 32,90
CG11501 20,97
TotM 13,27
Hsp70Aa 9,51
Hsp70Ab 9,45
TotC 7,52
TotA 6,50
Hsp70Bc 6,11
Hsp70Bbb 5,98
Hsp70Bb 5,90
Hsp70Ba 5,86
CG11459 4,76
Hsp68 4,03
CG6639 3,71
CG31704 2,77
Lsd-1 2,68
Lcp65Ag1 2,68
Lcp65Ag2 2,41
CG42868 2,38
Lcp65Ag3 2,36
CG1773 2,22
Socs36E 2,20
ninaD 2,19
Cys 2,13
CG9616 2,13
CG42737 2,13
CG14205 2,10
lectin-37Da 2,10
CG6508 2,06
CG12517 2,03
PGRP-SC1a 2,00
Symbol Fold change
Lsp1beta 6,63
Lsp2 4,89
Obp99a 4,06
Cht4 3,73
Fst 3,34
GstD2 2,73
CG16704 2,33
Dro 2,31
Vml 2,28
Vm32E 2,23
CG10621 2,23
CG34291 2,23
ndl 2,08
psd 2,01
Supplementary Figure S3
a. Up-regulated genes, DCV, 24 hpi b. Down-regulated genes, DCV, 24 hpi
0 20 40 60 80
extracellular matrix organization
lipid metabolic process
defense response
organelle localization
humoral immune response
Fold enrichment 
c. Gene Ontology
     Down-regulated genes, DCV, 24 hpi
Figure S3 |  List of genes that are (a) upregulated and (b) downregulated (>2-fold 
over mock) in wild-type flies at 24 hours after DCV infection. (c) Gene 
ontology analysis of downregulated genes. All significantly enriched level 
4 GO terms are shown (P < 0.05 in a hypergeometric test with Benjamini 
& Hochberg correction).
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Symbol Fold change
CG11501 59,30
TotX 58,08
lectin-24A 38,32
TotM 30,70
Dpt 13,55
AttC 12,91
CG32185 12,82
TotC 12,73
DptB 12,47
TotA 11,96
CG10332/IM18 10,85
CG11459 10,56
CecA1 9,32
AttA 9,25
AttB 9,00
CG33926 5,90
PGRP-SB1 5,86
Mtk 4,79
CG14527 4,41
Cys 4,00
CG14205 3,71
CG14526 3,68
Dro 3,53
Obp56a 3,43
CG1773 3,29
PGRP-SD 3,25
CG3106 3,03
CG5246 2,97
Cyp4d1 2,83
CG31704 2,79
Jon66Cii 2,69
CG4259 2,68
CG42737 2,57
CG9676 2,53
CG9377 2,48
betaTub85D 2,45
CG30431 2,43
LysS 2,43
CG7829 2,43
CG6495 2,39
CG8329 2,39
Npc2d 2,38
Rfabg 2,36
CG13936 2,36
PGRP-SC1a 2,35
CG3239 2,35
CG14225 2,31
CG14872 2,30
PGRP-SC1b 2,22
CG31041 2,20
CG2772 2,17
CG16836 2,16
CG11911 2,16
CG32523 2,14
ap 2,14
Hml 2,13
CG2736 2,13
tim 2,11
CG5618 2,10
CG12057 2,10
CG11912 2,10
GstD5 2,08
Jon66Ci 2,08
Tequila 2,08
CG11852 2,07
CG6361 2,06
CG6295 2,06
CG32368 2,04
CG42868 2,03
sug 2,00
CG17032 2,00
Symbol Fold change
CG7203 14,52
fln 8,28
TpnC4 7,73
Nplp3 6,54
Cht4 6,02
Fst 5,86
Cpr49Ae 4,50
CG9090 4,38
CG14246 3,97
CG3264 3,78
CG15434 3,73
Lsp2 3,71
CG34172 3,58
Mur11Da 3,53
CG4066 3,46
CG15571 3,41
CG14245 3,34
TpnC41C 3,29
CG31926 3,23
CG16772 3,18
CG7409 3,12
Cp19 3,12
CG15065 3,10
CG16704 3,03
CG13084 3,03
Femcoat 2,89
CG13083 2,83
Act79B 2,77
CG12716 2,75
CG9297 2,73
Cp7Fa 2,73
CG2022 2,62
CG4757 2,58
proPO-A1 2,58
Mlc1 2,55
Cp16 2,50
CG11425 2,48
Spn31A 2,46
CG31205 2,45
Mlc2 2,45
Fhos 2,39
CR31084 2,31
Cpr72Ec 2,30
Act88F 2,28
Cpr62Bb 2,28
CG13113 2,27
CG4000 2,25
CG31928 2,20
Npc2e 2,20
CG15528 2,19
Gasp 2,17
Ugt35b 2,16
wupA 2,16
CG34291 2,16
CG16978 2,13
CG34365 2,11
retinin 2,10
CG8193 2,10
Spn43Aa 2,08
CG31904 2,07
Prm 2,04
Pkcdelta 2,04
CG33521 2,03
nAcRbeta-64B 2,00
Supplementary Figure S4
a. Up-regulated genes, CrPV, 24 hpi b. Down-regulated genes, CrPV, 24 hpi
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response to temperature stimulus
cytoskeleton organization
Fold enrichment 
c. Gene Ontology
     Down-regulated genes, CrPV, 24 hpi
Figure S4 |  List of genes that are (a) upregulated and (b) downregulated (> 2-fold 
over mock) in wild-type flies at 24 hours after CrPV infection. (c) Gene 
ontology analysis of downregulated genes. All significantly enriched level 
4 GO terms are shown (P < 0.05 in a hypergeometric test with Benjamini 
& Hochberg correction).
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Supplementary Figure S5
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Figure S5 |  Western blot analysis of Hsp70 proteins in DCV infected S2 cells at 16 
and 24 hpi. An anti-Hsp70 monoclonal antibody was used to stain the 
inducible form of Hsp70. The asterisk indicates a nonspecific band and 
verifies equal loading of the gel. Molecular mass (kDa) is indicated on the 
left of the blot. 
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Figure S6 |  (a) Hsf expression in flies expressing an RNAi-inducing hairpin targeting 
Hsf (UAS-HsfRNAi) under control of a fat body specific driver (C564-
Gal4). Data are presented as percentage of Hsf expression in control 
flies expressing the fat body driver but not RNAi-inducing hairpin (C564-
Gal4>+). A Student’s t-test was used to compare the difference in 
expression (*P < 0.05). (b) Firefly (FLuc) and Renilla (Ren) luminescence 
counts and (c) FLuc/Ren ratios in flies subjected to in vivo transfection 
with Firefly and Renilla reporter plasmids, together with a dsRNA 
targeting Firefly luciferase (dsFluc) or a nonspecific dsRNA (dsGFP). Data 
are means and s.d. of three independent pools of (a) 15 or of (b, c) 10 
female flies for each genotype and condition. 
a
b c
173
The heat shock response restricts virus infection
4
Supplementary Table S1 | Primer list. 
Target Primer sequence (5’-3’)
Rp49 ATGACCATCCGCCCAGCATAC
CTGCATGAGCAGGACCTCCA
Hsp70 CACGATGTCGTGGATCTGAC
GGGCCAAGACTTCTACACCA
Hsp23 TGCCCTTCTATGAGCCCTAC
TCCTTTCCGATTTTCGACAC
Hsp26 TAGCCATCGGGAACCTTGTA
GTGGACGACTCCATCTTGGT
Hsp27 GACTGGGTCGTCGTCGTTAT
ACACCTGGAAGCCATCTTTG
Hsf GCGATTGACTCACACTTTGG
TGAGCATTAGCTCGCACAAC
DCV TTGCCATTGCACCACTAAAA
AAAATTTCGTTTTAGCCCAGAA
vir-1 ATTACTCCGAATTCGAAGCTTCC
CGAATTCTTCACGCTCCTTC
TotA CCCTGAGGAACGGGAGAGTA
CTTTCCAACGATCCTCGCCT
TotM ACCGGAACATCGACAGCC
CCAGAATCCGCCTTGTGC
Vago CAGCCAAGCGATTCCTTATC
CTCATACAGTGGGCAGCATC
Drosomycin GTACTTGTTCGCCCTCTTCG
ACAGGTCTCGTTGTCCCAGA
Metchnikowin TACATCAGTGCTGGCAGAGC
AATAAATTGGACCCGGTCTTG
Diptericin TGTGAATCTGCAGCCTGAAC
GCTCAGATCGAATCCTTGCT
Given the high sequence identity amongst members of 
the Hsp70 genes family, Hsp70 primers detect multiple 
Hsp70 genes (Hsp70Aa, Hsp70Ab, Hsp70Ba, Hsp70Bb, 
Hsp70Bc). 
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Abstract
The fruit fly Drosophila melanogaster is a valuable model organism for the 
discovery of innate immune pathways. Several antiviral defense mechanisms 
have been characterized over the past years, but host responses to virus 
infection remain incompletely understood. Here, we describe a novel virus 
restriction factor, Sgroppino (Sgp). Genetic depletion of Sgroppino in adult 
flies causes hypersensitivity to RNA virus infection, which was accompanied 
by higher levels of replication for some viruses (Drosophila X virus and 
Drosophila C virus). Canonical antiviral immune pathways remain functional 
in Sgroppino mutants, suggesting that Sgroppino exerts its antiviral activity 
via an as yet uncharacterized process. We demonstrate that Sgroppino 
localizes to peroxisomes, organelles involved in lipid metabolism. In 
accordance, Sgroppino-deficient flies show a defect in lipid metabolism, 
reflected by a higher body mass and thicker abdominal fat tissue. Knock-
down of Pex3, an essential peroxisome biogenesis factor, increased 
sensitivity to virus infection, supporting the hypothesis that peroxisomes are 
required for antiviral defense. Together, our results establish a link between 
the peroxisomal protein Sgroppino and resistance to virus infection. 
Importance
Insights into antiviral immunity of insects is important for our understanding 
of virus transmission by blood-feeding insects and may inspire new control 
strategies for insect-transmitted viruses with medical, agricultural, or 
economic importance. In this manuscript, we identify a new gene – which 
we named Sgroppino – that controls antiviral defense in the fruit fly. We 
show that Sgroppino is a peroxisome-associated protein and that defects 
in the gene are associated with altered fat metabolism, increased sensitivity 
to specific RNA viruses, and higher viral loads. These results indicate that 
peroxisomes are essential for host defense to infection, which has thus far 
received limited attention in any experimental system. Moreover, along with 
recent literature, our work indicates that virus infection in insects induces a 
multi-faceted host response. 
177
Sgroppino and antiviral immunity
5
Introduction
Viruses are the most abundant biological entities on earth and are capable 
of infecting all cellular life forms (1). As intracellular parasites, viruses exploit 
host cell machineries and establish contacts with cellular components at 
every step of their replication cycle. As a consequence, host cells evolved 
a myriad of defense mechanisms that directly or indirectly restrict viral 
replication. 
Cellular organelles are exploited by viruses for entry, replication, and 
assembly (2). For example, many viruses enter the cell through endosomal 
compartments; Flock House virus (FHV) exploits outer mitochondrial 
membranes as replication sites (3), several DNA and RNA viruses remodel 
the ER network into replication organelles to facilitate their own replication 
(4, 5), whereas enveloped viruses use cellular membranes for their assembly 
(4). In addition to being exploited by pathogens, cellular organelles are sites 
of immune signaling (6). For instance, the plasma membrane and endosomal 
compartments are the sites where Toll-like receptors patrol the extra-
cellular environment to detect pathogen-associated molecular patterns 
(PAMPs) (7). Mitochondrial membranes are the site for a major immune 
signaling complex, of which the main component MAVS (mitochondrial 
antiviral signaling protein) is activated after sensing of viral RNA by RIG-I-like 
receptors in the cytoplasm (7). 
One of the most successful model organisms for the discovery of novel 
immune genes is the fruit fly Drosophila melanogaster (8). The vast genetic 
toolbox available in that organism facilitated the characterization of several 
antiviral defense pathways. RNA interference (RNAi), for example, is a major 
antiviral mechanism, which is initiated by processing of viral double-stranded 
RNA by Dicer-2 into small interfering RNAs. These siRNAs guide cleavage 
of viral RNA by the Argonaute-2 containing RNA induced silencing complex 
(9, 10). In addition, virus infection may activate several signaling pathways, 
including Jak-Sat and the NF-kB-dependent pathways Toll and Imd that 
participate in antiviral defense in a virus-specific manner (11-17). Their 
contribution to the overall immune response may also depend on the route 
of inoculation; for instance, Toll signaling is required for resistance to oral, 
but not systemic infection (17). Finally, other essential cellular processes, 
such as autophagy and the heat shock response, are also required for 
resistance to virus infection (18-21). 
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Here, we describe a novel restriction factor of RNA viruses in Drosophila, 
which we named Sgroppino. Sgroppino-deficient flies are hypersensitive to 
virus infection, and support higher levels of replication of some viruses. We 
demonstrate that Sgroppino localizes to peroxisomes and that knock-down 
of the peroxisome biogenesis factor, Pex3, causes hypersensitivity to virus 
infection. Altogether, our data demonstrate that Sgroppino participates in 
antiviral defense, possibly by affecting peroxisome function. 
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Materials and Methods
Fly strains and husbandry 
Flies were raised on standard cornmeal-agar medium at 25°C in a light/
dark cycle of 12h/12h. The CG13091/Sgroppino mutant (referred to as 
Sgp-/-) contains a P{EPgy2} transposon insertion in the 3’-untranslated 
region of the CG13091 transcript (22) (Fig. S1B). Sgp-/- and Arm-Gal4 
driver lines were obtained from Bloomington Stock Center (stock numbers 
15973 and 1561). The SgpRNAi and Ago2RNAi hairpin-expressing lines were 
obtained from the Vienna Drosophila Stock center (stock no. 100943 and 
49473) and Pex3RNAi from the NIG-Fly Stock Center (stock no. 6859R-4). 
Hsf4 and CnBw fly lines have been described previously (21). We used y1w1 
flies as the genetic background control for Sgp-/- in all experiments. In vivo 
RNAi experiments were performed by crossing GMR-Gal4, UAS-thRNAi/
CyO; Ago2321/TM6,Sb virgins (23) with SgpRNAi , Ago2RNAi, or with control 
male flies containing the attP landing site that was used to introduce the 
RNAi-inducing transgene (y1v1; attP2; Bloomington stock no. 36303). The 
eye phenotype was assessed in three to five-day-old female F1 offspring, 
containing the TM6, Sb balancer and lacking the CyO balancer. 
Starvation and heat shock assay
For the starvation assay, three to five-day-old flies were transferred, without 
using CO2 anesthesia, from standard fly food to starvation medium, 
consisting of distilled water jellified with 0.66% agar (wt/vol) (adapted from 
(24)). For the heat shock assay, three to five-day-old flies were incubated at 
35°C. Flies were transferred to fresh medium every 3 days, and survival was 
assessed daily.
Weight measurement
Embryos were collected on apple juice-agar plates as previously described 
(25), and 50 were transferred to a single culture vial containing standard 
cornmeal-agar medium and cultured at 25°C. Five to seven-day-old flies 
were collected and frozen in groups of ten individuals of a single sex. The 
weight of each group was determined on a precision scale, and expressed 
as mass per individual fly. 
180
Chapter 5
Time to pupation assay
Fifty embryos were grown on standard cornmeal-agar medium at 25°C, as 
described for weight measurement. The appearance of pupae was scored 
twice a day. 
Quantification of triglycerides
Three pools of two flies were homogenized in 150 μL lysis buffer (1% NP-
40). Samples were heated for 5 minutes at 90°C and allowed to cool down 
at room temperature; this step was repeated twice. Debris was pelleted by 
centrifugation at 16,000 g for 2 min, and supernatant was transferred to a 
new tube. Protein was quantified using the Pierce BCA protein assay kit 
(Thermo Scientific) on 25 μL of undiluted lysate, following the manufacturer’s 
instructions. Triglycerides were measured with the Triglyceride Quantification 
kit (Biovision), following the manufacturer’s instructions using a 1:40 dilution 
of the same lysate. Colorimetric measurements were performed at 570 nm 
using a Biotek Synergy 2 plate reader. All measurements were performed 
in triplicate, and triglyceride levels were normalized against protein levels. 
Virus infection 
Fly stocks were cleared of Wolbachia and persistent virus infections as 
previously described (25). After anesthesia with CO2, three to five-day-old 
flies were inoculated by intrathoraxical injection with a Nanoject II injector 
(Drummond). Inocula contained 1.000 median tissue culture infectious doses 
(TCID50) of DCV and CrPV; 14,000 TCID50 of IIV-6; 3,000 TCID50 of FHV; and 
2.000 TCID50 of DXV for all survival assays. An inoculum of 10,000 TCID50 
of DCV was used in experiments in which transcriptional responses were 
analyzed. Flies were transferred to fresh food every 3 days, and survival 
was assessed daily. Lethality on the first day was attributed to the injection 
procedure and excluded from the survival analysis. Unless noted otherwise, 
three pools of 10 to 15 flies were injected per condition with independent 
dilutions of virus stock. 
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Virus titration
Viral titers were determined by end-point dilution, as previously described (25).
 
In vivo RNAi reporter assay 
RNAi competency of adult flies was analyzed using a reporter assay, as 
described previously (26) . Briefly, three to five-day-old female flies were 
injected in the abdomen with suspension containing lipofection reagent 
complexed with Firefly luciferase (Fluc) and Renilla luciferase (Rluc) reporter 
plasmids, and Fluc specific or non-specific control (GFP) dsRNA. Fluc and 
Rluc activity was measured in fly homogenate, Fluc over Rluc ratios were 
calculated for each sample, and data are presented as fold silencing relative 
to the non-specific dsRNA control. 
RNA analysis
RNA was isolated from flies using Isol-RNA lysis Agent (5-Prime). cDNA 
synthesis was performed on 1 μg of DNase I (Ambion)-treated RNA using 
TaqMan Reverse Transcription Reagents (Applied Biosystems) according to 
the manufacturer’s instructions. qPCR was performed using SYBR Green I 
Master reagents on a LightCycler 480 (Roche). The qPCR program was the 
following: 95°C for 5 min, and 45 cycles of 95°C for 5s, 60°C for 10s, 72°C 
for 20s. Expression of the gene of interest was normalized to transcript 
levels of the housekeeping gene Ribosomal Protein 49 (Rp49), and fold 
change was calculated using the ddCt method (27). Primers sequences are 
provided in Table S1. 
Plasmids 
Insect expression plasmids pAc-tagRFP and pAc-tagEGFP were constructed 
by modifying pAc5.1-V5-His-A (Invitrogen) to allow expression of transgenes 
with GFP and RFP at the N-terminus. The full-length coding sequences of 
Sgp and PMP34 were amplified from cDNA of adult CnBw flies, and cloned 
into pAc-tagRFP and pAc-tagEGFP, using SacI for Sgp and XbaI and SacI for 
PMP34. Primers sequences are provided in Table S1. 
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dsRNA synthesis
In vitro transcription using T7 RNA polymerase was performed on a PCR 
product flanked by T7 promoters. The reaction was incubated at 37°C for 3 
hours, followed by an incubation at 80°C for 10 minutes and gradual cooling 
to room temperature. dsRNA was purified using the GenElute Mammalian 
Total RNA Miniprep Kit (Sigma) following the manufacturer’s instructions. 
Primers sequences are provided in Table S1. 
Immunostaining
For subcellular localization of Sgroppino and PMP34, 2 x 105 S2 cells 
(Invitrogen) per well were seeded in a 24-well plate. A day later, cells were 
transfected with 500 ng of pAc-tagRFP-Sgp and pAc-EGFP-PMP34, and, 
where applicable, 20 ng of dsRNA using Effectene transfection reagents 
(Qiagen) following the manufacturer’s instructions. Three days post-
transfection, cells were resuspended and seeded on coverslips coated 
with 50 μL Concavalin A (0.5 mg/μL) (28). Two hours later, samples were 
fixed with 4% paraformaldehyde for 20 minutes. The cover slips were then 
washed in PBS and permeabilized in PBS/0.1% Triton for 15 minutes. The 
nuclei were stained with Hoechst reagent (1:15,000 dilution in PBS/0.1% 
Triton) for 5 minutes, washed in PBS, and mounted with Mowiol. Pictures 
were taken on an Olympus FV1000 confocal microscope and processed 
using FIJI (29).
Statistical analysis
Unpaired two-tailed Student’s t-test, as implemented in Graphpad Prism 
version 6, was used to compare differences in gene expression, viral RNA 
levels, and log-transformed viral titers. Survival assays were assessed 
using Kaplan-Meier analyses and log-rank tests, as implemented in SPSS 
Statistics (version 20, IBM). P-values below 0.05 were considered statistically 
significant.
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Results
Sgroppino mutant flies are more sensitive to RNA virus 
infection
To identify novel genes involved in antiviral defense in Drosophila, we 
previously performed a transcriptome analysis on virus-infected flies, which 
were either mutant for the epigenetic regulator, G9a, or their wild-type 
controls (26). Amongst the uncharacterized genes that were upregulated 
upon Drosophila C virus (DCV) infection in G9a mutant flies was CG13091, 
which we named Sgroppino (Sgp). 
To determine whether Sgroppino is important in antiviral defense, we reduced 
Sgp expression in adult flies by ubiquitous expression of an RNAi-inducing 
hairpin RNA (SgpRNAi) under control of the Actin-Gal4 driver, and monitored 
survival rates upon viral challenge. Upon infection with DCV, a positive-
sense RNA virus from the Dicistroviridae family, SgpRNAi flies exhibited lower 
survival rates than control flies expressing the Actin-Gal4 driver only (Fig. 
1A; mean survival = 5.3 and 7.0 days; P < 0.001). We confirmed by reverse 
transcription followed by quantitative PCR (RT-qPCR) that the Sgp knock-
down was efficient, as Sgp mRNA levels were reduced by 80% in male and 
female adult flies (Fig. S1A).
Next, we sought to confirm this observation using a mutant fly line 
containing a P{EPgy2} transposon insertion in the 3’-untranslated region 
of the Sgp gene (22) (Fig. S1B). We demonstrated that Sgp expression 
was reduced by 93% (Fig. S1C), and for the remainder of our study we 
used this hypomorphic mutant (SgpEY06744, which we for brevity refer to as 
Sgp-/-). Sgroppino-deficient flies had no obvious defects in development 
and exhibited a similar lifespan as wild-type flies under standard 
laboratory conditions (Fig. S1D). Upon challenge with DCV, Sgp mutant 
flies had a reduced survival time compared to the wild-type control (y1w1) 
flies (Fig. 1B; mean survival = 4.4 and 7.1 days, respectively; P < 0.001), 
confirming the phenotype observed upon RNAi-mediated knock-down of 
Sgp (Fig. 1A). We verified that mock infection did not affect survival rates 
as a result of injury-associated stress and mortality (Fig. S2A). Moreover, 
other abiotic stresses, such as heat shock (Fig. S2B) and starvation did 
not trigger premature mortality, excluding a broad sensitivity to various 
stressors (Fig. S2C). 
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Figure 1 |  Sgroppino mutants are hypersensitive to RNA virus infection.   
(A) Survival upon DCV infection of flies ubiquitously expressing an RNAi-
inducing hairpin targeting Sgp. The ubiquitous Actin driver line (Actin-
Gal4) was used to drive expression of the transcription factor Gal4, which 
binds to the Upstream Activating Sequence to induce expression a short 
hairpin targeting Sgp (UAS-SgpRNAi). Flies expressing the Actin-Gal4 driver, 
but not the UAS responder (Actin-Gal4>+), were included as controls. (B-F) 
Survival of wild-type (y1w1) and Sgp-/- mutant flies upon (B) DCV, (C) CrPV, 
(D) FHV, (E) DXV and (F) IIV-6 infection. Data represent means and s.d. of 
three biological replicates of at least 15 female flies for each genotype.
We next challenged Sgp mutants with another dicistrovirus, Cricket 
paralysis virus (CrPV). As for DCV, infected mutant flies succumbed earlier 
to CrPV challenge (Fig. 1C; mean survival = 4.4 and 5.6 days; P < 0.001). 
Hypersensitivity to viral infection was not sex-dependent, as male Sgp 
mutant flies also had reduced survival rates upon DCV (Fig. S2D; mean 
survival = 5.3 and 3.2 days; P < 0.001) and CrPV infection (Fig. S2E; mean 
survival = 4.0 and 6.0 days; P < 0.001). Next we evaluated survival rates 
upon infection with two other RNA viruses: Flock House virus (FHV), a 
positive sense RNA virus from the Nodaviridae family, and Drosophila X 
virus (DXV), a double stranded RNA virus from the Birnaviridae family. Mean 
survival times were 6.7 and 6.9 days for wild-type flies upon FHV and DXV 
infection, respectively, which was significantly reduced to 5.3 and 5.5 days 
in Sgp mutant flies (P < 0.001 for both). 
To test whether Sgp mutants were also more sensitive to DNA virus infection, 
we challenged flies with Invertebrate iridescent virus 6 (IIV-6). In contrast 
to our observations with RNA viruses, survival rates of Sgp mutants were 
slightly higher, with mean survival times of 16.5 days for wild-type flies and 
19.1 days for Sgp mutants (Fig. 1F; P = 0.02). Together, our results indicate 
that Sgroppino mutants are hypersensitive to infections with RNA viruses, 
but not a DNA virus.
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Figure 2.|  Sgroppino mutants support higher viral replication.  
(A, C) Viral titers of wild-type and Sgp mutant flies inoculated with (A) DCV 
and (C) CrPV at 24 and 48 hpi. The dashed line represents the detection 
limit of the titration. (B,D-G) Viral RNA levels measured by RT-qPCR in 
wild-type and Sgp mutant flies infected with (B) DCV, (D) CrPV, (E) FHV, 
(F) DXV and (G) IIV-6. Viral RNA levels were normalized against transcript 
levels of the housekeeping gene Ribosomal Protein 49 and presented as 
fold change relative to wild-type flies at the same time point. *P < 0.05, **P 
< 0.01, ***P < 0.001 (Student’s t-test). Data represent (A, C) mean and s.d. 
of three independent experiments, each consisting of three replicates of at 
least 5 female flies for each genotype or (B, D-G) means and s.d. of three 
biological replicates of at least 15 female flies for each genotype. 
DCV and DXV replicate to higher levels in Sgroppino mutant 
flies  
To determine whether hypersensitivity to virus infection was accompanied 
by higher viral replication, we next determined virus titers using an endpoint 
dilution assay and viral RNA levels by RT-qPCR over a 2-day time course 
after challenge with the panel of viruses shown in Figure 1. 
Upon DCV infection, we observed a ~6-fold increase in viral titers in Sgp 
mutants relative to wild-type controls at 24 hpi and a less pronounced 
difference at 48 hpi (3-fold), but these differences did not reach statistical 
significance (Fig. 2A). Next, we measured DCV RNA levels and observed 
a 18-fold increase in DCV levels 24 hpi (P < 0.001), as well as a significant, 
5.5-fold increase at 48 hpi in Sgp mutants relative to wild-type flies (Fig. 
2B). In contrast, upon CrPV infection, no difference was found for viral titers 
and viral RNA levels between Sgp-/- and control flies, both at 24 and 48 hpi 
(Fig. 2C, D). We observed a similar phenotype upon FHV infection, as no 
significant increase in FHV RNA levels could be detected in Sgp-/- flies over 
the 2 days following infection (Fig. 2E). Conversely, we measured a 5 to 
10-fold increase of DXV RNA levels in Sgp mutant flies, relative to wild-type 
flies, at 24 and 48 hpi (P < 0.05 at 48 hpi, Fig. 2F). Finally, we measured 
transcript levels of the 85L gene of IIV-6, and found no significant change in 
Sgp mutant flies compared to wild-type controls (Fig. 2G). Taken together, 
these results indicate that Sgroppino mutant flies support higher replication 
of some (DCV and DXV), but not all tested RNA viruses. 
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RNA interference and canonical immune pathways are not 
defective in Sgroppino-deficient flies
To characterize the mechanism underlying the hypersensitivity of Sgp 
mutant flies to virus infection, we asked whether canonical antiviral defenses 
were functional in those mutants. RNA interference (RNAi) is one of the main 
antiviral immune pathway in Drosophila (9, 10), and, using two independent 
assays in vivo, we show that it remains functional in Sgp mutant flies 
(Figure S3 and Supplemental text). 
 
In addition to the RNAi pathway, several immune pathways are activated 
upon viral challenge (12, 30). The Jak-Stat pathway controls expression of 
genes encoding the stress-related proteins Turandot proteins A and M (TotA 
and TotM) and the virus-specific gene virus induced RNA-1 (vir-1) (11, 13). Toll 
and Imd, which are NF-ĸB-related pathways, regulate expression of genes 
encoding antimicrobial peptides, such as Drosomycin, Metchnikowin, and 
Diptericin, which are secreted by the fat body upon bacterial challenge and 
in some cases upon viral infections (14-16). To test whether those signaling 
cascades were functional in Sgp mutant flies, we monitored expression 
of these downstream genes by RT-qPCR, at 24 and 48 hours after DCV 
infection (Fig. 3A and 3B).
No strong induction of Jak-Stat or NF-kB-dependent factors was detected 
at 24 hpi with DCV in wild-type or Sgp mutant flies (Fig. 3A). Amongst 
the genes analyzed, we observed the highest induction (4-fold) for vir-1 in 
Sgp mutants. However, for none of the genes a significant difference was 
observed between mutant flies and controls at 24 hpi (Fig. 3A). At 48 hpi, 
expression of vir-1 was strongly increased in Sgp mutants (12.7-fold), while 
it was not induced in wild-type flies (0.8-fold, p<0.05; Fig. 3B). This is most 
likely due to higher DCV levels in Sgp mutants (Fig. 2A and 2B). For the other 
Jak-Stat or NF-kB regulated genes, we observed only low induction upon 
infection, and, more importantly, no significant difference between wild-type 
and mutant flies. Overall, these date indicate that canonical antiviral defense 
mechanisms were intact in Sgroppino mutant flies. 
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Figure 3 |  Canonical immune pathways are functional in Sgroppino mutants.  
 (A, B) Expression of immune genes at (A) 24 and (B) 48 hours after DCV 
infection (TCID50 = 10,000) determined by RT-qPCR in wild-type or Sgp 
mutant flies. Expression of the gene of interest was normalized to transcript 
levels of the housekeeping gene Ribosomal Protein 49 and expressed as 
fold change relative to mock infection (Tris buffer). Data are means and 
s.d. of three independent pools of 10 female flies for each genotype. *P < 
0.05 (Student’s t-test).
Sgroppino localizes to peroxisomes
To obtain more insights into the function of Sgroppino, we analyzed 
its intracellular localization. In a previously published in silico analysis, 
Sgroppino was predicted as one of the orthologs of the human fatty acyl-
CoA reductase (FAR-1) protein, which transforms Fatty acyl CoA into fatty 
alcohol within the ether lipid synthesis pathway in peroxisomes (31). To 
determine whether Sgroppino localizes to peroxisomes in Drosophila, we 
expressed Sgp fused to Red Fluorescent Protein (RFP) at its N-terminus 
from an Actin-driven expression plasmid. As a marker for peroxisomes, we 
used an expression vector containing N-terminally GFP-tagged Peroxisomal 
Membrane Protein 34 (PMP34) that contains a peroxisome membrane 
targeting signal and six transmembrane domains, and localizes in the 
peroxisomal membrane. To control for specificity and to determine whether 
190
Chapter 5
Sgp knock-down affects peroxisome integrity, we cotransfected cells with 
dsRNA targeting Sgp, PMP34, or, as a negative control, Luciferase. Upon 
transfection with the control dsRNA, we observed punctate cytoplasmic 
GFP staining demonstrating that PMP34-GFP localizes to peroxisomes 
(Fig. 4). Strikingly, Sgroppino-RFP localized to the similar punctae, and the 
merged image reveals a strong colocalization of Sgroppino and PMP34. 
The RFP or GFP signals were strongly reduced upon knock-down of Sgp 
and PMP34, respectively, demonstrating the specificity of the fluorescent 
signal (Fig. 4). Moreover, Sgp knock-down did not affect the distribution 
or density of PMP34-GFP punctae, suggesting that Sgp is not required 
for peroxisome biogenesis or integrity. These results demonstrate that Sgp 
localizes to peroxisomes in Drosophila S2 cells. 
Hoechst PMP34-GFP Sgp-RFP Merge 
dsLuc
dsSgp
dsPMP34
Figure 4
5 μM
5 μM
5 μM
Figure 4 |  Sgroppino localizes to peroxisomes.  
Localization of RFP-tagged Sgroppino and GFP-tagged Peroxisomal 
Membrane Protein 34 (PMP34) in Drosophila S2 cells. Expression 
plasmids were co-transfected with dsRNA targeting Sgp, PMP34, or, as a 
non-targeting control, Luciferase (dsLuc), and cells were fixed and stained 
3 days later. Nuclei are stained with Hoechst. Images were obtained by 
confocal microscopy. 
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Sgroppino mutant flies have a defect in lipid metabolism  
Peroxisomes are intra-cellular organelles that are important for lipid 
metabolism, including ether lipid biosynthesis, α-oxidation of branched 
chain fatty acids, and β-oxidation of fatty acids. In addition, reactive oxygen 
species (ROS) are generated during β-oxidation, and peroxisomes contain 
enzymes (oxidases and catalases) that regulate oxidative stress (31). Thus, 
we first sought to determine whether Sgroppino mutants had major defects 
in metabolism or growth. First, we determined the weight of adult flies, and 
noticed a significant increase in the weight of Sgp mutants compared to wild-
type flies, both in males and females (Fig. 5A). Pupation is a highly regulated 
process in Drosophila, dependent amongst others on hormonal signaling, 
circadian clock, and weight (32, 33). To test how the time to pupation of 
Sgroppino mutants compare to wild-type flies, we analyzed the formation 
of pupae in vials in which the same number of embryos had been placed. 
However, we found no significant difference in pupae formation between 
wild-type and Sgp mutant flies, suggesting that Sgroppino deficiency does 
not impact larval growth and the transition from the larval to the pupal stage 
(Fig. 5B).
The increased weight of adults was even noticeable visually, with Sgp mutants 
seeming to have a larger abdomen than wild-type flies. In agreement, we 
observed that, after removal of the digestive track and reproductive system, 
a larger mass of fat body tissue remained loosely attached to the abdominal 
carcass (Fig. 5C). It appeared white and formed large oleaginous droplets 
(reminiscent of the Sgroppino cocktail). We thus quantified triglycerides and 
found, in accordance with our visual observation (Fig. 5C), that Sgp mutant 
flies contained significantly higher amounts of triglycerides than wild-type 
flies (Fig. 5D). Together, these observations suggest that Sgroppino mutants 
have a defect in lipid metabolism, which is likely related to its function in 
peroxisomes.
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Figure 5 |  Sgroppino-deficiency causes weight increase and accumulation of fat in 
adult flies (A) Weight of female and male wild-type and Sgp mutant flies. 
Three to five-day-old flies were weighed in groups of 10 on a precision 
scale. (B) Time to pupation of wild-type and Sgp mutant flies. Fifty eggs 
were incubated on standard cornmeal-agar media at 25°C, and monitored 
for the appearance of pupae at least twice a day. The 0 h time point 
corresponds to the appearance of the first pupae, which was identical 
for wild-type and mutant flies. (C) Abdominal carcasses after removal of 
digestive and reproductive organs of wild-type and Sgp-/- flies as seen 
under a stereomicrosope. (D) Basal levels of triglycerides in 3 to 5-day-
old female wild-type and Sgp mutant flies. Data represent mean and s.d. 
of three biological replicates of (A) 50 eggs, (B) 5 flies and (D) 2 flies for 
each genotype. A Student’s t-test was used to compare the differences in 
weight and triglycerides (**P < 0.01, ***P < 0.001).
193
Sgroppino and antiviral immunity
5
Peroxisomes are required for antiviral host defense
As Sgroppino is important for antiviral defense and localizes to 
peroxisomes, we asked whether those organelles are necessary for 
host defense. To this end, we used RNAi to reduce expression of Pex3, 
which is essential for de novo peroxisome biogenesis and function (34). 
As previously shown, elimination or strong reduction of the number 
of peroxisomes is developmentally lethal (34). To achieve a non-lethal 
reduction in the number of peroxisomes, we induced ubiquitous knock-
down of Pex3 using the armadillo-Gal4 driver. This lead to a 40% reduction 
in Pex3 expression (Fig. 6A).
We challenged Pex3-deficient flies along with control flies expressing either 
the armadillo-Gal4 (arm-Gal4>+) driver or the Pex3RNAi hairpin (Pex3RNAi>+) 
with DCV and monitored survival rates. The mean survival time of flies with 
reduced Pex3 expression was 3.6 days, whereas it was 6.7 days for arm-
Gal4>+ control flies and 5.4 days for UAS-Pex3RNAi>+ control flies (P<0.001) 
(Fig. 6B). Finally, we determined viral RNA levels Pex3-deficient flies, and 
found that they increased by 8-fold relative to the controls at 48 hpi (Fig. 
6C). We therefore conclude that peroxisomes are necessary for effective 
host response to DCV infection.
Discussion 
Although several mechanisms for antiviral immunity have been discovered 
in Drosophila over the last years, our knowledge remains incomplete. Here, 
we describe Sgroppino as a novel restriction factor of RNA virus infection. 
Sgroppino-deficient flies are hypersensitive to RNA virus infection, and, 
for some viruses, support higher levels of virus replication. Sgroppino 
localizes to peroxisomes and partial depletion of peroxisomes causes 
hypersensitivity of adult flies to viral infection, accompanied by an increase 
in virus replication. Overall, our data indicate that Sgroppino is an RNA 
virus restriction factor whose antiviral function is possibly linked to lipid 
metabolism within peroxisomes. 
The mechanism by which Sgroppino restricts virus infection remains to be 
defined. Strikingly, Sgroppino mutant flies harbor higher levels of virus when 
infected with DCV and DXV, but not with CrPV and FHV, even though higher 
mortality rates were observed for all four viruses.
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Figure 6 |  Peroxisomes are required for host defense to DCV infection.  
(A) Pex3 expression in flies expressing an RNAi-inducing hairpin targeting Pex3. 
The ubiquitous armadillo driver (arm-Gal4) was used to drive expression of the 
transcription factor Gal4, which binds to the Upstream Activating Sequence 
to induce expression a short hairpin targeting Pex3 (arm-Gal4>UAS-Pex3RNAi). 
Expression of Pex3 was normalized to transcript levels of the housekeeping 
gene Ribosomal Protein 49 and expressed as fold change relative to control 
flies expressing arm-Gal4 only (arm-Gal4>+). (B) Survival and (C) viral RNA 
levels upon DCV infection of Pex3RNAi flies (arm-Gal4>UAS-Pex3RNAi). Flies 
expressing only the arm-Gal4 driver (arm-Gal4>+) or the UAS-Pex3RNAi 
responder (UAS-Pex3RNAi>+) were included as controls. Viral RNA levels were 
normalized against transcript levels of the housekeeping gene Ribosomal 
Protein 49 and presented as fold change relative to viral RNA levels in UAS-
Pex3RNAi>+ control flies at the same time point. Data represent means and 
s.d. of three independent pools of (A, C) 5 or (B) 15 female flies for each 
genotype. A Student’s t-test was used to compare the difference in Pex3 or 
DCV expression levels (*P < 0.05, **P < 0.01).
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This may be caused by differences in tissue tropism of the viruses tested, 
and the expression pattern of Sgroppino itself. Sgroppino is expressed 
at high levels in the adult fat body, according to FlyAtlas data (35). The 
abdominal fat body supports high DCV replication in adult flies (36) and 
this tropism may explain the more pronounced phenotype of Sgroppino 
mutants upon DCV infection (tropism of DXV is not well-defined). The higher 
viral loads of DCV and DXV could partially explain the hypersensitivity of Sgp 
mutants to infection. We cannot exclude that hypersensitivity to CrPV and 
FHV infection is caused by tissue-specific differences in viral replication that 
are below the sensitivity threshold of our assays. Another possibility is that 
Sgroppino also contributes to tolerance to viral infection, a process that is 
essential for survival, but does not directly control viral replication (25).
Mechanistic insights into immune function of peroxisomes are limited. Many 
cellular organelles have been studied in the context of metabolism, and have 
only recently been implicated in immune signaling. Studies in mammalian 
cells revealed that peroxisomes are important sites for antiviral signal 
transduction, as had previously been reported for mitochondria (37). RIG-I 
like receptors (RLR) can signal via MAVS on peroxisomes to drive induction 
of type III interferons, which have tissue-specific roles in antiviral immunity 
(38). Whether peroxisomes play a role in immune signal transduction in 
Drosophila has not been studied yet. However, we did not find defects in 
Jak-Stat or NF-kB signaling, suggesting that the Sgroppino phenotype is 
not caused by defects in canonical immune pathways. 
In silico analyses predict that Sgroppino participates in the ether 
phospholipid synthesis pathway (31), which is initiated in peroxisomes and 
completed in the ER. Functions of ether lipids are still elusive, but they 
are likely to contribute to a decrease in membrane fluidity, and might act 
as scavengers for reactive oxygen species to avoid the oxidation of other 
exposed membrane lipids (39). At the subcellular level, ether lipid deficiency 
alters cholesterol distribution, resulting in its accumulation in endosomal 
and lysosomal compartments, and causing structural changes in the ER 
and Golgi apparatus (40-42). Remarkably, both cholesterol and intracellular 
membranous networks are exploited by viruses for their replication (2, 4, 43-
45). For instance, novel compounds that inhibit the synthesis of triglycerides 
and cholesterol esters in lipid droplets inhibit assembly of infectious Hepatitis 
C virus (HCV) particles (45). It is thus possible that dysregulation in lipid 
metabolism in Sgroppino-deficient flies generates an environment that is 
favorable for virus replication. 
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Lipid droplets, which are intracellular bodies for storage of neutral lipids 
such as triglycerides and sterol esters, have recently gained importance 
in our understanding of host-pathogen interactions. In addition to HCV 
(45), several other viruses including Hepatitis B virus, Dengue virus, as 
well as bacteria (i.e Mycobacterium, Chlamydia) and Plasmodium parasites 
intimately interact with lipid droplets (46). Intriguingly, studies in yeast cells 
revealed that peroxisomes form extensive physical contacts with lipid 
droplets, coupling metabolic pathways of both compartments (47). In the 
absence of Pex5, which leads to peroxisomal malfunction, lipids that fail 
to be oxidized accumulate in the cytoplasm. It is possible that a similar 
phenomenon occurs in Sgp mutant flies, in which a defect in peroxisomal 
function could trigger the accumulation of unprocessed lipid inclusions in 
cells, explaining the increased mass of fat tissue in the flies abdomen. 
Human diseases linked to peroxisome dysfunction, such as Zellweger 
Syndrome, are rare and difficult to treat. Recent development of fly models 
for peroxisomal defects (31, 34, 48, 49) offer great promise to gain insights 
in their functions, both in metabolism, and intriguingly, immunity.
 
197
Sgroppino and antiviral immunity
5
Funding information
This work was financially supported by a PhD fellowship from the Radboud 
Institute for Molecular Life Sciences (RIMLS), and a Consolidator Grant 
from the European Research Council under the European Union’s Seventh 
Framework Programme (ERC grant number 615680) to RPvR. The funders 
had no role in study design, data collection and interpretation, or the 
decision to submit the work for publication.
Acknowledgements
We thank members of the laboratory and Joseph Faust for helpful discussion. 
For providing fly stocks, we thank the Bloomington Stock Center (NIH 
P40OD018537), the Vienna Drosophila Stock center, and the Drosophila 
Genetic Resource Center at the Kyoto Institute of Technology.
198
Chapter 5
References 
1. King AMQ, Lefkowitz E, Adams MJ, 
Carstens EB. 2011. Virus Taxonomy: 
Ninth Report of the International 
Committee on Taxonomy of Viruses. 
Elsevier Science.
2. Inoue T, Tsai B. 2013. How viruses use 
the endoplasmic reticulum for entry, 
replication, and assembly. Cold Spring 
Harb. Perspect. Biol. 5:a013250.
3. Miller DJ, Schwartz MD, Ahlquist P. 
2001. Flock house virus RNA replicates 
on outer mitochondrial membranes 
in Drosophila cells. J. Virol. 75:11664-
11676.
4. Romero-Brey I, Bartenschlager R. 
2014. Membranous replication factories 
induced by plus-strand RNA viruses. 
Viruses 6:2826-2857.
5. Tolonen N, Doglio L, Schleich S, 
Krijnse Locker J. 2001. Vaccinia virus 
DNA replication occurs in endoplasmic 
reticulum-enclosed cytoplasmic mini-
nuclei. Mol. Biol. Cell 12:2031-2046.
6. Chow J, Franz KM, Kagan JC. 2015. 
PRRs are watching you: Localization of 
innate sensing and signaling regulators. 
Virology 479-480:104-109.
7. Kumar H, Kawai T, Akira S. 2011. 
Pathogen recognition by the innate 
immune system. Int. Rev. Immunol. 
30:16-34.
8. Hoffmann JA. 2003. The immune 
response of Drosophila. Nature 426:33-
38.
9. Bronkhorst AW, van Rij RP. 2014. The 
long and short of antiviral defense: small 
RNA-based immunity in insects. Curr 
Opin Virol 7:19-28.
10. Kemp C, Imler J-L. 2009. Antiviral 
immunity in drosophila. Curr. Opin. 
Immunol. 21:3-9.
11. Kemp C, Mueller S, Goto A, Barbier V, 
Paro S, Bonnay F, Dostert C, Troxler 
L, Hetru C, Meignin C, Pfeffer S, 
Hoffmann JA, Imler JL. 2013. Broad 
RNA interference-mediated antiviral 
immunity and virus-specific inducible 
responses in Drosophila. J. Immunol. 
190:650-658.
12. Merkling SH, van Rij RP. 2013. Beyond 
RNAi: antiviral defense strategies in 
Drosophila and mosquito. J. Insect Physiol. 
59:159-170.
13. Dostert C, Jouanguy E, Irving P, Troxler 
L, Galiana-Arnoux D, Hetru C, Hoffmann 
JA, Imler JL. 2005. The Jak-STAT signaling 
pathway is required but not sufficient for 
the antiviral response of drosophila. Nat. 
Immunol. 6:946-953.
14. Costa A, Jan E, Sarnow P, Schneider 
D. 2009. The Imd pathway is involved in 
antiviral immune responses in Drosophila. 
PLoS ONE 4:e7436-e7436.
15. Avadhanula V, Weasner BP, Hardy GG, 
Kumar JP, Hardy RW. 2009. A novel 
system for the launch of alphavirus RNA 
synthesis reveals a role for the Imd pathway 
in arthropod antiviral response. PLoS 
Pathog. 5:e1000582.
16. Zambon Ra, Nandakumar M, Vakharia 
VN, Wu LP. 2005. The Toll pathway is 
important for an antiviral response in 
Drosophila. Proc. Natl. Acad. Sci. U. S. A. 
102:7257-7262.
17. Ferreira ÁG, Naylor H, Esteves SS, Pais 
IS, Martins NE, Teixeira L. 2014. The Toll-
Dorsal Pathway Is Required for Resistance 
to Viral Oral Infection in Drosophila. PLoS 
Pathog. 10:e1004507.
18. Moy Ryan H, Gold B, Molleston 
Jerome M, Schad V, Yanger K, Salzano 
M-V, Yagi Y, Fitzgerald Katherine A, 
Stanger Ben Z, Soldan Samantha S, 
Cherry S. 2014. Antiviral Autophagy 
Restricts Rift Valley Fever Virus Infection 
and Is Conserved from Flies to Mammals. 
Immunity 40:51-65.
19. Nakamoto M, Moy RH, Xu J, Bambina S, 
Yasunaga A, Shelly SS, Gold B, Cherry 
S. 2012. Virus recognition by Toll-7 activates 
antiviral autophagy in Drosophila. Immunity 
36:658-667.
20. Shelly S, Lukinova N, Bambina S, 
Berman A, Cherry S. 2009. Autophagy 
is an essential component of Drosophila 
immunity against vesicular stomatitis virus. 
Immunity 30:588-598.
21. Merkling SH, Overheul GJ, van Mierlo JT, 
Arends D, Gilissen C, van Rij RP. 2015. 
The heat shock response restricts virus 
infection in Drosophila. Sci Rep 5:12758.
199
Sgroppino and antiviral immunity
5
22. Bellen HJ, Levis RW, Liao G, He Y, 
Carlson JW, Tsang G, Evans-Holm M, 
Hiesinger PR, Schulze KL, Rubin GM, 
Hoskins RA, Spradling AC. 2004. The 
BDGP gene disruption project: single 
transposon insertions associated with 
40% of Drosophila genes. Genetics 
167:761-781.
23. Meyer WJ, Schreiber S, Guo Y, 
Volkmann T, Welte MA, Muller 
HA. 2006. Overlapping functions of 
argonaute proteins in patterning and 
morphogenesis of Drosophila embryos. 
PLoS Genet. 2:e134.
24. Smith EM, Hoi JT, Eissenberg 
JC, Shoemaker JD, Neckameyer 
WS, Ilvarsonn AM, Harshman LG, 
Schlegel VL, Zempleni J. 2007. 
Feeding Drosophila a biotin-deficient 
diet for multiple generations increases 
stress resistance and lifespan and 
alters gene expression and histone 
biotinylation patterns. J. Nutr. 
137:2006-2012.
25. Merkling SH, van Rij RP. 2015. 
Analysis of resistance and tolerance 
to virus infection in Drosophila. Nat. 
Protoc. 10:1084-1097.
26. Merkling SH, Bronkhorst AW, Kramer 
JM, Overheul GJ, Schenck A, Van 
Rij RP. 2015. The epigenetic regulator 
g9a mediates tolerance to RNA virus 
infection in Drosophila. PLoS Pathog. 
11:e1004692.
27. Livak KJ, Schmittgen TD. 2001. 
Analysis of Relative Gene Expression 
Data Using Real-Time Quantitative PCR 
and the 2−ΔΔCT Method. Methods 
25:402-408.
28. Rogers SL, Rogers GC. 2008. Culture 
of Drosophila S2 cells and their use for 
RNAi-mediated loss-of-function studies 
and immunofluorescence microscopy. 
Nat. Protoc. 3:606-611.
29. Schindelin J, Arganda-Carreras I, 
Frise E, Kaynig V, Longair M, Pietzsch 
T, Preibisch S, Rueden C, Saalfeld 
S, Schmid B, Tinevez JY, White DJ, 
Hartenstein V, Eliceiri K, Tomancak P, 
Cardona A. 2012. Fiji: an open-source 
platform for biological-image analysis. 
Nat. Methods 9:676-682.
30. Lamiable O, Imler JL. 2014. Induced 
antiviral innate immunity in Drosophila. 
Curr. Opin. Microbiol. 20:62-68.
31. Faust JE, Verma A, Peng C, McNew JA. 
2012. An inventory of peroxisomal proteins 
and pathways in Drosophila melanogaster. 
Traffic 13:1378-1392.
32. De Moed GH, Kruitwagen CLJJ, De 
Jong G, Scharloo W. 1999. Critical 
weight for the induction of pupariation in 
Drosophila melanogaster: genetic and 
environmental variation. J. Evol. Biol. 
12:852-858.
33. Di Cara F, King-Jones K. 2013. How 
clocks and hormones act in concert to 
control the timing of insect development. 
Curr. Top. Dev. Biol. 105:1-36.
34. Faust JE, Manisundaram A, Ivanova 
PT, Milne SB, Summerville JB, Brown 
HA, Wangler M, Stern M, McNew 
JA. 2014. Peroxisomes are required for 
lipid metabolism and muscle function 
in Drosophila melanogaster. PLoS ONE 
9:e100213.
35. Robinson SW, Herzyk P, Dow JA, 
Leader DP. 2013. FlyAtlas: database 
of gene expression in the tissues of 
Drosophila melanogaster. Nucleic Acids 
Res. 41:D744-750.
36. Deddouche S, Matt N, Budd A, Mueller 
S, Kemp C, Galiana-Arnoux D, Dostert 
C, Antoniewski C, Hoffmann JA, Imler 
JL. 2008. The DExD/H-box helicase 
Dicer-2 mediates the induction of antiviral 
activity in drosophila. Nat. Immunol. 
9:1425-1432.
37. Dixit E, Boulant S, Zhang Y, Lee AS, 
Odendall C, Shum B, Hacohen N, Chen 
ZJ, Whelan SP, Fransen M, Nibert 
ML, Superti-Furga G, Kagan JC. 2010. 
Peroxisomes are signaling platforms for 
antiviral innate immunity. Cell 141:668-681.
38. Odendall C, Dixit E, Stavru F, Bierne H, 
Franz KM, Durbin AF, Boulant S, Gehrke 
L, Cossart P, Kagan JC. 2014. Diverse 
intracellular pathogens activate type III 
interferon expression from peroxisomes. 
Nat. Immunol. 15:717-726.
39. Braverman NE, Moser AB. 2012. 
Functions of plasmalogen lipids in health 
and disease. Biochim. Biophys. Acta 
1822:1442-1452.
200
Chapter 5
40. Gorgas K, Teigler A, Komljenovic D, 
Just WW. 2006. The ether lipid-deficient 
mouse: tracking down plasmalogen 
functions. Biochim. Biophys. Acta 
1763:1511-1526.
41. Thai TP, Rodemer C, Jauch A, 
Hunziker A, Moser A, Gorgas K, Just 
WW. 2001. Impaired membrane traffic in 
defective ether lipid biosynthesis. Hum. 
Mol. Genet. 10:127-136.
42. Schedin S, Sindelar PJ, Pentchev P, 
Brunk U, Dallner G. 1997. Peroxisomal 
impairment in Niemann-Pick type C 
disease. J. Biol. Chem. 272:6245-6251.
43. Ilnytska O, Santiana M, Hsu NY, Du 
WL, Chen YH, Viktorova EG, Belov 
G, Brinker A, Storch J, Moore C, 
Dixon JL, Altan-Bonnet N. 2013. 
Enteroviruses harness the cellular 
endocytic machinery to remodel the 
host cell cholesterol landscape for 
effective viral replication. Cell Host 
Microbe 14:281-293.
44. Rothwell C, Lebreton A, Young Ng C, 
Lim JY, Liu W, Vasudevan S, Labow 
M, Gu F, Gaither LA. 2009. Cholesterol 
biosynthesis modulation regulates 
dengue viral replication. Virology 389:8-
19.
45. Liefhebber JM, Hague CV, Zhang 
Q, Wakelam MJ, McLauchlan J. 
2014. Modulation of triglyceride and 
cholesterol ester synthesis impairs 
assembly of infectious hepatitis C virus. 
J. Biol. Chem. 289:21276-21288.
46. Herker E, Ott M. 2012. Emerging 
role of lipid droplets in host/pathogen 
interactions. J. Biol. Chem. 287:2280-
2287.
47. Binns D, Januszewski T, Chen Y, 
Hill J, Markin VS, Zhao Y, Gilpin 
C, Chapman KD, Anderson RG, 
Goodman JM. 2006. An intimate 
collaboration between peroxisomes and 
lipid bodies. J. Cell Biol. 173:719-731.
48. Mast FD, Li J, Virk MK, Hughes SC, 
Simmonds AJ, Rachubinski RA. 2011. 
A Drosophila model for the Zellweger 
spectrum of peroxisome biogenesis 
disorders. Dis. Model. Mech. 4:659-672.
49. Nakayama M, Sato H, Okuda T, 
Fujisawa N, Kono N, Arai H, Suzuki 
E, Umeda M, Ishikawa HO, Matsuno 
K. 2011. Drosophila carrying pex3 
or pex16 mutations are models of 
Zellweger syndrome that reflect its 
symptoms associated with the absence 
of peroxisomes. PLoS ONE 6:e22984.
201
Sgroppino and antiviral immunity
5
Supplemental figure legends
0
20
40
60
80
100
Sg
p 
ex
pr
es
sio
n
 (%
%
 o
f A
ct>
+ 
co
nt
ro
l)
*** **
Males Females
Actin>+
Actin>SgpRNAi
20
40
60
80
100
***
y1w1
Sgp-/-
Sg
p 
ex
pr
es
sio
n
 (%
 o
f y
w 
co
nt
ro
l)
Supp. Figure 1 
A
C Lifespan 
0 10 20 30 40 50 60 70 80 90
20
40
60
80
100
Time (Days)
Su
rv
iva
l (
%
)
y1w1
Sgp-/-
C
B
EY06744
ATG
Sgp
Figure S1 |  Sgp expression levels are reduced in SgpRNAi and Sgp mutant lines, and 
Sgp deficiency does not alter life-span. (A) Relative Sgp expression levels 
in flies expressing Actin-Gal4>UAS-SgpRNAi (Act>SpgRNAi) compared 
to flies expressing Actin-Gal4 only (Actin>+). Expression of Sgp was 
normalized to transcript levels of the housekeeping gene Ribosomal 
Protein 49 and expressed relative to Actin-Gal4>+. (B) Structure of the 
Sgroppino locus. Boxes represent exons (5’ and 3’-untranslated regions 
in gray, and coding sequence in white). The EY06744 insertion site of a 
P{EPgy2} transposable element is depicted by dashed lines. (C) Relative 
Sgp expression levels in flies carrying the EY06744 transposon insertion 
in the 3’-untranslated region of the Sgp transcript. Expression of Sgp 
was normalized to transcript levels of the housekeeping gene Ribosomal 
Protein 49 and expressed relative to wild-type control flies (y1w1). (D) 
Lifespan of Sgp mutant and y1w1 wild-type flies at 25°C. Data represent 
means and s.d. of three biological replicates of (A, C) 5 or (D) 20 flies for 
each genotype. A Student’s t-test was used to compare the difference in 
Sgp expression (**P < 0.01, ***P < 0.001).
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Figure S2.  Sgp mutant flies are not sensitive to abiotic stressors, and hypersensitivity 
of Sgp mutant flies to RNA virus infection is not sex-dependent. (A) 
Survival of wild-type (y1w1) and Sgp mutant flies following inoculation 
with Tris buffer that serves as a mock control for the infections of Figure 
1. (B) Survival upon heat shock at 35°C of Sgp and Heat Shock Factor 
(Hsf) mutant flies, compared to their wild-type controls, y1w1 and CnBw, 
respectively. (C) Survival of Sgp mutants and control flies upon starvation. 
(D, E) Survival of male Sgp-/- and w1118 control flies upon (D) DCV and 
(E) CrPV infection. Data represent means and s.d. of three biological 
replicates of (B-E) 15 flies for each genotype. Panel A are data from one 
pool of 20 flies per genotype. A Student’s t-test was used to compare the 
difference in Sgp expression levels (**P < 0.01, ***P < 0.001).
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Figure S3 |  RNAi is functional in Sgroppino mutant flies.  
(A) Eye phenotype of 5 to 7-day-old flies expressing a hairpin RNA targeting 
the Drosophila Inhibitor of Apoptosis thread (thRNAi), combined with a hairpin 
targeting Ago2 (Ago2RNAi), a hairpin targeting Sgp (SgpRNAi), or the genetic 
background of the SgpRNAi line (control). No eye phenotype was observed 
in flies that do not expressing the thRNAi transgene. Three representative 
images are shown for each genotype. (B) In vivo RNAi reporter assay. Firefly 
(Fluc) and Renilla (Ren) luciferase reporter plasmids were co-transfected 
with Fluc specific dsRNA or non-specific control dsRNA in Sgp and 
Dcr2-/- mutant flies and their wild-type control y1w1. Fold silencing by Fluc 
dsRNA relative to control dsRNA was calculated and presented as the 
percentage of silencing relative to wild-type controls. Data are means 
and s.d. of three independent pools of 5 female flies for each genotype. 
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Supplementary text 
RNA interference (RNAi) is one of the main antiviral immune pathways in 
Drosophila (1, 2). To test its functionality, we first monitored RNAi activity 
using an in vivo sensor assay (3) that is based on an RNAi-inducing hairpin 
RNA that silences the inhibitor of apoptosis thread (thRNAi) (4, 5). When 
driven specifically in the eye using the GMR-Gal4 driver, expression of thRNAi 
triggers severe apoptosis in the developing eye, characterized by a loss 
of pigmentation and reduction of the size of the eye. Mutant flies missing 
the central catalytic component of the pathway, Argonaute 2 (AGO2), do 
not exhibit this phenotype, demonstrating its full dependence on the RNAi 
pathway (4, 5). We confirmed this here, as concomitant expression of thRNAi 
and Ago2RNAi hairpins in the eye did not induce the eye phenotype (Fig. S3A). 
Simultaneous expression of thRNAi and SgpRNAi hairpins, however, triggered 
an RNAi-induced eye phenotype (Fig. 3A), as did expression of thRNAi alone 
in a control fly line that has the same genetic background as the SgpRNAi 
line (Fig. S3A). Altogether, these results suggest that the RNAi pathway is 
functional in Sgroppino-deficient flies. 
Furthermore, we confirmed the efficiency of RNAi in Sgp-/- mutant flies 
using a luciferase-based RNAi sensor assay, described previously (5, 6). 
Silencing efficiency was measured in fly lysates, collected 3 days after in 
vivo transfection with Firefly (Fluc) and Renilla luciferase reporter plasmids 
together with either Fluc-specific dsRNA or control dsRNA. The strong 
reduction of silencing activity in Dicer-2 null mutants, compared to their 
wild-type controls (y1w1), demonstrates that silencing of Fluc expression 
was RNAi-dependent (Fig. S3B). No reduction in fold silencing was detected 
in Sgp-/- mutant flies relative to wild-type levels, confirming that RNA 
interference is fully functional in Sgp-/- mutant flies (Fig. S3B).
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The fruit fly, Drosophila melanogaster, is a well-established model organism 
used to study fundamental innate immune processes. It was instrumental 
in the discovery and characterization of major host defense components, 
such as Toll receptors, over the last decades. More recently, resistance 
and tolerance have been conceptualized in the field of immunology. While 
mechanisms of resistance, aiming at direct elimination of pathogens, have 
been widely studied, mechanisms of tolerance remain poorly elucidated. 
This thesis has been centered on discovering novel aspects of resistance 
and tolerance in Drosophila. In the following section, I will discuss our results 
and future prospects, in the light of recently published literature. 
Experimentally assessing tolerance and resistance 
Choosing infection routes
Systemic viral infections are performed in the vast majority of published 
literature, as well as in all our studies (chapter 2, 3, 4, 5). They consist 
of injecting, via a capillary, a viral inoculum in the body cavity of an adult 
fly. This infection technique allows high reproducibility, as the initial site 
of infection and virus dose are very consistent. Moreover, the inoculated 
virus titer is chosen such that infection rate will be 100% in the challenged 
population. Despite the technical benefits of systemic infections, they 
remain fundamentally different from how infections occur in natural settings. 
Few studies have analyzed transmission modes of Drosophila viruses in 
wild populations. For two viruses that are prevalent in wild populations, 
Drosophila C virus (DCV) and Nora virus, it was reported that transmission 
occurred horizontally via the oral-faecal route. Feeding on food sources with 
virus-contaminated faeces or eggs seems to be a main infection route in the 
wild (1-4). 
Infection routes are important both for pathogen and host: pathogens have 
transmission strategies that depend of the host tissues they encounter, 
and hosts mount distinct immune responses in different cells and tissues. 
Systemic and oral infections have been reported to induce different defense 
responses and pathogenic outcomes. For instance, while systemic infections 
with DCV are highly lethal (5-8), oral inoculation triggers only low mortality 
rates (10-30%) in wild-type flies (9). Similarly, RNAi-deficient adult flies are 
highly susceptible to systemic RNA and DNA virus infections (10-12), but 
unpublished observations from our laboratory suggest that the phenotype 
209
Discussion
6
is less pronounced in oral infections. Such disparities are also observed in 
bacterial infections: When orally fed, the bacterium Serratia marcescens is 
able to cross the gut barrier and invade the hemolymph. Interestingly, these 
specific systemic bacteria are less pathogenic when injected directly into 
the hemolymph at corresponding numbers (13). 
Not only does the infection route affect the outcome of an experiment, it 
also conditions the discovery of novel immune pathways. The contribution 
of the Toll pathway to antiviral immunity remained poorly supported by 
studies consisting of viral challenges of Toll pathway mutants (14). However, 
usage of an oral infection model clearly showed that Toll signaling was, 
indeed, involved in antiviral responses in Drosophila (9). Similarly, the ERK 
pathway has been shown to restrict viral replication in early midgut stages, 
thus preventing systemic infection (15). Although the role of ERK signaling 
in systemic infection had not formally been assessed, it seems reasonable 
to assume that its antiviral function would have been difficult to uncover in 
systemic infection set-ups. 
Beyond the importance of the infection route, these results highlight the 
notion that immune responses are structured in space, and evolve as the 
infection spreads to different tissues. Mere activation of antibacterial or 
antiviral pathways is not anymore believed to be sufficient for efficient host 
defense: Experimental data in chapter 3 and other published reports (16-
18) highlight the need for immune responses to be regulated in time and 
magnitude; recent studies discussed above add a spatial component to the 
prerequisites for efficient immune responses. 
These observations are particularly relevant in the context of virus 
transmission by vector mosquitoes that are initially infected via blood 
feeding on viremic hosts. The inoculation route is crucial in experimental 
studies aimed at deciphering interactions between arboviruses and vector 
mosquitoes, and virus transmission to a new vertebrate host. The antiviral 
function of the Toll and Jak-Stat pathways upon Dengue virus infection in 
Aedes aegypti mosquitoes has been demonstrated following transcriptome 
studies of mosquitoes fed with virus-containing human blood (19, 20). 
This is consistent with the observation in Drosophila that Toll is involved in 
resistance to orally-inoculated viruses (9). 
Functional studies in Aedes aegypti mosquitoes remain insufficient, so far, to 
understand to which extent RNAi participates in antiviral immunity, especially 
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at the midgut invasion stage (21-23). Published studies examined titers of 
Sindbis virus and Dengue virus at 7 to 14 days after the blood meal, which is 
long after the virus disseminated from the midgut and established a systemic 
persistent infection (21-23). Expression of the Flock House virus suppressor 
of RNAi, FHV-B2, in mosquitoes effectively reduced the proficiency of the 
RNAi pathway, but failed to enhance viral dissemination rates of Dengue 
virus, suggesting that RNAi is not a primary antiviral pathway in early-stage 
infections (22). This may also be consistent with the observations made in the 
Drosophila oral infection experiments discussed above. 
Further functional studies will be necessary to characterize antiviral 
processes, in Drosophila and Aedes mosquitoes. The rapid development 
of genome editing technologies, such as TALEN or CRISPR/Cas9, will be 
instrumental for such studies in the future (24-26). RNAi-mediated knock-
down of genes of interest is a major limiting factor for functional studies 
in mosquitoes. It requires tedious injections of double-stranded RNA, has 
limited efficiency, only transiently reduces gene expression, and does not 
allow tissue-specific targeting. Using genome editing tools, it is possible 
to generate full knock-out mosquitoes (24-26), but also to epitope-tag 
endogenous genes, and add spatial or temporal control to the knock-out. 
That component might be particularly crucial in the discovery of novel viral 
restriction factors in organs such as the midgut, where the initial infection 
occurs, or the salivary glands, where the virus accumulates before being 
transmitted to a new host. A more complex project would be to use 
catalytically dead Cas9 as a general DNA-binding domain and fuse it to 
functional effectors, such as transcriptional activators or epigenetic modifiers 
(27). Perhaps it will be possible to “reprogram” immune responses, and fine-
tune them such that mosquitoes would not be permissive to arboviruses. 
Selecting the right pathogen
Like the method of inoculation, the choice of the virus used to study host-
pathogen interactions determines the experimental outcome. We provide, in 
chapter 1 and 2, overviews of model viruses most frequently used to study 
Drosophila immunity. DCV and Nora virus infect Drosophila populations in 
the wild, as well as laboratory stocks (4). Other model viruses, such as 
Cricket paralysis virus (CrPV) and FHV, have originally been isolated from 
respectively field crickets and beetles, but have a broad experimental host 
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range amongst insects (28-31). Host defense and viral counter-defense 
mechanisms co-evolve within the natural host species, which is a strong 
incentive to study immune mechanisms in a natural evolutionary context. 
However, the corollary of this idea is that the presence of viral counter-
defense mechanisms might impede the identification of immune processes. 
For example, some viruses may encode specific antagonistic activities 
that inhibit the activation or signaling of the Toll and Imd pathways. Many 
mammalian viruses encode interferon antagonists that interfere with the 
pathways that lead to the production of type I interferon or with downstream 
effector mechanisms (32). As a consequence, robust interferon production 
may not be detectable unless the viral interferon antagonist is inactivated. 
Similarly, a lack of antimicrobial peptide production, that generally is used as a 
proxy for Toll and Imd pathway activation, should be interpreted with caution, 
as it could be due to viral interference with immune signaling. Indeed, there is 
evidence that arboviruses are able to suppress immune pathways in insects. 
For instance, DENV is capable of repressing the Toll and Imd-dependent 
induction of antimicrobial peptides (AMPs) in response to bacterial challenge 
in Aedes aegypti cell lines (33). Similarly, Semliki Forest virus (SFV) inhibited 
reporter gene expression under Toll, Imd and Jak-Stat responsive promoters 
in Aedes albopictus derived cells after activation by a constitutively active 
Toll construct or by heat-inactivated E. coli (which activates the Imd and Jak-
Stat pathways) (34). SFV induces a global inhibition of host gene expression 
in these cells, which may contribute to the inhibition of inducible immune 
responses (34). Whether suppression of inducible immune responses is a 
general strategy of arboviruses and how these activities contribute to virus 
transmission by mosquitoes remains to be established.
Interestingly, viral antagonism of NF-ĸB activity has also been reported 
in non-Dipteran insects. Polydnaviruses, such as Microplitis demolitor 
bracovirus that infects the parasitoid wasp M. demolitor, encode inhibitory 
proteins (H4 and N5) that are homologous to the IĸB factors that inhibit of 
NF-ĸB activation. These viral IĸB mimics bind to the NF-ĸB-like transcription 
factors Dif and Relish and thereby inhibit Toll and Imd-dependent AMP 
production (35-37). These results imply that NF-ĸB dependent pathways are 
activated in the parasitized host, and that polydnaviral NF-ĸB antagonists 
prevent expression of downstream effectors.
The only immune pathway for which viral antagonism is firmly demonstrated 
Chapter 6
212
in Drosophila is the RNAi pathway. Many suppressors of RNAi, which 
interfere at different stages of the pathway, have been characterized in 
Drosophila and mosquito viruses over the last years (38-41). The presence 
of these viral suppressors did not hinder the characterization of RNAi as 
an antiviral mechanism, but rather strengthened its importance (10, 11). 
Core components of the RNAi machinery are constitutively expressed 
in all Drosophila cells, and have not been reported to be up- or down-
regulated upon infection at a systemic level (chapter 1, 3 and 4). Conversely, 
transcriptional changes of component or downstream effectors of inducible 
antiviral pathways often occur upon infection, and are readily detectable by 
qRT-PCR or transcriptomics approaches (chapter 1). We cannot exclude, at 
this stage, that viruses encode suppressors of immune pathways that are 
activated upon virus infection. In such a scenario, transcriptome analyses 
would likely fail to identify such pathways. 
Surprisingly, no published study has analyzed antagonistic activities of 
natural Drosophila viruses towards canonical immune pathways. Using 
Drosophila cell lines and reporter plasmids for Toll, Imd or Jak-Stat activity, it 
would be technically feasible to determine whether virus infection interferes 
with those signaling cascades. Thus, depending of which immune process 
one aims to study, a more informed decision could be made regarding the 
virus to use as a model. Obviously, such issues can also be addressed by 
using a panel of viruses, diverse enough to minimize virus-specific effects. 
In our studies, for instance in chapter 4 and 5, we have indeed observed 
that a phenotype of a given mutant fly was uncovered with some viruses, 
but not others. Whether this is due to viral antagonist activities, tropism, or 
other factors remains to be investigated. 
Diversifying experimental read-outs
In chapter 2, we describe a step-by-step protocol for the analysis of resistance 
and tolerance in Drosophila. It consists of a procedure for preparation of fly and 
virus stocks, and experimental read-outs of viral infection. In that protocol, we 
recommend to perform survival analysis in combination with measurement of 
viral replication to determine whether a given gene is involved in resistance or 
tolerance to virus. If the tested flies are hypersensitive to virus and harbor higher 
viral replication levels, they most likely have a defect in resistance pathways. 
Conversely, if the hypersensitivity phenotype is not accompanied by an increase 
in viral load, the studied gene is probably involved in tolerance processes. 
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This principle has been instrumental for the characterization of epigenetic 
regulation by G9a as a tolerance mechanism (chapter 3), and the heat shock 
pathway as a resistance mechanism (chapter 4). However, survival analyses 
and viral load measurements have several limitations: They are very coarse 
measurements of pathogenesis that may be complemented with more 
refined phenotypical descriptions. The field of mammalian immunology uses 
a much wider set of tools to describe pathogenic processes: measurement of 
inflammation markers, behavioral studies, and physiological and metabolic 
read-outs are often used to gain better understanding of the phenotype at 
hand. 
Such read-outs are integrated more and more frequently in immune studies 
in Drosophila, but remain too rare. It was recently reported that systemic 
DCV infection leads to intestinal obstruction. The tropism of DCV for the 
anterior part of the gut explains the pathological symptoms observed upon 
infection, consisting of abdominal swelling due to food blockage in the 
digestive track (42). Measurements of food ingestion and defecation, imaging 
of gut tissue morphology, and quantification of glucose or triglyceride levels 
were necessary for a better understanding of the lethal phenotype. DCV 
also induces behavioral changes, particularly in sleep patterns, which might 
be an adaptive sickness behavior (43). Flock house virus (FHV) localizes 
and replicates at high levels in cardiac muscle tissues. Cardiotropic viruses 
can lead to myocarditis and sudden death by cardiac arrest in humans, 
however, underlying mechanisms are mainly unknown. Several methods for 
the study of Drosophila heart function have been developed, and could 
be instrumental in the characterization of virus-induced heart disease (44). 
Finally, a link between CrPV infection and depletion of hemocyte population 
has been suggested (45). Because of the low numbers of hemocytes in 
adult flies (ranging from 100 to 400), their study has thus far been technically 
challenging (46). Recent development in flow cytometry techniques do, 
however, offer great promise for the study of that cell population in coming 
years (47). For example, hemocyte-specific data sets, such as transcriptome 
analyses, would provide detailed insights into the function of these immune 
cells often called “macrophage-like”(48), but whose role in viral infection 
remains elusive. 
Through the experiments performed in this thesis, we came across 
phenotypes that revealed some pathophysiological aspects. For instance, 
we observed in the abdomen of G9a mutants (chapter 3) the presence of 
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dark spots that are melanotic tumors (data not shown), more often reported 
in Jak-Stat mutant flies (49). It would have been interesting to determine 
when these tumors appeared, and whether they contribute to earlier 
lethality upon viral challenge. It was also consistently verifiable that G9a 
flies developed faster than their wild-type control flies. It seemed that they 
transitioned more rapidly from larval to pupal stages, possibly because of 
a dysregulation in their metabolism. Collaborators from the department of 
Genetics are currently investigating this observation, which ultimately could 
shed more light on the complex phenotype of G9a mutant flies. Additionally, 
in chapter 5, we analyzed the response of Sgroppino mutant flies to viral 
infection. For that project, an important observation was the accumulation of 
fat tissues in the abdomen of mutant, which could be an important cause of 
the enhanced sensitivity to infection. We are currently performing follow-up 
experiments that should help us to determine which aspect of metabolism 
is affected by Sgroppino deficiency.
Whereas early studies on Drosophila host defense have focused on the 
sensing and signaling molecules of canonical immune pathways, the field 
is progressively shifting towards a more integrated vision of immunity. The 
discovery that immune processes are themselves regulated by metabolism, 
hormones or circadian rhythms invites the use of more holistic approaches 
in the study of host-pathogen interactions (50-53). This seems particularly 
important in the study of tolerance, which is likely mediated, at least partly, 
by physiological processes. 
Fundamental open questions in insect immunity 
Pathogen sensing
Despite the fact that our understanding of immune signaling cascades 
improved over the last years, many important questions regarding sensing 
of viruses in insects remain to be addressed. First, putative cellular receptors 
that detect a virus infection and the nature of the detected viral molecular 
patterns should be identified. In mammals, the DEAD-box helicases RIG-I 
or MDA5, collectively known as RIG-I-like receptors (RLRs), are the major 
cytosolic receptors that detect viral RNAs (54). The closest homologue 
of the DEAD-box helicase domain of mammalian RLRs is the helicase 
domain of Dicer-2, which cleaves viral RNAs into small interfering RNAs 
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(10, 11, 55). More recently, genetic screens have found antiviral functions 
for additional DEAD-box helicases, such as DDX17 (also known as Rm62 in 
Drosophila (56)), which also exerts antiviral activity against arthropod-borne 
bunyaviruses in both insects and humans (57, 58). In mammals, several DNA 
sensors have been identified. Toll-like receptor 9, AIM2, and DAI interact 
directly with DNA molecules, and key adaptors like STING are essential 
for downstream immune signaling (59). However, no homologs have been 
identified in flies yet, and no Drosophila DNA sensor has been characterized 
thus far. 
Double-stranded RNA is readily detectable in cells infected with positive 
(+) and negative (-) sense RNA viruses, dsRNA viruses, and DNA viruses, 
but not in non-infected cells (60, 61). It is therefore not surprising that this 
viral PAMP is a potent inducer of innate antiviral responses in mammals. 
However, injection of dsRNA into insects does not induce an antiviral state 
(21, 62, 63). Thus in insects, dsRNA alone does not seem to suffice to initiate 
an inducible immune response and additional signals may be required for 
a robust immune response. For instance, induction of the antiviral gene 
Vago seems to require dsRNA sensing by Dicer-2, in addition to other virus-
induced signals that remain to be defined (64). 
The quest to understand the nature of the signals that trigger immune 
responses has occupied in the field of immunology for decades. The theory 
that the immune system could distinguish self from non-self has existed since 
the 1950’s (65). In the 1990’s, Polly Matzinger suggested a new paradigm 
for immune recognition, called the danger signal theory (66). Rather than 
recognizing pathogenic motifs, such as peptidoglycans or dsRNA, the 
immune system would distinguish the dangerous from the benign. Twenty 
years later, it is obvious that, rather than being mutually exclusive, those 
two visions of immune sensing are complementary (67). It may be that 
for efficient activation of any immune response, the signals identifying the 
class of pathogen at hand, as well as the associated “danger” need to be 
integrated. For instance, damaged cells from virus-infected tissues may act 
as or release danger signals that could activate an immune response, in 
addition to viral RNA sensing. In chapter 4, we describe the heat shock 
response as a novel immune pathway, but do not identify the molecular 
mechanisms underlying that function. Upon heat stress, the heat shock 
response is triggered by the accumulation of unfolded proteins. Possibly, 
the folding and accumulation of viral proteins in the cytoplasm during the 
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replication cycle could constitute a “danger signal” triggering the heat 
shock response. Additionally, it was suggested that heat shock proteins, 
themselves may be recognized as “danger signals” by the immune system 
(68, 69). Our observation that constitutive activation of the heat shock 
response protects against viral infection, and in some cases even leads to 
clearance is a strong incentive for further explorations. 
Antiviral effectors
It is well established that the activation of the Toll and Imd signaling 
pathway upon bacterial infection triggers release of antimicrobial 
peptides that inhibit bacterial growth (70, 71). However, the nature and 
function of antiviral effectors that are induced by Toll, Imd and Jak-Stat 
signaling remain unknown. Many reports, including our study in chapter 
3, report mild induction of antimicrobial peptides upon virus infection, 
but it is unclear whether they directly contribute to antiviral defense in 
Drosophila. It would be interesting to test whether double mutants in Toll 
and Imd pathways, which fail to express AMP genes (72, 73), are more 
sensitive to viral infection. Several studies have addressed this question in 
mosquitoes. High-throughput sequencing of the A. aegypti salivary gland 
transcriptome in response to DENV infection revealed a strong induction of 
a gene belonging to the Cecropin family (AAEL000598). The corresponding 
(chemically synthesized) peptide inhibited DENV replication in A. albopictus 
cells and Chikungunya virus replication in a human cell line (74). Ectopic 
expression of Defensin-A and Cecropin-A in the fat body of transgenic 
A. aegypti mosquitoes also inhibited replication of DENV, both in midgut and 
fat body (74, 75). An antiviral activity of AMPs or other downstream targets 
is also suggested by the observation that pretreatment of A. albopictus 
cells with heat-inactivated bacteria, which activate the Imd and Jak-Stat 
pathways, inhibited replication of SFV (34). Thus, AMPs seem to participate 
in antiviral responses in mosquitoes, yet, their mechanism of action remains 
unclear. AMPs in Drosophila directly target microbial invaders by disrupting 
bacterial and fungal membranes. This mechanism is unlikely to be active 
against non-enveloped viruses, such as CrPV and DCV, but may be active 
against enveloped viruses. Vertebrate AMPs (Defensins) can inhibit virus 
replication through various other means, such as inhibiting cell attachment 
or virus entry (76), and similar mechanisms may also play a role in antiviral 
immunity in insects.
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In mammals, a much wider set of virus-induced genes has been identified 
downstream of interferon signaling pathways, commonly referred to as 
Interferon Stimulated Genes (ISGs) (77). This large spectrum of ISGs is 
comprised of positive and negative regulators of interferon signaling, as well 
as antiviral effectors (77). A few of those regulators, such as Suppressor 
of Cytokine Signaling (SOCS) or STAT1/2 are well conserved in Drosophila 
(49, 78). However, thus far no ortholog of a mammalian antiviral ISG has 
been reported in Drosophila. Amongst the best characterized ISGs are 
the 2',5'-oligoadenylate synthetase (OAS)/RNase L and Protein Kinase 
RNA-activated (PKR). Detection of foreign cytosolic RNA by OAS leads to 
the synthesis of 2’-5’-oligoadenylates, which act as intracellular second 
messengers that activate the latent RNaseL. This leads to indiscriminate 
cleavage of RNA, both host and virus-derived (79). Upon sensing of dsRNA, 
PKR phosphorylates the alpha subunit of eukaryotic initiation factor 2 
resulting in a blockade of translation initiation, both for viral and cellular 
transcripts (80). Antiviral effectors with such functions have not been 
described in insect systems, but bioinformatic studies to find structural or 
functional similarities between insect and mammalian virus-induced proteins 
might be highly informative. Even though mammalian immunology profited 
greatly from fundamental studies in fruit flies, crosstalk will probably benefit 
both fields even more in the future. 
Resistance, Tolerance, and treatment of infectious 
diseases
Resistance and tolerance are two distinct and complementary host defense 
strategies. Understanding the biological processes that are critical for host 
survival is important for choosing therapeutic approaches. While resistance 
mechanisms are well characterized, those associated with tolerance are 
less so (81, 82). Nevertheless, manipulation of tolerance to improve health 
is already common practice in modern medicine (83). For instance, patients 
suffering of cholera often die of severe dehydration, and the primordial 
treatment against this pathology is the administration of electrolytes to 
maintain strong hydration levels (84). This increases tolerance levels, 
limits pathology, and allows that patients survive long enough for efficient 
activation of resistance mechanisms that directly target the pathogen. 
Bacterial meningitis is a disease in which tolerance is modulated directly 
by the administration of corticosteroids that diminish inflammation levels, in 
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combination with an antibiotic treatment that is directly aimed at reducing 
pathogen load. Usage of this combined treatment, modulating both 
resistance and tolerance, significantly decreases the risk of mortality and 
hearing loss associated with the pathology (85).
He
alt
h
Pathogen load
Increased 
tolerance
Increased 
resistance
I r  
tolerance
Figure 1 |  Resistance and tolerance in disease treatment. The tolerance curve 
described health in relation to pathogen load. Two treatment strategies 
can improve health: increasing resistance by reducing pathogen load, 
or increasing tolerance without affecting pathogen load. Adapted from 
Schneider, D. & Ayres, J. (2008). 
A more systematic study of tolerance mechanisms could lead to better 
description of host defense, and ultimately to improved clinical practice 
(83). For this, rather than measuring only pathogen loads or patient fitness, 
both types of data should be combined in order to define a tolerance curve 
(Figure 1). It illustrates the notion that, to re-establish a healthy state, both 
tolerance and resistance can be increased. It was recently proposed that 
such curves could be used to determine whether sickness is caused by 
suboptimal resistance or tolerance, and to choose a personalized treatment 
on the basis of this knowledge (83) (Figure 1). 
Manipulation of immune tolerance, rather than resistance, is also predicted to 
differently affect evolution of pathogens, as it might prevent the emergence 
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A more systematic study of tolerance mechanisms could lead to better 
description of host defense, and ultimately to improved clinical practice 
(83). For this, rather than measuring only pathogen loads or patient fitness, 
both types of data should be combined in order to define a tolerance curve 
(Figure 1). It illustrates the notion that, to re-establish a healthy state, both 
tolerance and resistance can be increased. It was recently proposed that 
such curves could be used to determine whether sickness is caused by 
suboptimal resistance or tolerance, and to choose a personalized treatment 
on the basis of this knowledge (83) (Figure 1). 
Manipulation of immune tolerance, rather than resistance, is also predicted to 
differently affect evolution of pathogens, as it might prevent the emergence 
of resistant microorganisms (86). In the case of immune resistance, 
interactions between hosts and pathogens are generally driving co-
evolution of defense and counter-defense mechanisms. If a host develops 
an immune response that directly targets a pathogen, it may then evolve 
mechanisms to counteract or evade the response. Furthermore, as this 
selects for more resistant traits in the pathogen population, more effective 
immune mechanisms will subsequently emerge in the host population. 
Such co-evolutionary relationships will most likely drive the emergence of 
highly resistant microorganisms. In contrast, such selective pressures are 
not predicted to exist in cases where the host increases its tolerance to the 
pathogen. Because tolerance reduces the negative impact of an infection 
on the host, it is likely to have neutral, if not positive effects, on the pathogen 
(87, 88). It might allow the pathogen to persist longer in the host, and improve 
its prevalence and spread. 
Mechanisms that improve tolerance are therefore not predicted to lead to 
the emergence of resistant strains and might provide a basis for therapy that 
can be used for longer periods of time (89). However, the type of tolerance 
mechanisms that could be used for drug development must be carefully 
chosen. As some of them are directly linked with resistance mechanisms, 
and maybe even inversely correlated, their manipulation could affect both 
branches of host defense, and lead to unpredictable outcomes. This once 
more highlights a strong need for immunologists to gain better insights into 
the mechanisms of tolerance. 
Future directions
Studies on the fundamental processes governing innate immune responses 
using the Drosophila model have made important contributions to our 
knowledge about host defense over the last 20 years. While early studies 
focused on deciphering molecular components of canonical immune 
pathways, such as Toll and Imd, the field is now shifting towards more global 
studies that integrate physiological, hormonal, or metabolic factors in immune 
studies. Additional parameters, such as the choice of pathogen infection 
route recently gained importance, as they seem to affect experimental 
outcomes more than previously anticipated. For both Drosophila and 
mosquito studies, it will be important to diversify and optimize such 
experimental set-ups. The rapid development of CRISPR/Cas9 technology 
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in both systems offers great promise for the future of insect immunology. 
The ability to not only edit, but also fine-tune and reprogram the genome 
will surely be of primordial importance in gaining deeper insights into host 
defense. Hopefully, characterization of novel immune sensors, antiviral 
effectors, and tolerance mechanisms will stay a research focus in insects 
and mammals, and provide additional ways to control diseases and improve 
global health. 
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Summary 
When facing a problem in daily life, one can use different strategies to solve 
it: directly eliminating its source, or minimizing the damage it causes. A 
parallel can be drawn with the immune system and the methods it uses 
to combat microbial infections. The first strategy, called resistance, is well 
studied and incorporates all mechanisms that mediate pathogen recognition 
and elimination. The second defense mechanism, termed tolerance, is 
studied in a less methodical manner. It includes all the processes that 
reduce the negative impact of infections on a host. The fruit fly Drosophila 
melanogaster is a powerful tool for uncovering fundamental aspects of host 
defense. The wide array of genetic tools and a high degree of conservation 
of innate immune processes with mammals enabled major discoveries in 
immunology over the last 20 years. The main goal of this doctoral research 
was to gain insights into mechanisms of tolerance and resistance upon viral 
infection in Drosophila. 
In the introductory chapter (chapter 1), we discuss the importance of 
insect immunity in the context of global human health and epidemics 
caused by pathogenic viruses that are transmitted by insect vectors. For 
example, according to the World Health Organization, 3.9 billion people are 
at risk for infection with Dengue virus, which is transmitted to humans by 
Aedes mosquitoes. Novel vector control tools, other than insecticides that 
ultimately give rise to resistance, are urgently needed to counteract arboviral 
epidemics. Deeper insights into vector biology and immunology will surely 
be instrumental in such an enterprise. In addition to RNA interference, which 
is a well-established antiviral defense mechanism in insects, several antiviral 
immune processes have been discovered over the last decade. Those 
comprise canonical immune signaling pathways such as Toll, Imd and Jak-
Stat, but also additional cellular mechanisms like autophagy. We also review 
the critical role of endosymbionts, such as Wolbachia, and gut microbiota 
that have recently been suggested to affect host defense. 
For functional analyses of antiviral resistance and tolerance mechanisms, 
reliable, reproducible, and well-controlled experimental procedures are 
needed. In chapter 2, we provide guidelines for such experiments and 
describe protocols for preparation of fly and virus stocks, inoculation of 
flies, and analyses of survival and virus production. When analyzing the 
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literature, we noted a lack of uniformity and reproducibility between results 
obtained by different research groups. The causes of these inconsistencies 
are not obvious, but may be partially due to confounding factors that were 
recently described. Indeed, infection with persistent viruses and Wolbachia, 
and the presence of single nucleotide polymorphisms (SNPs) in genomic 
loci such as Pastrel, may affect the response to virus infection; methods to 
address these issues are described. Finally, we provide recommendations 
for sample sizes and controls necessary for correct statistical analyses and 
data interpretation.
In chapter 3, we describe a novel mechanism for tolerance to viral infection 
in Drosophila. The study focuses on G9a, an enzyme that catalyzes 
dimethylation of the lysine 9 residue of histone 3 (H3K9), an epigenetic 
signature generally associated with transcriptional repression. G9a-deficient 
flies are highly sensitive to RNA virus infection, but, to our surprise, did not 
harbor higher viral replication. No major immunodeficiency was detected in 
G9a mutants; on the contrary, transcriptome analyses revealed that they 
overexpressed a subset of virus-induced genes, especially those controlled 
by the Jak-Stat signaling cascade. Using chromatin immunoprecipitation 
assays, we demonstrated that G9a epigenetically regulates Jak-Stat-
dependent genes, and dampens their expression to prevent exuberant 
immune responses. To assess whether the hyperactivation of Jak-
Stat signaling was, at least partially, responsible for the hypersensitivity 
phenotype of G9a mutant flies, we ectopically activated Jak-Stat signaling 
in adult flies. Indeed, we found that Jak-Stat hyperactivation resulted in early 
lethality to virus infection and therefore mimicked the phenotype of G9a 
mutant flies. Overall, we demonstrate that epigenetic control of Jak-Stat 
signaling by G9a restrains antiviral immunity, prevents immunopathology, 
and therefore constitutes a novel tolerance mechanism. 
Several transcriptome analyses on virus-infected Drosophila have been 
published over the last years, including our own study in chapter 3. 
Almost all of them report the induction of the heat shock response upon 
infection, without assessing its actual contribution to antiviral immunity. In 
chapter 4, we further analyze the activation of the heat shock response 
in vivo and in vitro upon infection with a range of DNA and RNA viruses. 
Both heat shock proteins (HSPs) and the heat shock transcription factor 
that controls their expression (Hsf) exhibited different induction dynamics, 
depending on the viruses tested. Hsf-deficient flies did not exhibit defects 
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in classical antiviral defense pathways, but were hypersensitive to RNA 
virus infection. Intriguingly, ubiquitous overexpression of Hsp70 or Hsf in 
adult flies enhanced their resistance to virus infection. For a subset of flies 
overexpressing Hsf, viral loads were even reduced to undetectable levels. 
In summary, we provide in this chapter strong evidence that the heat shock 
response is a novel antiviral resistance mechanism. 
Exploiting the transcriptome data described in chapter 3, we performed 
a small-scale functional screen to uncover novel antiviral factors. Amongst 
them, we uncovered CG13091, that we later named Sgroppino. In chapter 
5, we demonstrate that Sgroppino-deficient flies are hypersensitive to virus 
infection, and in some cases, support higher levels of viral replication. In 
silico studies established a set of Drosophila genes that were homologous 
to human peroxisomal proteins, amongst which was Sgroppino. We tested 
this prediction by performing fluorescence microscopy in Drosophila S2 
cells, and confirmed that Sgroppino indeed colocalized with peroxisomes. 
These cellular organelles have mainly been studied in the context of lipid 
metabolism. Interestingly, we observed that Sgroppino-deficient flies had 
an increased body mass, and contained more fat tissue than wild-type flies. 
In addition, we showed that peroxisomes are involved in antiviral immunity. 
Depletion of peroxisome numbers via knock-down of Pex3, a component 
required for their biogenesis, increased sensitivity to virus infection. Together, 
our findings provide strong evidence that Sgroppino and peroxisomes are 
important factors for antiviral host defense. Future studies are needed to 
understand the basis of lipid metabolism deregulation in Sgroppino mutant 
flies, which may lead to a better understanding of the overall phenotype.  
In chapter 6, our findings are examined in a broader context, and discussed 
in the light of recently published literature. Future experiments and challenges 
are discussed as well. 
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Er zijn verschillende manieren om in het dagelijks leven een probleem op te 
lossen: de oorzaak van het probleem elimineren of de schade minimaliseren. 
Een parallel kan getrokken worden met de mechanismes waarmee 
het immuunsysteem microbiële infecties aanpakt. De eerste strategie, 
resistentie, omvat de mechanismes die de herkenning en verwijdering van 
micro-organismen verzorgen. In de tweede afweerstrategie, tolerantie, 
gedoogt het afweersysteem de indringer, maar voorkomt het dat de infectie 
schade veroorzaakt. Resistentie is uitgebreid bestudeerd, maar over 
tolerantie is weinig bekend. 
De fruitvlieg Drosophila melanogaster is een krachtig modelorganisme voor 
het bestuderen van fundamentele aspecten van afweer. Omdat aangeboren 
immuniteit evolutionair geconserveerd is, kunnen inzichten uit de fruitvlieg 
ook belangrijk zijn voor ons begrip van de afweer in zoogdieren. Geholpen 
door een breed repertoire aan experimentele tools, heeft onderzoek in 
Drosophila geleid tot belangrijke ontdekkingen in de immunologie. Het 
doel van mijn promotieonderzoek was om inzichten te verwerven in de 
mechanismes van tolerantie en resistentie tijdens virusinfectie in Drosophila. 
In de algemene inleiding (hoofdstuk 1) bespreken we het belang van 
insectenimmuniteit in de context van pathogene virussen die door 
bloedvoedende insecten verspreid worden. Een belangrijk voorbeeld is 
Dengue virus, dat verspreid wordt door vectormuggen van het geslacht 
Aedes. De Wereldgezondheidsorganisatie (WHO) schat dat er jaarlijks 
3.9 miljard mensen risico lopen op een infectie met Dengue virus. Omdat 
er geen vaccin of medicijn beschikbaar is, is vectorbestrijding de enige 
mogelijkheid om de verspreiding van het virus tegen te gaan. Aan het 
gebruik van insecticiden kleeft het risico van resistentie-ontwikkeling, en 
het is daarom belangrijk om nieuwe methodes voor vectorbestrijding te 
ontwikkelen. Gedetailleerde inzichten in vectorbiologie en immunologie 
zullen hiervoor belangrijk zijn. Naast het antivirale RNA interferentie (RNAi) 
mechanisme, is er de afgelopen jaren een aantal antivirale afweerreacties 
beschreven. Hieronder zijn cellulaire routes voor signaaloverdracht, zoals 
Toll, IMD en Jak-Stat, maar ook intracellulaire mechanismes zoals autofagie. 
In dit hoofdstuk bespreken we deze mechanismes en beschrijven we recente 
studies die suggereren dat endosymbionte bacteriën, zoals Wolbachia en 
de darmflora, de afweer tegen virussen beïnvloeden. 
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Voor functionele studies naar resistentie en tolerantie zijn betrouwbare en 
reproduceerbare procedures nodig. In hoofdstuk 2 geven we richtlijnen 
voor zulke experimenten en beschrijven we protocollen voor de bereiding 
van vlieg- en virusstocks, het inoculeren van vliegen, en de analyse van 
overleving en virusproductie. Studies van verschillende onderzoeksgroepen 
naar resistentie/tolerantie leverden in een aantal gevallen tegenstrijdige 
bevindingen op. Deze verschillen zijn niet eenvoudig te verklaren, maar 
zouden gedeeltelijk veroorzaakt kunnen worden door confounders (storende 
factoren) die recent ontdekt zijn. Bijvoorbeeld, infecties met persistente 
virussen, de intracellulaire bacterie Wolbachia, en genmutaties, zoals in het 
gen Pastrel, kunnen de immuunreactie op een virusinfectie beïnvloeden. We 
beschrijven in dit hoofdstuk methodes om met deze confounders rekening 
te houden. Tenslotte geven we aanbevelingen voor groepsgrootte en 
controles die nodig zijn voor statistische analyses en correcte interpretatie 
van resultaten. 
In hoofdstuk 3 beschrijven we een nieuw mechanisme voor tolerantie voor 
virusinfectie in Drosophila. In dit hoofdstuk bestuderen we het enzym G9a/
EHMT, dat verantwoordelijk is voor di-methylering van Lysine 9 op Histon-eiwit 
3 (H3K9), een epigenetische marker die geassocieerd is met transcriptionele 
repressie. G9a-deficiënte vliegen zijn zeer gevoelig voor RNA-virusinfectie, 
maar tot onze verbazing repliceerde het virus niet tot hogere titers. Deze 
vliegen hadden geen immuundeficiëntie, maar onze transcriptome analyses 
lieten zien dat een deel van de virus-geïnduceerde genen tot hogere 
expressie kwam, met name genen die gereguleerd worden door de Jak-Stat 
signaaloverdrachtsroute. Met behulp van chromatine immunoprecipitatie 
assays konden we aantonen dat G9a Jak-Stat-afhankelijke genen reguleert 
en hun expressie dempt om een te sterke afweerreactie te voorkomen. Om 
te analyseren of de hyperactivatie van Jak-Stat verantwoordelijk is voor de 
gevoeligheid van G9a-deficiënte vliegen voor virusinfectie, hebben we met 
behulp van genetische technieken de Jak-Stat pathway geactiveerd in 
volwassen vliegen. We vonden inderdaad dat Jak-Stat hyperactivatie vroege 
sterfte na virusinfectie veroorzaakt en dus het G9a fenotype nabootst. De 
resultaten in dit hoofdstuk tonen dus aan dat epigenetische controle van de 
Jak-Stat signaleringscascade door G9a de antivirale immuunreactie dempt 
en immunopathologie voorkomt. Epigenetische regulatie van Jak-Stat is dus 
een nieuw mechanisme voor tolerantie. 
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Een aantal transcriptome analyses van virus-geïnfecteerde fruitvliegen is 
recent gepubliceerd, waaronder onze studie uit hoofdstuk 3. Bijna al deze 
studies rapporteren de inductie van de heat shock respons na infectie, zonder 
het belang van de respons voor antivirale afweer verder te bestuderen. In 
hoofdstuk 4 hebben we deze respons bestudeerd tijdens in vitro en in 
vivo infectie met een aantal RNA- en DNA-virussen. Verschillende virussen 
induceren de expressie van heat shock eiwitten en de transcriptiefactor die 
hun expressie reguleert (Heat shock factor, Hsf ), met een virus-specifieke 
dynamiek. Hsf-deficiënte vliegen zijn hypergevoelig voor RNA-virusinfectie, 
maar hebben geen defect in klassieke afweermechanismes, zoals RNA 
interferentie en de Jak-Stat signaaloverdrachtsroute. Het verhogen van de 
expressie van Hsp70 of Hsf in volwassen vliegen, met behulp van genetische 
technieken, vergroot hun weerstand tegen virusinfectie. In een aantal van 
deze vliegen was de virusproductie zelfs ondetecteerbaar, wat suggereert 
dat de infectie volledig opgeruimd was. We concluderen dat de heat shock 
respons een nieuw antiviraal mechanisme in Drosophila is. 
Gebruikmakend van de transcriptome data uit hoofdstuk 3, hebben we een 
functionele screen gedaan om nieuwe antivirale factoren te identificeren. 
In deze screen hebben we het gen CG13091 geïdentificeerd, dat we later 
Sgroppino genoemd hebben. In hoofdstuk 5 laten we zien dat Sgroppino-
deficiënte vliegen zeer gevoelig zijn voor virusinfectie en dat dit in een 
aantal gevallen gepaard gaat met hogere virusproductie. Bioinformatische 
studies hadden voorspeld dat Sgroppino een ortholoog eiwit is van een 
humaan peroxisomaal eiwit. We hebben deze voorspelling getest met 
behulp van fluorescentiemicroscopie en vonden dat Sgroppino inderdaad 
in peroxisomen gelokaliseerd is. Deze cellulaire organellen zijn tot nog toe 
voornamelijk bestudeerd in relatie met het metabolisme van lipiden. In 
overeenstemming hiermee vonden we dat Sgroppino-deficiënte vliegen een 
hoger lichaamsgewicht hebben en meer vetweefsel bevatten dan controle 
vliegen. Daarnaast konden we aantonen dat peroxisomen een rol spelen 
in antivirale afweer. Hiervoor reduceerden we het aantal peroxisomen 
in de vlieg door het gen Pex3, dat belangrijk is voor de biogenese van 
peroxisomen, te inactiveren. Dit resulteerde in verhoogde gevoeligheid 
voor virusinfectie en hogere virusproductie. Deze resultaten laten zien dat 
Sgroppino en peroxisomen belangrijke factoren zijn voor afweer tegen 
virusinfectie. Verdere studies zijn nodig om het mechanisme voor de 
verhoogde gevoeligheid voor virusinfectie te ontrafelen. 
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In hoofdstuk 6 bediscussieer ik de resultaten uit mijn proefschrift in relatie 
tot de recente literatuur en bepreek ik uitdagingen en aanbevelingen voor 
vervolgonderzoek. 
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Résumé
Dans la vie de tous les jours, on dit souvent qu’un problème a plusieurs 
solutions. Pour le résoudre, on peut éliminer sa source, ou essayer de 
minimiser les inconvénients qu’il pose. Un parallèle peut être fait avec 
notre système immunitaire, et les stratégies déployées pour combattre les 
infections. La première stratégie est appelée « résistance ». Bien étudiée, 
elle comprend les mécanismes responsables de la reconnaissance et de 
l’élimination des pathogènes. La seconde, appelée « tolérance », est moins 
bien caractérisée. Elle décrit tous les processus qui réduisent l’impact négatif 
d’une infection sur l’hôte. La mouche à vinaigre Drosophila melanogaster 
est un organisme modèle très utile du l’étude fondamentale des réponses 
immunitaires. De nombreux outils génétiques ont été développés, et le fort 
degré de conservation des processus immunitaires entre la mouche et les 
mammifères (Y compris l’Homme) ont permis de nombreuses découvertes 
en immunologie ces 20 dernières années. Le but de ces recherches 
doctorales aura été de comprendre en plus amples détails les mécanismes 
sous-jacents à la résistance et la tolérance au cours d’une infection virale 
chez la drosophile. 
Dans le chapitre d’introduction (chapitre 1), l’importance de l’étude de 
l’immunité des insectes est discutée dans le contexte de la santé publique, 
et des épidémies causées par des virus pathogènes transmis par les 
insectes vecteurs. Par exemple, selon l’Organisation Mondiale de la Santé, 
3.9 milliards d’êtres humains risquent d’être infectés par le virus de la 
Dengue, transmis par les moustiques du genre Aedes, au cours de leur vie. 
De nouveaux moyens pour contrôler les insectes vecteurs de pathogènes, 
en plus des insecticides qui génèrent des résistances, sont nécessaires 
pour combattre ces épidémies. Une meilleure connaissance de la biologie 
des insectes et de leur immunité est nécessaire à cette opération. En plus 
de l’ARN interférence, qui est une branche bien caractérisée de la réponse 
antivirale chez les insectes, d’avantage de mécanismes de défense ont étés 
découverts durant la dernière décennie. Ceux-ci comprennent les voies de 
signalisation canoniques Toll, Imd et Jak-Stat, mais aussi des processus 
cellulaires comme l’autophagie. Sont aussi discutés, l’importance des 
symbiontes comme la bactérie Wolbachia, et de la flore microbienne 
intestinale dans les réponses immunitaires. 
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Pour l’analyse fonctionnelle des mécanismes de résistance et de tolérance 
aux virus, des procédures expérimentales qui sont fiables, reproductibles 
et bien contrôlées sont requises. Dans le chapitre 2, nous proposons un 
guide pour réaliser de telles expériences, et décrivons des protocoles pour 
la préparation des stocks de virus et de mouches, l’inoculation de ces 
dernières, et l’analyse de la survie et de la charge virale. En lisant les travaux 
publiés jusqu’à ce jour, nous avons remarqué un manque d’uniformité et 
de reproductibilité entre les résultats obtenus par différents groupes de 
recherche. Les raisons de ces disparités ne sont pas évidentes, mais 
pourraient être partiellement liées à des facteurs non contrôlés découverts 
récemment. En effet, l’infection des mouches avec des virus persistants 
et Wolbachia, et la présence de polymorphismes nucléotidiques (SNPs) 
dans des gènes tels que Pastrel, affectent les réponses antivirales. Des 
méthodes pour pallier à ces phénomènes sont décrites. Finalement, nous 
proposons aussi des recommandations quant aux tailles d’échantillons et 
contrôles nécessaires pour effectuer une analyse statistique correcte, ainsi 
qu’une juste interprétation des résultats. 
Dans le chapitre 3, nous décrivons un nouveau mécanisme de tolérance 
aux infections virales chez la drosophile. Notre étude se concentre sur G9a, 
une enzyme qui catalyse la diméthylation du résidu de lysine 9 sur l’histone 
3 (H3K9), une marque épigénétique généralement associée à la répression 
transcriptionelle. Les mouches déficientes pour G9a sont très sensibles 
aux infections avec des virus à ARN, mais, à notre grande surprise, n’ont 
pas une charge virale plus élevée que les mouches contrôles. Aucune 
immunodéficience majeure n’a été détectée chez les mouches mutantes 
pour G9a, au contraire, des analyses de transcriptomes ont révélées que ces 
mouches surexprimaient une catégorie de gènes généralement induits par 
une infection virale, appartenant à la cascade de signalisation Jak-Stat. En 
immunoprécipitant la chromatine, nous avons pu démontrer que G9a était 
un régulateur épigénétique de la voie Jak-Stat, qui avait pour fonction de 
réprimer l’expression de ces gènes afin d’éviter des réponses immunitaires 
exubérantes. Pour déterminer si la suractivation de la voie de signalisation 
Jak-Stat était, du moins partiellement, responsable de l’hypersensibilité des 
mouches mutantes G9a aux virus, nous l’avons activée ectopiquement dans 
la mouche adulte. En effet, cela provoqua une mort prématurée à l’infection 
virale, et représenta une mimique du phénotype observé chez les mouches 
mutées dans G9a. En conclusion, nous avons démontré que le contrôle 
épigénétique de la voie Jak-Stat par G9a module la réponse immunitaire, 
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évite l’immunopathologie, et ainsi représente un nouveau mécanisme de 
tolérance aux virus. 
Plusieurs analyses de transcriptome de mouches infectées par des virus 
ont été publiées ces dernières années, y compris celle présentée dans le 
chapitre 3. Presque toutes ces études décrivent l’induction de la réponse 
« heat shock » lors d’une infection virale, sans néanmoins en établir sa réelle 
contribution à l’immunité. Dans le chapitre 4, nous avons analysé l’activation 
de la réponse « heat shock » in vitro et in vivo, lors d’infections virales avec 
un panel de virus à ADN et ARN. Différentes dynamiques d’expression de 
protéines « heat shock », ainsi que du facteur de transcription « heat shock » 
sont décrites, et dépendent du virus testé. Les mouches déficientes pour 
le facteur « heat shock » se sont montrées hypersensibles aux infections 
avec les virus à ARN. Non sans surprise, les mouches surexprimants 
ubiquitairement ce même facteur se sont montrées bien plus résistantes à 
l’infection virale que les mouches contrôles. En plus, pour un sous-groupe 
de mouches surexprimants le facteur de transcription « Heat shock », la 
charge virale fût réduite à des niveaux indétectables. Pour résumer, nous 
apportons dans ce chapitre la preuve expérimentale que la réponse « heat 
shock » est un nouveau mécanisme de résistance aux infections virales.  
Finalement, nous avons utilisé les données de transcriptomique obtenues 
dans le chapitre 3 pour réaliser un criblage fonctionnel à petite échelle 
visant à découvrir de nouveaux facteurs antiviraux. Parmi eux, nous avons 
trouvé CG13091, que nous avons baptisé Sgroppino. Dans le chapitre 
5, nous démontrons que les mouches déficientes pour Sgroppino sont 
hypersensibles aux infections virales, et dans certains cas, contiennent une 
charge virale plus élevée. Des études in silico avaient déjà défini un groupe 
de gènes homologues aux protéines peroxisomales humaines, parmi 
lesquelles Sgroppino. Nous avons confirmé ce résultat chez la drosophile, 
en imageant dans la lignée cellulaire de drosophile S2 la localisation de 
Sgroppino dans les peroxisomes. Ces organelles ont surtout été étudiés 
dans le contexte du métabolisme des lipides. De manière intéressante, 
nous avons observé que les mouches déficientes pour Sgroppino avait une 
masse corporelle plus élevée, et contenaient d’avantage de tissus gras que 
les mouches sauvages. De plus, nous avons démontré que Sgroppino était 
nécessaire aux réponses immunitaires antivirales. La réduction du nombre 
de peroxisomes par le knock-down de Pex3, un facteur essentiel à leur 
biogenèse, a aussi provoqué un phénotype d’hypersensibilité aux virus. 
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Au final, nos résultats démontrent que Sgroppino, et ces organelles que 
sont les peroxisomes, sont des éléments essentiels à la réponse antivirale. 
D’avantages d’études seront nécessaires pour déterminer le mécanisme 
responsable de la dérégulation du métabolisme dans les mouches mutantes, 
ce qui contribuera à la compréhension globale du phénotype. 
Dans le chapitre 6, nos résultats sont débattus dans un contexte plus 
général, et à la lumière de récentes publications dans le domaine. Aussi, 
des défis et projets futurs sont discutés et proposés. 
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